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Abstract 
The purpose of this study was to evaluate the effectiveness of heart rate variability 
biofeedback (HRV BFB), a form of psychophysiological skills intervention, to improve athletes’ 
psychological response following an injury.  Further, to examine the effects of HRV BFB on 
self-efficacy, perceived stress and anxiety, pain management, and the psychological responses of 
injured athletes.  HRV BFB effects on athletes’ physiological indices including HRV, HR, and 
respiration rate were also assessed.  Participants were 32 athletes who had sustained a moderate 
to severe musculoskeletal sports injury, ranging in age from 18 to 36 years (Mage = 20.82, SD = 
3.41).  All participants were out of training and competition and engaged in a rehabilitation 
program.  This investigation was experimental in nature with a randomized, single-blinded study 
design.  Participants were randomized into one of three groups: HRV BFB Experimental group, 
HRV BFB Placebo group, or Control group.  Assessments of psychological outcomes and 
physiological indices were assessed at Baseline, Week 1, Week 2, and Week 3.  Compared with 
the participants in either the Placebo or Control groups, participants who received the HRV BFB 
intervention reported significantly greater reductions in psychological responses of devastation, 
reorganization, and isolation, (b) significantly greater declines in magnification regarding pain, 
(c) significantly greater improvements in LF HRV during rest, and (d) significantly greater 
declines in resting respiration rate.  The findings suggest that HRV BFB may hold potential to 
improve athletes’ psychological response after sustaining an injury and that it shows promise as a 
useful psychological skills intervention for injury rehabilitation.  
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Chapter 1: Review of Literature 
Participation in sport of any nature brings with it the possibility of athletic injury.  
Demonstrating this, Statistics Canada conducted a Community Health Survey, in which it was 
found that from 2009-2010, approximately 35% of injuries were a result of participation in sport 
and exercise (Statistics Canada, 2011).  Further, it was shown that amongst the population aged 
12 and over, sport and exercise was the leading cause of serious injury amounting to an 
overwhelming 1,470,000 incidents (Statistics Canada, 2011).  Hence, it appears that in sport, the 
occurrence of an injury is almost inevitable and depending on the type and severity of the injury, 
a lengthy rehabilitation period may ensue.  Rehabilitation, often comprised of physiotherapy, 
presents the athlete with many challenges, both physical and psychological.  Beyond the obvious 
physical limitations the injury evokes, the unsightly visual appearance, and physical therapy that 
follows, an injury can take a toll on an athletes' emotions and contribute to psychological distress 
in several ways.   
1.1 Psychological Response to Injury Theories 
While the physical aspects of an injury have and continue to be the focal point of injury 
research, a number of theoretical models have been adapted and deemed useful as frameworks 
for examining the psychological response to athletic injury (Walker, Thatcher, & Lavallee, 
2007).  For instance, Kubler-Ross (1969) constructed the Stage Approach to Grief Management 
through which it was proposed that grieving individuals experience and must deal with five 
emotional stages in a sequential order.  These stages include: denial, anger, bargaining, 
depression, and acceptance (Kubler-Ross, 1969).  Research on psychosocial responses to sport 
injury has provided partial support for this construct; however, certain stages (depression and 
anger) seem to be more prevalent amongst injured athletes than others (Walker et al., 2007).  In 
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order to address the limitations associated with the previous model, Wiese-Bjornstal, Smith, 
Shaffer, and Morrey (1998) constructed the integrated model of psychological response to the 
sport injury and rehabilitation process.  This model was centered on athlete’s cognitive 
appraisals, which are thought to influence ensuing recovery outcomes (Walker et al., 2007).  
Cognitive appraisals are considered to be processes in which an athlete perceives an 
event/situation as stressful and subsequently assesses the extent to which they are able to deal 
with the stress encountered.  The model proposed that in the occurrence of an injury, an athlete’s 
cognitive appraisal is influenced by both personal (e.g., personality, history of injury) and 
situational factors (e.g., level of competition, time of season).  Further, how the athlete appraises 
the injury will subsequently determine the athlete’s emotional and behavioural responses to the 
rehabilitation process (Wiese-Bjornstal et al., 1998).  To date, a large portion of the research 
surrounding the psychological response to athletic injury has been centered on the emotional 
responses evoked by injury.  However, Evans, Wadey, Hanton, and Mitchell (2012) examined 
the various stressors that triggered adverse emotions experienced by injured athletes and found 
that at onset of injury, a number of stressors are perceived as taxing including incapacitation, 
missed opportunities, loss of independence, and social comparison.  During the injury 
rehabilitation phase, stressors including lack of rehabilitation progress, loss of fitness, and fear of 
not being able to perform at pre-injury levels were cited (Evans et al., 2012).  This research was 
successful in highlighting the wide range of factors that can influence an athlete’s thoughts, 
emotions, and behavior during recovery.   
1.2 Psychological Impact of Injury 
In many cases, recovery can be a long and difficult process, where improvement gains are 
sluggish.  The result for many athletes, who do not recognize the extent and requirements of 
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rehabilitation, is a period of emotional distress and test of their mental toughness.  Injured 
athletes face many challenges throughout rehabilitation.  Cognitively, athletes need to understand 
the nature of the injury; emotionally, they must deal with numerous adverse emotions; and 
behaviorally, they must actively cope with their condition (Fisher, Scriber, Matheny, Alderman, 
& Bitting, 1993).   
It has been shown that injury rehabilitation, particularly the initial phase of sustaining the 
injury, is associated with the greatest mood disturbance and adverse emotionality (Tracey, 2003).  
The emphasis of an investigation by Tracey (2003) was examining the emotional response to the 
injury and rehabilitation process in college level athletes.  The findings demonstrated the 
dynamic and multidimensional nature of the psychological response to athletic injury and 
subsequent recovery.  Tracey (2003) described athletes as experiencing a “roller coaster” of 
emotions as they attempted to cope with their injury and the rehabilitation period they were 
confronted with.  Research has identified common feelings expressed by injured athletes, which 
may consist of anger, depression, frustration, decreased self-esteem, and feelings of helplessness.  
Athletes have also shown signs of being afraid, confused, worried, and anxious (Fisher et al, 
1993; Green & Weinberg, 2001; Tracey, 2003).  Furthermore, Sonestrom and Morgan (1989) 
found that the occurrence of an injury could negatively influence an athlete’s self-esteem, 
physical self-efficacy, and perceived competence in their physical ability.  Providing additional 
evidence for the emotional toll that an injury and subsequent recovery can have on athletes, it 
was demonstrated that clinician-based depressive symptoms in athletes with injuries surpassed 
those of healthy controls at 1 week post-injury, with symptoms persisting at 1 month following 
the injury onset (Appaneal, Levine, Perna, & Roh, 2009).  In terms of depressive symptoms and 
mood disturbances experienced by injured athletes, research has demonstrated a negative 
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relationship between athletic identity and adverse emotional impact after sustaining an injury.  It 
appears that highly competitive athletes are particularly vulnerable to experiencing psychological 
distress and mood disturbances associated with rehabilitation due to their sense of athletic 
identity being threatened (Brewer, 1993).   
In addition to the numerous unfavorable emotions and psychological impact that may 
occur following an injury, there is the obvious relationship between injury and the consequence 
of pain.  Research has indicated that pain and discomfort associated with injury can discourage 
athletes and prevent them from achieving their rehabilitation goals (Fisher et al., 1993).  Overall, 
it is clear that the experience of an athletic injury can be an extremely taxing period, consisting 
of both physical and psychological demands in order to achieve a successful recovery.  Further, 
it is apparent that the injury and subsequent recovery period has the potential to have a negative 
impact on the athlete’s emotions and psychological state.   
1.3 Positive Psychological Traits Associated with Injury Recovery 
Therefore, it is not surprising that researchers have begun to explore psychological 
factors associated with positive rehabilitation outcomes.  Various psychological traits and/or 
factors have been shown to be valuable in the recovery from an athletic injury.  Identification of 
these psychological traits regarded as beneficial to the recovery process is important in order to 
prevent athletes from demonstrating negative psychological responses to injury and 
rehabilitation.  For instance, Fisher et al. (1993) expressed the importance of encouraging 
athletes to increase their involvement in rehabilitation, have positive self-thoughts regarding 
recovery, and to remain motivated and confident.  Similarly, Manuel et al. (2002) found that 
positive stress and increased social support were associated with reduced depressive symptoms 
in injured athletes.  These findings speak to the importance of providing injured athletes with 
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support, and allowing them to feel proactive, informed, and involved in their rehab experience so 
that they can retain a certain degree of positive stress and uphold characteristics indicative of 
their ‘athletic identity’.  In a review of the literature, Brewer (1998) examined psychological 
traits associated with rehabilitation adherence and positive recovery outcomes.  Several factors 
have demonstrated a positive relationship with adherence including self-motivation, pain 
tolerance, task involvement, and mental toughness.  Further, traits such as attributing recovery to 
personally controllable factors, perceived ability to cope with the injury, emotional adjustment, 
instrumental coping and self-efficacy for rehabilitation have been shown to enhance adherence to 
rehabilitation (Brewer, 1998).   
A study investigating the relationships between self-efficacy, imagery use, and adherence 
during injury rehabilitation concluded that there was a moderate to strong relationship between 
self-efficacy and adherence (Wesch et al., 2012).  Self-efficacy refers to an individual’s belief in 
his/her ability to engage in a situation-specific behavior and obtain a desired outcome (Bandura, 
1986).  Wesch et al. (2012) advocated for the development of interventions to improve self-
efficacy in the injury rehabilitation environment, because of its potential to promote adherence 
and improve recovery outcomes.  Likewise, research conducted by Nicholls, Polman, and Levy 
(2010) indicated that there was a significant, inverse relationship between coping self-efficacy 
and both somatic and cognitive anxiety.  Coping self-efficacy can be defined as a person’s belief 
in his/her ability to implement strategies deemed beneficial in dealing with threats and managing 
reactions to stress (Bandura, 1997).  The ability to cope with the numerous stressors and elevated 
levels of negative affect experienced during rehabilitation clearly would be of benefit to the 
injured athlete.  This was further exemplified through research indicating that coping strategies 
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could help injured athletes manage mood disturbances and adverse psychological states 
associated with injury (Green & Weinberg, 2001; Udry, 1997).   
1.4 Psychological Skills Training 
Over the years, researchers have demonstrated the integral role of psychosocial factors in 
the occurrence of injuries and the subsequent recovery process (Brewer, Jeffers, Petitpas, & Van 
Raalte, 1994).  Further, researchers have strived to create awareness of the psychological impact 
an injury may have on injured athletes.  To manage the extent of negative affect following an 
injury, several researchers have investigated the influence of psychological factors and how these 
may affect an athlete's emotional state throughout their recovery.  Additionally, researchers have 
begun exploring the implementation of psychological strategies to assist individuals in their 
rehabilitation process; these include goal setting (Evans & Hardy, 2002), positive self-talk, stress 
inoculation training (Ross & Berger, 1996), cognitive restructuring, modeling (Maddison, 
Prapavessis, & Clatworthy, 2006), and imagery (Cupal & Brewer, 2001; Law, Driediger, Hall, & 
Forwell, 2006; Wesch et al., 2012).   
For instance, Evans and Hardy (2002) found that implementing a goal-setting program 
with injured athletes led to significant improvements in rehabilitation adherence and perceived 
self-efficacy.  Further, when examining the psychological responses of athletes post-injury, it 
was found that athletes showed significant reductions in dispirited, characterized by feelings of 
apathy and a loss of motivation, along with significant improvements in reorganization, 
characterized by feeling of confidence and sense of psychological recovery across time (Evans & 
Hardy, 2002).  Similarly, Ross and Berger (1996) implemented a stress inoculation training 
program with athletes undergoing arthroscopic surgery for meniscus injury.  Results indicated 
that those in the treatment group experienced significantly less postsurgical pain and anxiety 
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during the rehabilitation process, compared to their control group counterparts.  The potential 
benefits of psychological skills training interventions in the athletic injury rehabilitation setting 
was further demonstrated by Maddison et al. (2006) who provided athletes undergoing ACL 
reconstruction with a modeling intervention.  Findings demonstrated that those who received the 
modeling intervention reported significantly lower perceptions of expected pain preoperatively, 
greater self-efficacy for rehabilitation, and improved functional outcome scores compared to the 
control participants.  Additionally, Cupal and Brewer (2001) found that athletes undergoing ACL 
reconstruction who received a guided imagery and relaxation intervention experienced 
significantly less anxiety and pain than those in a placebo and control group.  Therefore, it 
appears that the implementation of psychological skills training interventions in a rehabilitation 
setting have the potential to assist athletes throughout their recovery and facilitate improved 
psychological and functional outcomes.   
Despite this, it appears that rehabilitation for injured athletes is still centered 
predominantly on the physical aspects of the injury, with a lack of attention being given towards 
intervention that facilitates the athletes psychologically throughout their rehabilitation and 
recovery.  This is surprising given the evidence, which has indicated that unnecessary injuries 
occur and that recovery can be compromised because of a failure to address psychological 
factors during the rehabilitation process (Cupal, 1998).  Use of psychological skills training 
interventions such as imagery, positive self-talk, relaxation, and goal setting have been shown to 
be positively correlated with healing times, successful rehabilitation, recovery rates, and 
satisfaction with rehabilitation (Cupal, 1998).  Furthermore, in a review of the psychological 
intervention in athletic injury rehabilitation literature, all rehabilitation interventions have been 
associated with at least one positive outcome, whether it be greater recovery of physical strength, 
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increased physical functioning, reduced pain, stress, and anxiety, or improved mood (Cupal, 
1998).  From these findings, it is clear that continued research into the development and 
implementation of psychological interventions during rehabilitation from sport injury should be 
encouraged.    
1.5 The Use of Heart Rate Variability Biofeedback and Related Physiology 
Another form of psychological skills training that has been shown to demonstrate 
considerable potential in a number of research environments, within the field of 
psychophysiology, is known as biofeedback (BFB).  Biofeedback modalities are applied to 
obtain self-regulation of bodily functions.  The goal of BFB is to increase voluntary control over 
the physiological processes that are otherwise outside one’s awareness, by using information 
about them in the form of an external signal or cue (Paul, Garg, & Sandhu, 2012).  Several 
methods of BFB have been used in both research and applied settings, including peripheral 
modalities (e.g., electromyography, electrodermal response, heart rate, skin temperature, blood 
volume pulse) and central modalities (e.g., neurofeedback or electroencephalography) (Pop-
Jordanova & Demerdzieva, 2010).  However, one modality of biofeedback that is of particular 
interest is heart rate variability biofeedback (HRV BFB).  Heart rate variability (HRV) refers to 
the beat-to-beat changes in the duration of RR intervals (RRIs) in the electrocardiogram (ECG).  
Further, HRV can be expressed as variability in the duration of interbeat intervals (IBIs) between 
consecutive heart beats (Lagos et al., 2008).  According to Appelhans and Luecken (2006), 
“HRV is a measure of the continuous interplay between sympathetic and parasympathetic 
influences on heart rate (HR) that yields information about autonomic responsiveness and, 
thereby represents the capacity for regulated emotional responding” (p. 230).  Additionally, HRV 
has been suggested to be a reliable assessment of autonomic function, an index of cardiovascular 
HEART RATE VARIABILITY BIOFEEDBACK 9 
adaptability, and lastly, as being indicative of autonomic or sympathovagal balance (Paul & 
Garg, 2012; Karavidas et al., 2007; Riganello, Garbarino, & Sannita, 2012).   
The heart is dual innervated by both, the sympathetic and parasympathetic branches of 
the autonomic nervous system (ANS).  These two branches are functionally opposing of one 
another, thereby exerting a regulatory effect on HR through influencing the activity of the 
sinoatrial (SA) node, the heart’s primary pacemaker (Appelhans & Luecken, 2006).  HR is 
increased through activation of the sympathetic branch of the ANS, which exerts an excitatory 
function over the SA node.  In contrast, activation of the parasympathetic branch of the ANS 
produces a decrease in HR through its influence on the activity of the SA node (Appelhans & 
Luecken, 2006; Lagos et al., 2008).  It has been suggested that through influencing cardiac 
activity, the two branches of the ANS regulate the duration of IBIs, with a slower HR having 
longer IBIs and a faster HR consisting of shorter IBIs (Appelhans & Luecken, 2006).  However, 
a healthy heart and its rhythm are influenced by a number of factors, both internal and external, 
therefore, the heart does not beat with absolute regularity. As influenced by the ANS, changes in 
HR can be a result of physiological indicators in attempts to maintain homeostasis, such as 
oxygen and carbon dioxide levels in the blood, blood pressure, body temperature, and respiration 
rate.  Further, HR is influenced by external factors such as behavioural and physical changes, 
consisting of exercise or fluctuating emotions (Lagos et al., 2008).  The ANS functions to 
maintain homeostasis in the human body, and as a result, responds to respiratory changes, 
thermoregulatory changes, and input from a number of visceral receptors through the interplay of 
its sympathetic (SNS) and parasympathetic (PNS) branches (Riganello, Garbarino, & Sannita, 
2012).  The SNS and PNS have been shown to interact antagonistically and therefore, activity of 
a particular branch becomes dominant under different situational demands and each exerts an 
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opposing effect on physiological arousal (Appelhans & Luecken, 2006).   
According to Appelhans and Luecken (2006), a flexible and healthy functioning ANS 
allows for physiological and emotional states to be altered in synchrony with changing 
situational demands, whereas, a less responsive ANS does not allow timely modulation of 
physiological and psychological states in response to a changing environment.  Similarly, with 
HRV deemed to be an indicator of autonomic and cardiorespiratory functioning, Wheat and 
Larkin (2010) proposed that higher HRV represents the autonomic nervous system’s ability to 
alter physiological arousal in accordance with situational demands, while low HRV has been 
related to decreased physiological responsiveness to changing environmental circumstances, with 
greater susceptibility to stress and disease.  Considered to be an indicator of impaired autonomic 
functioning, low HRV has been shown to be associated with a number of chronic illnesses and 
psychological health conditions such as coronary heart disease, heart failure, asthma, post-
traumatic stress disorder (PTSD), anxiety, depression, and fibromyalgia (Wheat & Larkin, 2010).  
In contrast, higher HRV has been shown to reflect improved adaptability of physiological 
arousal, in addition to a greater capacity for regulated emotional responding (Appelhans & 
Luecken, 2006). 
Hence, HRV BFB training is designed to produce increases in HRV and to improve 
autonomic reactivity (Hassett et al., 2007).  Through research, it has been demonstrated that 
changes in HR due to sympathetic activation take place rather slowly, whereas parasympathetic 
regulation on cardiac function has a very short response time, with changes in HR due to PNS 
activation occurring much faster (Appelhans & Luecken, 2006).  Therefore, the oscillations in 
HR produced by the parasympathetic and sympathetic branches occur at different rates or 
frequencies (Appelhans & Luecken, 2006).  In other words, the amplitudes of HRV in these 
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different frequency ranges are reflective of particular sources of autonomic control (Lehrer, 
Vaschillo, & Vaschillo, 2000).  According to Karavidas et al. (2007), HRV in the frequency 
range of 0.005-0.05 Hz, considered to be a very low frequency band, is under control of the 
sympathetic nervous system and may be indicative of thermal control, and baroreflex control of 
blood pressure (BP) through changes in total peripheral resistance.  HRV in the low frequency 
range, 0.05-0.15 Hz, is controlled by both sympathetic and parasympathetic branches of the ANS 
and may also reflect thermal control, and baroreflex control of BP through changes in heart rate.  
Lastly, HRV in the frequency range of 0.15-0.4 Hz, referred to as the high frequency band, is 
thought to be under control of the PNS and is related to respiratory activity (Karavidas et al., 
2007).   
It is clear that oscillations in HR can be a result of several internal mechanisms; however, 
a phenomenon known as respiratory sinus arrhythmia (RSA) is the variation in HR that 
accompanies respiration (Lehrer et al., 2000).  During inhalation, HR has been shown to 
increase, whereas during exhalation, it has been shown to decrease (Vaschillo, Vaschillo, & 
Lehrer, 2006).  Research has shown that in order for individuals to maximize their respiratory 
sinus arrhythmia, respiratory rates have to be reduced through paced breathing to approximately 
0.1 Hz, or roughly 6 breaths per minute (Lehrer et al., 2003; Vaschillo et al., 2006).  It has been 
proposed that through paced breathing at this frequency, resonance occurs within the 
cardiovascular system, thereby eliciting high-amplitude HR oscillations (Lehrer et al., 2000; 
Lehrer et al., 2003; Vaschillo et al., 2006).  Maximal amplitudes of HRV have been found to be a 
result of resonance occurring between cardiac rhythms associated with respiration, and those 
related to baroreflex activity (Vaschillo et al., 2006).  The arterial baroreceptors function to 
control changes in BP by evoking reflexes that result in either an increase or decrease in HR to 
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compensate for the shift in BP.  As stated by Vaschillo et al. (2006), “both HR and BP vary in 
the closed-loop, so that a change in either function causes a change in the other. However, HR 
reactions to BP shifts, as well as BP reactions to HR shifts are not instantaneous” (p. 130).  
Through breathing at the resonant frequency (~0.1 Hz), it has been found that HR oscillates 180° 
out of phase with BP, while HR and respiration oscillate in phase with each other (Lehrer et al., 
2003).  Therefore, when the individual inhales, HR increases, BP falls, and the baroreflex 
response results in a further increase in HR; on the contrary, when the individual exhales, HR 
decreases, BP rises, and due to baroreflex activity, there is a further decrease in HR (Lehrer et 
al., 2003).  Hence, researchers have determined that HRV BFB training, through paced breathing 
at one’s resonant frequency, produces resonance in the cardiovascular system, evokes high-
amplitude HR oscillations, and stimulates and exercises the baroreflexes, thereby improving 
modulation of autonomic activity (Lehrer et al., 2000).  McGrady (2007) suggested that the 
magnitude of an individual’s HRV signifies one’s ability to adapt to physiological and emotional 
changes due to HRV reflecting several mechanisms working together to maintain a sufficient 
level of cardiovascular activity.  Therefore, Wheat and Larkin (2010) suggested that HRV BFB 
training may strengthen an individual’s ability to manage stress through increased HRV.   
 In addition to the physiological mechanisms by which HRV BFB may produce 
improvements in HRV and a greater autonomic balance, thereby leading to beneficial effects,  
researchers have proposed a number of alternative mechanisms through which HRV BFB could 
yield beneficial effects and positive psychological outcomes (Karavidas et al., 2007; Hassett et 
al., 2007; Wheat & Larkin, 2010).  Paul and Garg (2012) suggested that HRV BFB training is a 
self-regulatory intervention, which may contribute to reductions in psychophysiological stressors 
and support optimal performance.  Further, Hassett et al. (2007) proposed that beneficial effects 
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seen through HRV BFB training may be a result of psychosocial processes rather than through 
solely physiological mechanisms.  Specifically, it was suggested that HRV BFB may produce 
effects through experiences of relaxation, stress reduction, and the individual being provided 
with the chance to become an active participant in treatment, which can enhance the patients 
perceived level of control and self-esteem (Hassett et al., 2007).  Karavidas et al. (2007) 
proposed that other possible mechanisms of HRV training may include symptom amelioration 
through increased attention to one’s breathing patterns and increased self-efficacy in self-
regulation of mood states.  Finally, Wheat and Larkin (2010) provided an explanation stating that 
individuals may employ the techniques acquired through HRV BFB training when experiencing 
an exacerbation of symptoms, which could explain clinical improvements without the 
accompanying physiological changes.  Therefore, beneficial effects of HRV BFB training may 
result from the coping skills obtained, stress management techniques utilized, relaxation 
strategies learned, and/or greater self-regulation achieved through increased awareness and 
control over breathing and HR. 
 HRV BFB is an emerging area of interest within the field of psychophysiology, and due 
to beneficial outcomes and encouraging results obtained in studies thus far; continued research 
implementing HRV BFB is warranted.  HRV methodologies have been shown to serve as a 
viable treatment option for an array of health conditions and as a form of alternative therapy or 
adjunct to more traditional medical interventions (Karavidas et al., 2007).  For this form of 
psychophysiological intervention, the benefits appear to outweigh the potential costs.  HRV BFB 
is noninvasive and safe with essentially no adverse side effects (Riganello, Garbarino, & Sannita, 
2012).  Further, BFB training and the related equipment is relatively inexpensive, the benefit/cost 
ratio has been shown to be high, and it allows individualized therapy/feedback providing 
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individuals with physiological information indicative of their own internal bodily rhythms 
(Lehrer et al., 2000; Riganello, Garbarino, & Sannita, 2012).  The following two sections will 
include an overview of previous research using this form of BFB training with both clinical and 
sport populations, respectively.  
1.6 Clinical Applications of HRV BFB 
 Several modalities of BFB have been used in clinical populations as a form of adjunct 
therapy to more traditional treatment options.  HRV BFB, in particular, has been of particular 
interest due to heart rate variability being an indicator of autonomic functioning and 
cardiorespiratory balance.  It is believed that a large number of chronic illnesses, both mental 
health conditions and physiological disorders, can be attributed to dysfunction of the autonomic 
nervous system (ANS).  Further, it has been demonstrated that a number of the symptoms 
associated with these chronic health conditions may be exacerbated by the imbalance between 
sympathetic and parasympathetic activity of the ANS.   
 For example, Karavidas et al. (2007) investigated the effectiveness of HRV BFB in the 
treatment of major depressive disorder (MDD).  To date, treatments for depression have been 
found to be costly, invasive, and with sub-standard outcomes.  Through research, it has been 
shown that reduced HRV has been linked to symptoms of depression, and this may be a 
consequence of autonomic dysfunction resulting in a state of elevated sympathetic activity (as 
cited in Karavidas et al., 2007).  As such, the researchers in this study hypothesized that an 
intervention targeting HRV in depressed patients may be effective as a treatment for symptom 
reduction.  Therefore, 11 individuals suffering from depression underwent ten weekly sessions of 
HRV BFB, with physiological and psychological indices being assessed at baseline and weeks 4, 
7, and 10.  Findings indicated that HRV BFB training led to increased HRV within the depressed 
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patients over the course of the weekly treatment sessions, and within sessions with LF HRV 
being higher at the end compared to the beginning.  In addition, heart rate was significantly 
reduced in patients at the end of the treatment compared to before undergoing BFB therapy.  
Lastly, depression severity and several neurovegetative symptoms of depression were 
significantly improved upon.  From the positive results obtained, it was concluded that HRV 
BFB might be a feasible therapy option for treatment of depression, associated with improved 
concentration and motivation, while reducing fatigue, loss of energy, and sleep disturbances 
(Karavidas et al., 2007).  However, due to the lack of a placebo and control condition, it cannot 
be ascertained that the reduction in symptoms was due solely to HRV BFB and not instead 
attributable to placebo effects or time passed.  
Therefore, Siepmann, Aykac, Unterdörfer, Petrowski, and Mueck-Weymann (2008) 
compared the effects of HRV BFB on autonomic function and mood in both depressed patients 
and healthy subjects.  The sample consisted of 14 depressed individuals and 12 healthy 
participants who received 6-sessions of BFB with paced breathing over a 2 week duration.  In 
addition, another 12 healthy subjects were assigned to an active control condition, in which they 
received BFB, but with no instruction or pacing stimulus.  Subjective ratings of mood, 
depression, and anxiety, in addition to HRV measurements, were administered at the beginning 
of the treatment (baseline), post-intervention (two weeks), and at a follow up (two weeks later).  
Findings demonstrated that depressed patients who received HRV BFB training significantly 
increased their HRV from baseline to follow up.  Further, depression symptoms and anxiety 
levels were significantly reduced in the depressed patients during BFB and at follow up 
compared to baseline.  In contrast, no such findings were indicated in either of the two healthy 
subject conditions, HRV BFB group or active control.  This research was successful in providing 
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additional evidence for HRV BFB’s efficacy as a treatment for depressive symptoms.  The 
researchers speculated that some of the benefits associated with BFB might have been obtained 
through HRV BFB training inducing relaxed concentration and emotional self-regulation in 
subjects (Siepmann et al., 2008).   
Further, Zucker, Samuelson, Muench, Greenberg, and Gevirtz (2009) examined the 
ability of HRV/ RSA BFB to serve as a treatment for Post-traumatic stress disorder (PTSD).  The 
researchers implemented an intervention where 38 participants were randomized into either a 
RSA BFB group or a progressive muscle relaxation group (PMR) and received treatment 
sessions over the course of four weeks.  Assessments of PTSD symptoms, depression, insomnia, 
and autonomic functioning were made pre-intervention and post-intervention.  It was 
hypothesized that patients in the RSA BFB condition would show greater improvements in 
PTSD symptomology, reductions in depression scores, and increases in HRV compared to those 
in the PMR group.  Findings supported this hypothesis as the RSA BFB group reported 
significantly greater reductions in depressive symptoms and subsequent increases in HRV.  
However, both groups demonstrated significantly reduced PTSD symptoms and showed signs of 
improvement in insomnia symptoms (Zucker et al., 2009).  Hence, it seems as though HRV BFB 
could be applied as an adjunctive therapy to standard treatments for a variety of psychiatric 
illnesses.  Also, it has the potential to serve as an intervention for improving upon traumatic 
stress and a variety of other symptoms.   
Researchers have also examined the effectiveness of HRV BFB in the treatment of 
various chronic health conditions such as asthma, heart failure, coronary heart disease, and 
fibromyalgia (Lehrer et al., 2004; Swanson et al., 2009; Del Pozo et al., 2004; Hassett et al., 
2007).  Lehrer et al. (2004) applied HRV BFB to a group of asthma patients to determine if it 
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could be used as an alternative treatment method, instead of relying solely on oral steroids and 
more traditional pharmacological treatments.  In this investigation, 94 asthma patients were 
recruited and randomly assigned into one of four treatment conditions; a) a full protocol of HRV 
BFB training with abdominal breathing through pursed lips with prolonged exhalation, b) HRV 
BFB only, c) placebo EEG BFB, or d) a waiting list control group.  Lasting ten weeks in 
duration, patients’ daily asthma symptoms, expiratory flows, HRV, medication use, and asthma 
severity levels were measured over the course of the intervention.  Encouraging results were 
obtained as both groups trained in HRV BFB demonstrated significantly greater reductions in 
medication consumption than their control and placebo counterparts.  In addition, HRV BFB 
appeared to produce significant decreases in airway resistance, and respiratory frequency, while 
increasing tidal volume and the patients’ HRV.  Lastly, asthma symptoms and severity improved 
an average of one full level for those in the HRV BFB and placebo groups.  Hence, Lehrer et al. 
(2004) concluded that HRV BFB could be used as a complementary therapy to reduce asthma 
severity and that it might lower dependence on use of oral steroids.  
In addition, Hassett et al. (2007) examined the effectiveness of HRV BFB for the 
treatment of fibromyalgia and associated symptomology.   It was suspected that HRV BFB may 
have provided added benefits to patients suffering from fibromyalgia beyond helping them with 
relaxation/stress management.  This study consisted of recruiting 12 women who all suffered 
from fibromyalgia, and were given the treatment option of completing 10 weekly sessions of 
HRV BFB.  In order to determine if HRV BFB was an efficacious, alternative treatment for 
fibromyalgia patients, physiological and questionnaire data (functioning, depression, pain, & 
sleep quality) were collected at sessions 1, 10, and at a 3-month follow up.  Findings were 
positive in nature and it appears through HRV BFB training, the patients were able to 
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significantly improve their overall functioning from baseline to 3-months follow up.  
Additionally, patients were found to have significant reductions in depression symptoms and 
self-reported pain.  Lastly, although not significant, there seemed to be a trend indicative of 
better sleep quality amongst the patients throughout the study.  The results obtained in this study 
provided evidence suggestive of HRV BFB’s potential as a successful treatment for 
fibromyalgia, while also speaking to the possibility of HRV BFB being used in pain management 
(Hassett et al., 2007).   
Regarding the idea of implementing HRV BFB as a treatment for pain management, there 
have been clinical demonstrations of the effectiveness of this intervention for the treatment of 
patients with chronic low back pain (Kapitza, Passie, Bernateck, & Karst, 2010), neck pain 
(Hallman, Olsson, von Schéele, Melin, & Lyskov, 2011) and for children experiencing chronic 
pain (Yetwin, 2012).  Further, an intervention employing pain coping skills with those 
undergoing knee arthroplasty was found to obtain encouraging results (Riddle et al., 2011).   
Kapitza et al. (2010) implemented an intervention comparing the effects of a non-
contingent respiratory BFB placebo group with a contingent BFB group in the treatment of 
chronic low back pain.  This study consisted of 42 patients with moderate chronic low back pain 
who were randomized into either a BFB contingent group or a non-contingent placebo.  The 
experimental protocol consisted of both groups completing 30-minutes of respiratory BFB 
training for 15 consecutive days, however, the pacing signal generated through the biofeedback 
instrumentation was not synchronized with the patient’s breathing depth and frequency for those 
in the placebo group.  A variety of assessments were completed both prior to beginning the 
intervention and upon completion of the treatment sessions.  These consisted of relaxation 
scores, pain measurements (i.e., pain diary, somatosensory profile, and psychopathology 
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questionnaires), and daily functioning.  When comparing results obtained between the two 
groups, real respiratory BFB training was found to produce greater relaxation, reductions in pain 
symptoms, and higher overall daily functioning (Kapitza et al., 2010).   
Similarly, Hallman et al. (2011) examined the effectiveness of HRV BFB in the treatment 
of chronic neck and shoulder pain.  The researchers were also interested in HRV BFB’s potential 
to improve upon the patient’s health-related quality of life, level of disability, stress, pain, 
anxiety and depression symptoms.  In this study, 24 patients were randomly assigned to either a 
HRV BFB or control group, where those in the BFB condition received ten weekly sessions of 
HRV BFB, while those assigned to the control group did not receive any prescribed treatment.  
Findings demonstrated that those in the HRV BFB group achieved significantly greater increases 
in LF HRV across sessions compared to their control counterparts.  Also, health-related quality 
of life indices (i.e., vitality, bodily pain, and social functioning) were significantly improved over 
time in the HRV group (Hallman et al., 2011).  Hence, it seems as though HRV BFB could be 
implemented as a psychophysiological intervention to help individuals manage their pain and 
learn effective coping techniques to aid in pain tolerance. 
1.7 Sports Applications of HRV BFB 
In the last decade, HRV BFB has been implemented as a psychophysiological 
intervention in a wide variety of sports for performance enhancement and emotional regulation.  
Many researchers have begun to examine the efficacy of BFB training as a potential mechanism 
to improve psychomotor performance, as well as cognitive and psychological domains associated 
with optimal performance outcomes.  The application of psychological skills training and 
subsequent research in the field has been around for some time, however, BFB has the distinct 
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advantage of allowing athletes the opportunity to become aware of the interdependent 
relationship which exists between the mind and body.   
Bar-Eli, Dreshman, Blumenstein, and Weinstein (2002) investigated the relationship 
between mental training with BFB and performance of young swimmers.  In this study, the 
researchers randomized 38 youth, competitive swimmers from two clubs into either an 
experimental or control group.  The experimental group underwent the first three phases of the 
Wingate five-step mental training program with biofeedback, in addition to their regular training, 
over the duration of the 14-week study.  This entailed introducing the athletes to self-regulation 
techniques, providing them with training using a BFB modality and finally, incorporating BFB 
training with simulated competitive stress (Bar-Eli et al., 2002).  The control group was only 
provided with relaxation strategies and told to continue their regular training for the course of the 
study.  Bar-Eli and colleagues (2002) found that the experimental group achieved significantly 
greater improvements in their swimming performance, with faster race times than their control 
group counterparts.  This led to the conclusion that mental training with BFB was advantageous 
to swimmers, and provided added training benefits over regular physical conditioning alone 
(Bar-Eli et al., 2002).   
Further, Raymond, Sajid, Parkinson, and Gruzelier (2005) were concerned with 
optimizing dance performances of 24 ballroom and Latin dancers.  Participants, all of whom 
were dancers on a college dance team, were randomly assigned to heart rate variability 
biofeedback, alpha-theta neurofeedback, or a no treatment control group.  It was hypothesized 
that the two experimental conditions would both impact the dancers’ performances in a positive 
manner, however the researchers believed that the effects would be associated with different 
performance criteria.  The dancers in both of the experimental conditions received ten sessions of 
HEART RATE VARIABILITY BIOFEEDBACK 21 
BFB training, which lasted roughly 20 minutes in duration.  Findings provided evidence that 
both neurofeedback and heart rate variability biofeedback improved dance performance, when 
compared to a no treatment control condition.  In addition, results indicated that those in the 
neurofeedback group achieved improvements in their timing, whereas biofeedback was shown to 
improve the subscale of technique (Raymond et al., 2005).  This research provided additional 
evidence suggesting the effectiveness of biofeedback for performance enhancement, and 
recommended its use alongside more conventional psychological interventions, such as guided 
imagery and relaxation training, in sport (Raymond et al., 2005).   
A case study conducted by Lagos et al. (2008) implemented HRV BFB with a 14-year-
old elite golfer to examine its effects on his mood, physiology, and subsequent performance on 
the golf course.  More specifically, Lagos et al. (2008) were interested if HRV BFB could be 
used as a strategy for helping young athletes to gain control of their emotions and regulate 
competitive anxiety.  The golfer in this particular study expressed concern and trouble dealing 
with stress and anxiety while competing and described frequently experiencing adverse 
physiological symptoms associated with his negative emotional states (increased heart rate, 
sweating, trouble breathing, etc.).  In attempts to provide a beneficial mental skills training 
intervention for the athlete, researchers implemented 10 weekly sessions of HRV BFB with the 
participant.  Findings were positive in nature and demonstrated successful outcomes in terms of 
psychological states, physiological functioning, and golf scores.  The subject expressed a 
dramatic improvement in feelings of depression, fatigue, anger, and anxiety after undergoing the 
BFB training.  Further, his total HRV and LF HRV increased during BFB training, in addition to 
his HF HRV, LF HRV, and total HRV improving across the sessions from baseline to 
completion of the treatment.  Improvements seen both psychologically and physiologically may 
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have assisted in his enhanced performance on the golf course, where he drastically reduced his 
score.  Overall, the results obtained in this study revealed that HRV BFB could be used to assist 
athletes with their mental game, giving them that important psychological edge associated with 
competition success.  However, due to being implemented with only one athlete, the researchers 
stated that future directions would entail applying HRV BFB with a larger sample size, varying 
ages, skill levels, and with a range of sports (Lagos et al., 2008).  
Paul, Garg, and Sandhu (2012) examined the effects of HRV BFB on psychomotor and 
performance skills in basketball players.  The investigation was found to have several strengths 
rooted in its experimental protocol and methodology, consisting of random assignment to 
conditions, a placebo and control group, double-blinded design, and a follow-up session.  
Participants recruited for this study were 30 basketball players who competed at the university, 
state, and national level.  Athletes included were between the ages of 18-28 years old, and were 
of mixed gender.  Participants assigned to the HRV BFB condition received ten sessions of HRV 
BFB training, lasting 20 minutes in duration each.  Those who were allocated to the placebo 
condition were shown motivational video clips for ten minutes daily on ten consecutive days.  
Lastly, there was a control group condition, in which the athletes did not receive any additional 
training, and simply continued their routine practice schedule.  The dependent variables were 
assessed pre-intervention (day 1), post-intervention (day 10), and at a 1-month follow up and 
consisted of psychological, physiological, and performance measures.  All three groups were 
found to exhibit improvements in concentration, reaction time, movement time, and shooting 
performance.  However, the HRV BFB group demonstrated significantly greater concentration, 
improved shooting performance, and faster movement times compared to those in either the 
placebo or control groups.  In addition, findings indicated that while all three groups showed 
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improvements in respiration rate, total HRV, LF HRV, and HF HRV over the duration of the 
intervention, lowered respiration rates and increases in heart rate variability were significantly 
greater in the HRV BFB group.  Within the HRV BFB group, total and LF HRV increased at the 
end of BFB training sessions, whereas HF HRV was seen to decrease post training.  From the 
findings, Paul and colleagues concluded that HRV BFB facilitated athletes in achieving a state of 
mental readiness, enhanced their ability to combat stress, and provided them with a better 
understanding of how to focus and concentrate in a competitive setting (Paul et al., 2012).  This 
study was successful in further demonstrating the efficacy of HRV BFB for performance 
enhancement, while also speaking to its effectiveness in helping athletes to regulate and control 
stress and anxiety associated with competition.   
Similarly, Paul and Garg (2012) applied HRV BFB to 30 male and female basketball 
players who competed at a university, state, and/or national level.  As with previous research, the 
purpose of this investigation was to explore the effectiveness of HRV BFB on the performance 
psychology and emotional self-regulation of anxious basketball players.  The experimental 
protocol and design methodology implemented for this study was comparable to the previous 
research by Paul et al., (2012).  A double-blinded study design, randomization into conditions, 
inclusion of both placebo and control groups, and a 1-month follow up were all seen as strengths.  
Participants were randomly assigned to one of three groups; a HRV BFB group that received 
biofeedback training for 10 consecutive days, a placebo group who were shown motivational 
video clips for 10 days, or a control group who received no additional training.  Again, 
dependent variables consisting of psychological measures (anxiety, coping self-efficacy), 
physiological measures (HRV, respiration rate), and performance measures (dribbling, passing, 
shooting) were assessed at baseline (Day 1), post-intervention (Day 10), and at a 1-month follow 
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up.  Findings indicated that the HRV BFB group exhibited significant improvements in the 
psychological, physiological, and performance measures over the course of the intervention.  
Further, those in the HRV BFB group were seen to produce significantly greater improvements 
in anxiety, basketball performance skills (shooting, passing, dribbling), respiration, and HRV 
compared to those in the placebo and control groups.  In terms of coping self-efficacy, both the 
placebo and HRV BFB group achieved increases, and while not demonstrating statistically 
significant inter-group differences, the BFB group did seem to have greater coping scores.  
Through the observed findings, the researchers discussed the dynamic relationship that seems to 
exist between BFB training and improvements in self-efficacy and coping, which may help the 
athletes in dealing with adverse emotional states such as stress and anxiety.  It was concluded 
that training in HRV BFB provides the potential for self-regulation of arousal states, reduction of 
psychological stressors, and performance optimization (Paul & Garg, 2012).   
1.8 Potential for HRV BFB Interventions in the Athletic Injury Population 
Overall, it appears that the use of biofeedback, specifically HRV BFB, is an area of 
particular interest within the realm of psychophysiology.  Researchers have been successful in 
demonstrating its effectiveness in both clinical populations and in the sport environment.  
Findings have been positive in nature and have served to advocate for further investigations 
surrounding HRV BFB.  Although shown to be beneficial in a wide array of populations, 
research regarding the use of HRV BFB could be regarded as being in its preliminary stages, 
with much work to be done until its use, effects, mechanisms by which it operates, and full 
potential are fully understood.  Research completed to date has indicated that HRV BFB is a 
promising psychophysiological intervention.  In terms of its use in sport, HRV BFB has been 
implemented for performance enhancement and performance psychology.  Research has 
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demonstrated its efficacy for creating self-regulation of mood states for optimal performance, 
enhancing relaxation while reducing stress and anxiety, and for creating awareness of the 
interdependent relationship existing between an athlete’s physiological symptoms and their 
subsequent psychological state.  In clinical populations, research has shown the potential of HRV 
BFB to serve as an adjunct treatment for a wide range of medical conditions and chronic 
illnesses associated with autonomic dysfunction.  In this setting, HRV BFB interventions have 
been implemented as a means to improve upon autonomic dysfunction and with the goal of 
symptom reduction.  However, this form of psychophysiological skills training has yet to be 
extensively researched as a form of intervention to facilitate the injured athlete during their 
rehabilitation process.  More specifically, as a means to reduce the negative affect and emotional 
distress experienced by injured athletes, while enhancing psychological traits seen to be 
beneficial to a successful recovery with optimal outcomes, both physical and psychological.   
Paul et al. (2012) stated that HRV BFB has the potential to create an “optimal tuning 
between physiological, psychological, and psychomotor processes of the human body” (p. 39).  
Additionally, Paul and Garg (2012) concluded that HRV BFB could be used in the area of sport 
psychophysiology for purposes of emotional and cognitive restructuring.  Biofeedback offers a 
distinct advantage of providing individuals with physiological information indicative of their 
own internal bodily rhythms to aid them in relaxation, help them to self-regulate physiologically, 
and ultimately, allow them to cope better when faced with stressors.  In both clinical and sports 
populations, HRV BFB has been shown to enhance positive psychological states (relaxation, 
concentration, coping, self-efficacy) while reducing negative symptoms (anxiety, stress, fatigue).  
Injured athletes have been shown to experience similar emotions and mood states as a depressed 
individual with high anxiety and a negative mood disposition (Appaneal et al., 2009).  Again, 
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HRV BFB training has been shown to enhance physiological functioning, reduce depressive 
symptoms, and improve anxiety.  Injured athletes could benefit from learning how to control and 
manage their mood states better, which is a beneficial result that has been found through BFB 
training.  Consequently, HRV BFB could hold significant promise for interventions with injured 
athletes given its demonstrated efficacy for enhancing self-regulation of mood states and 
improving upon symptomatology in these other populations.  Furthermore, BFB has been used as 
a therapy in helping to treat pain and improve pain management, with promising results.  In light 
of these findings, it is possible that HRV BFB can also be used in the athletic injury setting as a 
strategy to help athletes reduce pain catastrophizing and improve their management of perceived 
pain.  
1.9 Purpose 
Given the genesis of the research study to evaluate the effectiveness of HRV 
biofeedback, a form of psychophysiological skills training intervention, to improve athletes’ 
psychological response following an injury, the purpose was to examine the effects of HRV BFB 
training on self-efficacy, perceived stress and anxiety, pain management, and the psychological 
responses of injured athletes.  HRV BFB effects on athletes’ physiological indices including 
HRV, HR, and respiration rate were also assessed.  
1.10 Hypotheses 
Hypothesis 1. It was hypothesized that injured athletes who received the HRV BFB 
intervention would demonstrate significantly greater improvements in psychological outcomes 
pertaining to injury and rehabilitation across time than injured athletes who were not provided 
with this form of intervention (i.e., HRV BFB Placebo group and Control group).  Specifically, it 
was hypothesized that the HRV BFB Experimental group would report significantly greater 
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increases in perceptions of self-efficacy and reorganization, significantly greater decreases in 
perceived stress, anxiety, and pain, significantly greater reductions in psychological responses of 
devastation, feeling cheated, restlessness, and isolation, and finally, significantly greater declines 
in pain catastrophizing and disability due to pain over time, compared to both the HRV BFB 
Placebo group and Control group. 
 Hypothesis 2. It was hypothesized that injured athletes who received the HRV BFB 
intervention would demonstrate significantly greater improvements in physiological indices 
corresponding to BFB training than injured athletes who were not provided with this form of 
intervention (i.e., HRV BFB Placebo group and Control group).  Specifically, it was 
hypothesized that the HRV BFB Experimental group would demonstrate significant increases in 
both time-domain (e.g., SDNN) and frequency-domain (e.g., Total HRV, LF HRV, HF HRV) 
measures of HRV, and significant declines in HR and respiration rate over the duration of the 
study, compared to both the HRV BFB Placebo group and Control group.   
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Chapter 2: Methods 
 The following chapter will describe the (a) participants who were recruited to take part in 
the current investigation, (b) research design, (c) study procedures, (d) intervention delivery, (e) 
measures used, and lastly (f) equipment and technical procedures. 
2.1 Participants 
 Eligibility criteria. Participants recruited for this study were individuals who had 
sustained a moderate to severe musculoskeletal sports injury (Fuller et al., 2006), preventing 
their participation in training and competition for their respective sport.  A moderate sports 
injury is classified as an injury with 8-28 days elapsing from the date of injury to the date of the 
player’s return to full participation in team training and competition. A severe sports injury is 
classified as an injury, which may extend up to 428 days from the date of injury to the date of the 
player’s return to full participation in team training and competition (Fuller et al., 2006).  
Eligibility criteria included: (a) participants to be at least 16 years of age, (b) injuries to have 
occurred during participation in sport/athletic activity, (c) participants to be out of practice and/or 
competition for the sport in which the injury occurred, (d) participants to be undergoing 
rehabilitation for the injury (e.g., physiotherapy, massage therapy, athletic therapy) and (e) 
participants to be athletes involved in sport at a competitive level (e.g., regional, rep, varsity, 
provincial, national) and/or to be engaging in sport in a competitive environment (e.g., adult 
competitive league, training for specific events, road races, competitions, etc.).  Exclusion 
criteria included any volunteers with known medical disorders and/or heart abnormalities  (e.g., 
cardiac arrhythmia) that would impede them from performing the biofeedback procedures.  
Volunteers were excluded from study participation if they had a history/current diagnosis of 
psychosis, coronary artery disease, heart disease, heart failure, hypertension, chronic low blood 
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pressure, and/or kidney disease.  Volunteers receiving formal training in any form of relaxation, 
biofeedback, or breathing technique, and/or any volunteers receiving another psychological 
intervention of any kind were also excluded.  Eligibility criteria were assessed by way of self-
report through a recruitment email and subsequently a demographics questionnaire at baseline.   
 Sample. Participants were 32 athletes who had sustained a moderate to severe 
musculoskeletal sports injury, met eligibility criteria, and agreed to participate.   Due to four 
participants withdrawing from the study, the final sample was 28 (see Figure 1).  Participants 
ranged in age from 18 to 36 years (Mage = 20.82, SD = 3.41), with a greater distribution of males 
(n = 19; 67.9%) than females (n = 9; 32.1%).  The sport/athletic activity in which the injury 
occurred varied among the participants with eight different sports being cited.  The 
sports/athletic activities reported and number of participants whose injuries occurred in each 
were as follows: soccer (n = 8), football (n = 6), hockey (n = 6), rugby (n = 4), baseball (n = 1), 
basketball (n = 1), cheerleading (n = 1), and ultra-marathon running (n = 1).  At the time of 
injury onset, all participants were athletes involved in sport at a competitive level, majority being 
university varsity athletes (n = 25), but also including a provincial junior B athlete (n = 1), and 
competitive recreational athletes (e.g., adult competitive league, training for specific events) (n = 
2).  Types of injuries (i.e., location on body) sustained by participants included the knee (anterior 
or posterior cruciate ligament, medial or lateral collateral ligament, meniscus; n = 12), hip (n = 
5), ankle (n = 5), shoulder (dislocations; n = 2), and other (fractured fingers, groin strain, 
sprains; n = 4).  78.6% of participants (n = 22) had a previous history of athletic injury, with 
25% (n = 7) reporting four or more previous injuries, 21.4% (n = 6) reporting three, 14.3% (n = 
4) reporting two, and 17.9% (n = 5) reporting one, while only 21.4% (n = 6) reported never 
having sustained an injury before and/or no prior injury history.  At time of recruitment, 
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participants were at varying stages of their rehabilitation, however, all participants were out of 
training and competition for their respective sports and engaged in a rehabilitation program.  For 
a complete overview of participant demographic information, see Table 1.  
2.2 Research Design 
This investigation was experimental in nature with a randomized, single-blinded study 
design.  A 4 (Time: Baseline, Week 1, Week 2, Week 3; assessments across time) x 3 (Group: 
HRV BFB Experimental group, HRV BFB Placebo group, Control group; experimental 
conditions) mixed model design was utilized to examine the emotional experience and 
psychological responses of injured athletes as they progressed through injury recovery.  Different 
groups were required in order to evaluate if athletes' psychological responses regarding injury 
and rehabilitation differed depending on the specific training they received.  Specifically, there 
was an experimental group, which received the allocated intervention, in order to examine the 
effects of HRV BFB on injured athletes’ psychological responses post-injury.  A placebo group 
was included in order to control for any expectancy effects (e.g., attention, social support, etc.) 
and to allow the researchers to differentiate between these and true training effects.  Finally, a 
control group to determine if either of the above conditions produced effects different from 
receiving no treatment at all was included.   
2.3 Study Procedures 
Recruitment methods. Injured athletes were recruited as study participants from varsity 
athletics programs at Wilfrid Laurier University via the athletic therapy clinic and from three 
clinics specializing in athletic injury rehabilitation in the Kitchener-Waterloo vicinity.  Head 
athletic therapists, sport medicine doctors, and physiotherapists at these locations were informed 
regarding the study details and provided with a letter of information (see Appendix A).  All of 
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these individuals were gracious enough to assist with study recruitment by way of notifying any 
clients who may have met eligibility criteria of potential study participation.  Recruitment posters 
(see Appendix B) and participant letters of information (see Appendix C) were utilized to inform 
potential participants of the study parameters at these locations.  For study purposes (i.e., due to 
there being three separate experimental groups), the initial recruitment posters and information 
letters only partially disclosed the study objectives to potential participants.  Having frequent and 
on-going communication with the head athletic therapists (ATs) for Wilfrid Laurier varsity 
athletics, face-to-face introduction often served as a primary recruitment tool.  After being 
introduced by the ATs, the potential participant would be provided with a brief introduction to 
the study requirements and a letter of information.  If interested in study participation, injured 
athletes completed a tear-off section on the letter of information on which the candidates’ name, 
injury, email, and phone number was given.  At this point, potential participants would be sent a 
recruitment email screening for eligibility (see Appendix D).  A second example of recruitment 
was when face-to-face introduction did not occur, but rather the ATs provided the letter of 
information and obtained the injured athletes contact information, passing it on to the researcher, 
Scott Rollo, with the athlete’s consent.  At this point, potential participants would be sent a 
recruitment email screening for eligibility.  Finally, a third example of recruitment was when 
interested individuals contacted the researcher themselves after viewing the recruitment poster 
and/or being given the letter of information, at which point they were screened for eligibility.   
Protocol. If deemed eligible for study participation, volunteers were randomly assigned 
to one of three groups; A) HRV BFB Experimental Group (i.e., full protocol with abdominal 
breathing through pursed lips and prolonged exhalation), B) HRV BFB Placebo Group, or C) 
Control Group (i.e., no treatment).  Randomization was implemented by way of randomly 
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selecting one of three group tags out of a hat for each participant who showed interest and met 
eligibility criteria.  A baseline (pre-intervention) visit would then be arranged, in which eligible 
participants were thoroughly informed regarding study details (e.g., purpose, assessments, 
protocol, etc.), and provided with an informed consent (applicable to their assigned group; see 
Appendix E-G) to complete if they wished to proceed with study participation.  After signing and 
providing informed consent, the participant was asked to complete a demographics 
questionnaire, followed by self-report questionnaires for baseline measurement of psychological 
outcome variables.  Those participants assigned to either the intervention or placebo groups were 
then introduced to the setting, equipment, and basic procedures of biofeedback.  Finally, a 
psychophysiological assessment was administered to obtain the participants’ baseline 
physiological data (i.e., HRV, HR, and respiration measures).  During this assessment, roughly 
20 minutes in duration, physiological data was recorded during two ten-minute tasks: 1) Task A 
– rest period in which participants were asked to relax as much as possible, and 2) Task B – a 
paced breathing exercise.  For the paced breathing task, participants were instructed to utilize the 
biofeedback information provided on the computer screen and match the rhythm of their 
breathing to a slowly oscillating respiratory pacer, set at six breaths-per-minute.  During the 
baseline session pre-intervention, meeting times for corresponding training sessions and weekly 
assessments were arranged according to the participants schedule and availability.   
Those participants assigned to the HRV BFB group received six BFB training sessions, 
involving instruction in paced breathing at one’s resonant frequency and with the goal of 
maximizing HRV, over the course of three weeks (approx. two sessions per week).  Participants 
randomized into the Placebo group also received six BFB training sessions over the three-week 
duration (approx. two sessions per week), however these individuals were not instructed to 
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breathe in a paced way or to maximize their HRV.  Individuals in this group still received the 
same on-screen physiological information through biofeedback, however, they were provided 
with no additional information, other than to relax and continue their normal breathing pattern.  
Participants randomly assigned to the Control group received no training of any kind over the 
duration of the study.  In order to increase session attendance and provide a form of incentive, all 
participants were given a $10.00 gift certificate to Tim Hortons at study completion.   
In addition to data collection during the baseline assessment, psychological outcome 
questionnaires and the psychophysiological assessment were administered at Week One (i.e., day 
eight), Week Two (i.e., day 15), and Week Three (i.e., post-intervention, day 22) (see Figure 2 
for an illustrated overview of the research protocol).  All biofeedback training and data collection 
sessions were conducted in the Physiology laboratory in the Athletic Complex at Wilfrid Laurier 
University, with an ambient room temperature (20° C - 25° C) and sound attenuation.  The study 
protocol was approved by the Research Ethics Board at Wilfrid Laurier University (see 
Appendix H), and written informed consent was obtained from all participants.  Upon study 
completion, all participants were debriefed and provided with an explanation as to what the true 
purpose of the study was (see Appendix I).  Importance of the initial deceit upon study 
recruitment was justified and why this was necessary to obtain meaningful results was explained.   
2.4 Intervention 
 HRV BFB experimental group. Participants randomized into the HRV BFB group 
received six HRV BFB training sessions over the course of three weeks (approximately two per 
week), lasting roughly 30 minutes in duration.  The protocol designed by Lehrer et al. (2000) for 
HRV BFB training was implemented with these participants.  The BFB training sessions 
involved instruction in paced breathing at one’s resonant frequency with a specific emphasis on 
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maximizing HRV.  At the beginning of each session, the participant was asked to sit with their 
eyes closed in a semi-reclined position for five-minutes while attempting to relax and breathe 
normally.  After the initial resting period, allowing for the participant to get settled and clear 
their mind of any ‘noise’, participants were provided with 20 minutes of HRV BFB training.  In 
the first session, the participants were taught to breathe at their resonant frequency.  The resonant 
frequency was determined by asking the participant to breathe at variable respiratory rates for 2 
minutes each (6.5, 6.0, 5.5, 5.0, 4.5 breaths/minute).  A “pacing stimulus” was provided on the 
computer screen to aid the participant in this task.  The resonant frequency was identified as the 
respiratory frequency yielding the highest low-frequency HRV on the moving Fourier power 
spectrum displayed by the AD Instruments LabChart Pro 7.0 BFB software.  Participants were 
then asked to practice breathing at their respective resonant frequency and to relax.  In 
subsequent sessions, the participants were trained how to breathe using pursed lips, abdominal 
breathing techniques with prolonged exhalation in order to elicit high amplitude oscillations in 
HR at their resonant frequency.  Participants were provided with BFB (i.e., physiological data) in 
numerous forms.  Utilizing the physiological data displayed (e.g., beat-to-beat heart rate display, 
respiratory activity, and respiratory pacer), participants were instructed to increase the amplitude 
of heart rate oscillations that occur in phase with respiration. Through providing these 
individuals with a HRV BFB training protocol and HRV biofeedback, the goal was to teach 
participants to self-regulate by increasing their awareness and control over their breathing and 
HR.   
In addition to in-session training, participants were instructed and encouraged to practice 
breathing at their resonant frequency for 20 minutes daily outside of training (e.g., at home, 
and/or when feeling stressed, etc.).  Participants could engage in this practice using a clock 
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and/or timer, or with the use of a respiratory pacer via a downloadable application available for 
many Smartphones.  More in-depth details of the training protocol for HRV BFB can be found in 
Lehrer et al. (2000).  Participants in this group were also asked to attend four data collection 
sessions (i.e., Baseline, Week One, Week Two, and Week Three).  Scheduling of these 
assessments occurred during the initial baseline session carried out pre-intervention.  During data 
collection sessions, these participants were asked to complete psychological outcome 
questionnaires and the psychophysiological assessment. 
 HRV BFB placebo group. Participants randomly assigned to the Placebo group also 
received six BFB training sessions over the three-week duration (approx. two per week), lasting 
roughly 30 minutes in length.  However, the BFB training sessions for these participants did not 
involve instruction in paced breathing at one’s resonant frequency or techniques to maximize 
HRV.  At the beginning of each session, the participant was asked to sit with their eyes closed in 
a semi-reclined position for five-minutes while attempting to relax and breathe normally.  After 
the initial resting period, allowing for the participant to get settled and clear their mind of any 
‘noise’, participants were provided with 20 minutes of BFB.  Participants in this group still 
received the same on-screen physiological information through BFB, however, they were 
provided with no additional information, other than to relax and continue their normal breathing 
pattern.  Participants in this group were also asked to attend four data collection sessions (i.e., 
Baseline, Week One, Week Two, and Week Three).  Scheduling of these assessments occurred 
during the initial baseline session carried out pre-intervention.  During data collection sessions, 
these participants were asked to complete psychological outcome questionnaires and the 
psychophysiological assessment. 
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 Control group. Participants randomly assigned to the Control group received no training 
of any kind over the duration of the study.  Participants in this group were only asked to attend 
data collection sessions (i.e., Baseline, Week One, Week Two, and Week Three).  Scheduling of 
these assessments occurred during the initial baseline session carried out pre-intervention.  
Completion of psychological outcome questionnaires and the psychophysiological assessment 
were the only tasks requested of these participants.   
2.5 Measures 
 Demographic information. All participants were asked to complete a demographics 
questionnaire (see Appendix J) that assessed background information including name, age, sex, 
history of athletic injuries, sporting involvement, the sport/athletic activity in which the present 
injury occurred, level of competition, current injury, time since injury, estimated time to return to 
play, and type of injury rehabilitation.  
Self-efficacy. The Athletic Injury Self-Efficacy Questionnaire (AISEQ; Milne et al., 
2005; see Appendix K) was used to assess the athlete’s self-efficacy for rehabilitation.  The 
AISEQ is composed of seven items that represent two types of self-efficacy; task self-efficacy 
and coping self-efficacy.  An example of a task item would be “I am confident that I can perform 
all of the required rehabilitation exercises.”  An example of a coping item is “I am confident that 
I can do my rehabilitation exercises even though I am feeling some discomfort.”  A scale ranging 
from 0% (no confidence) to 100% (completely confident) was used by participants to rate their 
perceived level of self-efficacy.  The AISEQ has demonstrated sound psychometric properties 
and reliability has been found to be acceptable (alphas: task efficacy = .76-.95, coping efficacy = 
.79-.90).  
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Perceived stress. The Perceived Stress Scale-10 (PSS-10; Cohen, Kamarck, & 
Mermelstein, 1983; see Appendix L) was used to assess the degree to which situations in an 
individual’s life are appraised as stressful.  The PSS-10 is a 10-item questionnaire, which is 
designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.  
Items are measured on a 5-point Likert scale, in which participants are asked to indicate how 
often they have felt or thought a certain way (0=never, 1=almost never, 2=sometimes, 3=fairly 
often, 4=very often).  The standard response time frame used in the current study was “In the last 
week . . .”  Example items on the PSS-10 are “how often have you felt nervous and “stressed”” 
or “how often have you been angered because of things that were outside of your control?”  The 
PSS-10 has adequate internal reliability with a Cronbach’s coefficient alpha = .90.   
 Psychological responses to sport injury. Participants’ psychological responses to athletic 
injury were assessed using the 19-item Psychological Responses to Sport Injury Inventory 
(PRSII; Evans, Hardy, Mitchell, & Rees, 2008; see Appendix M).  The PRSII measure is 
comprised of five subscales; devastation (i.e., reflects feelings of intense shock and emptiness), 
feeling cheated (i.e., reflects bitterness at being injured), restlessness (i.e., characterized by 
feelings of anxiety, guilt, and hostility), reorganization (i.e., represents increased confidence and 
a sense of psychological recovery), and isolation (i.e., represents feelings of isolation).  Items are 
measured on a 5-point Likert scale anchored at 5 (strongly agree) and 1 (strongly disagree).  
Each subscale score (with the exception of reorganization) ranges from a low of 4 to a high of 
20.  For reorganization, this equates to a low of 3 and a high of 15.  Example items on the PRSII 
are, “I feel as if I have been cheated by being injured” and “I am unusually anxious.”  Evans et 
al. (2008) provided evidence of content and predictive validity. Cronbach’s alpha coefficients 
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averaged over the time phases of injury were .82 for devastation, .75 for reorganization, .77 for 
feeling cheated, .85 for restlessness, and .72 for isolation. 
Anxiety. The State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch, & Lushene, 
1970; see Appendix N) was used to measure anxiety in the athletes.  The STAI is a self-report 
questionnaire, comprised of 40-items, which are measured on a 4-point Likert scale (1=not at all, 
2=a little, 3=somewhat, 4=very much so).  Consisting of two subscales, the STAI includes 20 
items to assess trait anxiety, and 20 items to assess situational anxiety.  For purposes of this 
study, only the items representing the state anxiety subscale were used.  The STAI has 
demonstrated test-retest correlations for the Trait Scale ranging from .73-.86, and for the State 
Scale ranging from .16-.54.  Reliability coefficients for the Trait Scale range from .86-.92, and 
for the State Scale range from .83-.92. 
Pain management. The Pain Catastrophizing Scale (PCS; Sullivan, Bishop, & Pivik, 
1995; see Appendix O) was used to assess the athletes’ level of pain catastrophizing through the 
degree to which various thoughts and feelings surrounding pain are experienced.  The PCS was 
designed to capture the extent of a patient’s negative or exaggerated orientation to pain and it 
addresses primary constructs of rumination, magnification, and helplessness (Sullivan et al., 
1995).  The PCS is a 13-item questionnaire with items being ranked using a 5-point scale, 
ranging from 0 (not at all) to 4 (all the time).  Examples of items on the PCS are “when I’m in 
pain, it’s terrible and I think it’s never going to get any better,” or “when I’m in pain, there is 
nothing I can do to reduce the intensity of the pain.”  The PCS has been demonstrated to have 
adequate to excellent internal consistency (coefficient alphas: total PCS = .87, rumination = .87, 
magnification = .66, and helplessness = .78). 
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Athletes’ subjective experience of pain during rehabilitation was measured using the 
Visual Analogue Scale (VAS; Keefe, Brown, Scott, & Ziesat, 1982; see Appendix P), which 
requires participants to rank the level of pain experienced on a 10-point scale ranging from “no 
pain” to “pain as bad as it could be”. 
Additionally, the impact of pain on daily functioning was evaluated through the use of 
the Pain Disability Index (PDI; Tait et al., 1987; Tait et al., 1990; see Appendix Q).  The PDI 
was designed to measure the degree to which aspects of life are disrupted by pain and disability.  
This questionnaire consists of seven subscales, each of which represents a different area of 
functioning: (a) family/home responsibilities, (b) recreation, (c) social activity, (d) occupation, 
(e) sexual behavior, (f) self-care, and (g) life support activity.  For each subscale, an 11-point 
scale ranging from 0 (no disability) to 10 (worst disability) measures the impact of pain and 
overall disability.  This index has shown a relatively high value for internal consistency (alpha = 
.86).  
Rehabilitation adherence. Athletes’ rehabilitation adherence was assessed using a 
measure designed by Milne et al. (2005) (see Appendix R).  Rehabilitation adherence was 
evaluated in three ways: the frequency that rehabilitation exercises were undertaken, the duration 
of these exercises, and the quality with which they were completed (Milne et al., 2005). 
Frequency of exercise was measured with two questions: “How often does your physiotherapist 
want you to do your rehabilitation exercises (e.g., once per day)?”, which indicates the 
prescribed frequency, and “How often do you actually do your rehabilitation exercises?”, which 
indicates the actual frequency.  Similarly, exercise duration also was measured with two 
questions: “How long (minutes) does your physiotherapist want you to spend on your exercises 
each time you do them?” (i.e., prescribed) and “How long (minutes) do you actually spend on 
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your exercises each time you do them?” (i.e., actual).  The percentage scores for frequency and 
duration of exercise were calculated by dividing the actual into the prescribed and multiplying by 
100; a score greater than 100% indicated that participants performed their rehabilitation exercise 
more frequently or for a longer duration than prescribed.  Quality of exercise was measured with 
one question: “What percentage (%) of the time do you believe that you perform your 
rehabilitation exercises correctly?’’  Milne et al. (2005) obtained face validity from four 
physiotherapists in the development phase of this adherence measure. 
Psychophysiological assessment. Prior to meeting for data collection at each of the 
weekly assessments, participants were reminded to refrain from caffeine, alcohol, eating large 
meals and engaging in heavy exercise beforehand.  For the psychophysiological assessment 
during data collection sessions, participants were asked to sit in a semi-reclined position while 
remaining comfortable and relaxed.  The purpose of this assessment period was outlined for the 
participant so they understood all instructions and the tasks being asked of them.  After providing 
any instruction required the respiration-monitoring belt, ECG sensors, and finger-pulse 
transducer were attached to the participant in the appropriate locations (see Equipment and 
Technical Procedures).  During this assessment, roughly 20 minutes in duration, physiological 
data was recorded during two ten-minute tasks: Task A – Rest Period and Task B – Paced 
Breathing Exercise.  For Task A, participants were instructed to relax as much as possible and 
breathe normally (i.e., normal resting breathing pattern and/or however was most comfortable) 
for a ten-minute period.  Following this, the participant completed Task B, a paced breathing 
exercise in which they were instructed to utilize the biofeedback information provided on the 
computer screen and match the rhythm of their breathing to a slowly oscillating respiratory 
pacer, set at six breaths-per-minute.  For both the resting period and the paced breathing exercise, 
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HRV time-domain and frequency-domain indices were calculated.  SDNN, which is the standard 
deviation of normal-to-normal intervals, was calculated.  pNN50, which is the percentage of 
successive normal inter-beat intervals which differ by 50 milliseconds (ms) or more, was also 
calculated by dividing the NN50 count by the total number of all NN intervals.  A spectral power 
analysis was administered over each of the tasks by means of a fast Fourier transformation 
(FFT).  Total power (Total HRV), and power values for two frequency bands, low-frequency 
(0.04-0.15 Hz; LF HRV) and high-frequency (0.15-0.4 Hz; HF HRV) were assessed.  For both 
tasks, the participants’ average heart rate (Mean HR; beats per minute) and average respiration 
rate (breaths per minute) were calculated. 
2.6 Equipment and Technical Procedures 
 All HRV BFB training sessions and psychophysiological assessments were administered 
using an AD Instruments PowerLab 26T biofeedback unit with LabChart Pro 7.0 software and 
the HRV module add-on (AD Instruments, Canada.).  Physiological indices were measured and 
amplified with the utilization of sensors, attached to participants via electrodes and a respiration 
strap, which were connected to the AD Instruments PowerLab 26T encoder.  The analogue to 
digital converter transforms the electrical signals (i.e., voltage) to digital conversion points, and 
physiological data is recorded into a computer to be processed, displayed, and analyzed by 
specialized AD Instruments LabChart Pro 7.0 BFB software.  During BFB training sessions and 
psychophysiological assessments, respiration, HRV indices, and HR as measured by cardiac 
activity (ECG) and pulse (beats per minute) were recorded.  Respiratory patterns were collected 
by use of a respiration-monitoring belt with sensors placed around the participant’s upper 
abdomen (see Figure 3), digitized at a rate of 256 samples/second.  HR and cardiac rhythm were 
measured using ECG sensors, connected to the participant via three electrodes placed on the 
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medial aspect of the participants’ forearms (one electrode placed on the right arm and two 
electrodes placed on the left arm) (see Figure 4), using a sampling rate of 2048 samples/second.  
HR was also calculated by way of a finger-pulse transducer inserted on the participant’s middle 
finger.  AD Instruments LabChart Pro 7.0 software offers numerous display screens for a variety 
of training and data reporting purposes.  The raw ECG signal, HR (pulse), instantaneous HR 
(beats per minute), an RSA graph, respiration rate and a respiratory pacer (for Task B and/or 
HRV BFB Experimental group training only) were presented to the participants during the 
psychophysiological assessments and HRV BFB training sessions (see Figure 5 for an image of 
the BFB display screen).  Indices of HRV (frequency-domain and time-domain variables) were 
calculated for data collection purposes.  Specifically, the time-domain HRV values, SDNN and 
pNN50, and frequency-domain values, LF HRV, HF HRV, and Total HRV were measured from 
the psychophysiological assessment.  All HRV raw data was edited before calculations were run 
to measure HRV indices, consisting of normalizing the IBI data and removing any artifacts 
within the recorded sessions.  First, R-wave detection settings were adjusted to detect all genuine 
beats by increasing the threshold enough to avoid unwanted peaks or “noise” in the sample or by 
decreasing the threshold to detect genuine beats that were missed.  If needed, beats were 
manually inserted in cases where true beats were missed or in the instance of abnormally large 
artifacts due to “noise” (i.e., equipment error).  After editing, analyses for all HRV indices were 
performed and values were entered into Microsoft Excel.   
 
 
 
 
HEART RATE VARIABILITY BIOFEEDBACK 43 
Chapter 3: Results 
 The following chapter includes a summary of the overall findings based on the original 
hypotheses.  Specifically, the chapter describes the stages of analysis by examining (a) data 
cleaning procedures and (b) statistical tests performed, followed by discussing (c) descriptive 
statistics, and (d) baseline measurements, as well as testing the specific hypotheses surrounding 
the influence of the HRV BFB intervention on (d) self-efficacy, (e) perceived stress, (f) 
psychological responses to sport injury, (g) perceived anxiety, (f) pain management, and (g) 
rehabilitation adherence.  Hypotheses surrounding the influence of the HRV BFB intervention on 
(h) physiological indices will also be tested. 
3.1 Data Cleaning Procedures 
Data analysis. Post data collection, all self-report psychological outcome questionnaires 
completed by participants at each of the four assessments (i.e., Baseline, Week 1, Week 2, Week 
3) were scored and values were entered into Microsoft Excel for each of the respective 
dependent variables.  With regards to the psychophysiological assessment, participants’ 
physiological indices were recorded during two ten-minute tasks (Task A & Task B) at each of 
the four assessments, producing eight ten-minute recordings for each participant.  As mentioned 
previous, raw data for each recording was analyzed and all HRV data was edited consisting of 
normalizing the IBI data and removing any artifacts within the recorded sessions.  R-wave 
detection settings were adjusted to detect all genuine beats, and if needed, beats were manually 
inserted.  After editing, analyses for all HRV indices were performed and values were entered 
into Microsoft Excel.  Participant’s average respiration rates for both tasks were calculated and 
these were entered into Microsoft Excel.  
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Removal of participants. Prior to data analysis, the removal of data from four 
participants was carried out.  Over the length of the study, there were four athletes who met 
eligibility criteria and agreed to participate, but subsequently withdrew from participation prior 
to study completion.  Specifically, two participants from the HRV BFB Placebo group withdrew 
from study participation after Baseline before Week 1, one participant from the HRV BFB 
Experimental group withdrew prior to Week 1, and one participant from the Control group 
withdrew prior to Week 1.  One participant did not provide reasoning for withdrawing, two cited 
time conflicts as a reason, and one cited personal reasons for doing so.   
Dealing with missing data. During data entry, all missing data points were coded by 
imputing a random numerical value (e.g., 200).  The statistical analyses performed on the data 
allowed for missing observations under a missing at random assumption. If a value for a 
dependent variable was missing for a participant at one or more assessments, the participant was 
subsequently excluded from the analysis for that variable. 
3.2 Statistical Analyses 
 Statistical analyses were performed using the Statistical Package for Social Sciences 
(SPSS) version 22.0.  There were two independent factors incorporated into this study design.  
The repeated-measures independent variable was data collection sessions (i.e., assessments 
across time) and the between-group independent variable was the three experimental conditions 
(i.e., group).  An analysis of variance (ANOVA) with a 4x3 mixed-model design was conducted 
for each dependent variable to assess for both within-subjects (i.e., Baseline, Week One, Week 
Two, and Week Three) and between-subjects (i.e., HRV BFB Experimental Group, HRV BFB 
Placebo Group, and Control Group) effects.  Specifically, to test for differences between groups 
across time with respect to psychological outcome questionnaire scores and psychophysiological 
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assessment measures.  Simple contrasts with Baseline as the reference category were run for 
within-subjects time main effects and the time x group interaction.  Follow-up Tukey tests were 
run for the between-subjects main effect of group.  A P value < .05 was regarded as significant.  
Skewness and Kurtosis values by group were examined for each dependent variable across time 
and revealed reasonably normal distributions given sample size and parameters.  The assumption 
of sphericity occurs in repeated-measures ANOVAs with more than two levels.  Where 
Mauchly’s test of sphericity was violated, the Huynh-Feldt correction was used for reporting p-
values. 
3.3 Baseline Measurements 
 In order to assess for any group differences at Baseline pertaining to both the 
psychological outcome questionnaire scores and psychophysiological assessment measures, a 
series of one-way ANOVAS were conducted for each variable.  These were mainly conducted 
due to the realization that on a number of the psychological outcome variables, group means for 
the HRV BFB Placebo group were noticeably different from either of the other two groups at 
Baseline.  From these analyses, although there were still concerns as to why the Placebo group 
appeared to be different at Baseline on a number of variables, it was confirmed that there were 
no statistically significant group differences other than for the psychological response to sport 
injury subscale of devastation, F (2, 25) = 4.07, p < .05.  For devastation, post-hoc Tukey tests 
revealed that the Placebo group was significantly lower in levels of devastation than the HRV 
BFB Experimental group at Baseline.  
3.4 Self-efficacy  
 Task. Table 2 contains the group means and standard deviations for perceived task self-
efficacy at Baseline, Week 1, Week 2, and Week 3, as measured by the AISEQ.  Results of the 
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analysis of task self-efficacy showed no significant main effect for time, indicating that task self-
efficacy scores for all groups remained relatively the same across time from Baseline to Week 3, 
F (2.22, 55.60) = 1.62, p = .21, η2 = .06.  The 4x3 mixed design ANOVA results revealed no 
main effect for group, indicating that there were no significant differences in task self-efficacy 
between groups, F (2, 25) = 1.63, p = .22, η2 = .12.  As can be seen by Figure 6, means for all 
three groups suggest that participants had high task self-efficacy and that this persisted across 
time for each group.   
Coping. Table 2 contains the group means and standard deviations for perceived coping 
self-efficacy at Baseline, Week 1, Week 2, and Week 3, as measured by the AISEQ.  Results of 
the analysis revealed a significant time main effect for coping self-efficacy, F (1.90, 47.41) = 
5.40, p < .01, η2 = .18.  Within-subjects contrasts showed a significant difference between 
Baseline and Week 3 reflecting a significant increase in participants level of coping self-efficacy 
between these two time phases, F (1, 25) = 4.98, p < .05, η2 = .17.  There was no significant 
Time x Group interaction found, F (3.79, 47.41) = .56, p = .68, η2 = .04.  The 4x3 mixed design 
ANOVA results showed no main effect for group, indicating that there were no significant 
differences in coping self-efficacy between groups, F (2, 25) = 1.50, p = .24, η2 = .11.  As can be 
seen by Figure 7, means for all groups suggest that coping self-efficacy was relatively high 
among participants at Baseline and further increased across time.   
3.5 Perceived Stress 
The means and standard deviations for perceived stress at Baseline, Week 1, Week 2, and 
Week 3 for each of the three groups are shown in Table 3. Results of the analysis revealed a 
significant time main effect for perceived stress, F (3, 75) = 5.95, p < .01, η2 = .19.  Within-
subjects contrasts showed a significant difference between Baseline and Week 3 reflecting a 
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significant decrease in participants level of perceived stress between these two time phases, F (1, 
25) = 12.13, p < .01, η2 = .33.  There was no significant Time x Group interaction found, F (6, 
75) = 1.63, p = .15, η2 = .12.  The 4x3 mixed design ANOVA results showed no main effect for 
group, indicating that there were no significant differences in perceived stress levels between 
groups, F (2, 25) = .92, p = .41, η2 = .07.  As can be seen by Figure 8, groups means suggest that 
perceived stress significantly decreased over time from Baseline to Week 3.  
3.6 Psychological Response to Sport Injury  
 Devastation. Table 4 contains the group means and standard deviations for the 
psychological response to sport injury subscale of devastation at Baseline, Week 1, Week 2, and 
Week 3, as measured by the PRSII-19.  Analyses of the subscales of the PRSII produced a 
significant time main effect for devastation, F (3, 75) = 12.87, p < .001, η2 = .34.  Within-
subjects contrasts revealed significant differences between Baseline and Week 1, F (1, 25) = 
4.41, p < .05, η2 = .15, Baseline and Week 2, F (1, 25) = 12.42, p < .01, η2 = .33, and Baseline 
and Week 3, F (1, 25) = 23.88, p < .001, η2 = .49, reflecting a significant decrease in participants 
level of devastation across the time phases.  Results of the analysis also produced a significant 
Time x Group interaction, F (6, 75) = 5.84, p < .001, η2 = .32.  This indicates that levels of 
devastation at the different time phases differed between groups.  To break down this interaction, 
contrasts were performed comparing each of the weekly assessments to Baseline across groups.  
These revealed significant interactions when comparing Experimental, Placebo, and Control 
group levels of devastation at Week 1 compared to Baseline, F (2, 25) = 4.90, p < .05, η2 = .28, 
Week 2 compared to Baseline, F (2, 25) = 6.63, p < .01, η2 = .35, and Week 3 compared to 
Baseline, F (2, 25) = 10.84, p < .001, η2 = .46.  Looking at the interaction graph, Figure 9, this 
suggests that decreases in devastation from Baseline to Week 1, Week 2, and Week 3 found for 
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the Experimental group were significantly greater than for either the Placebo or Control group.  
The 4x3 mixed design ANOVA results showed no main effect for group, indicating that there 
were no significant differences in levels of devastation between groups, F (2, 25) = .47, p = .63, 
η2 = .04.  As Figure 9 shows, although participants level of devastation decreased across time, it 
can be concluded that this decrease was significantly more pronounced for those in the 
Experimental group compared to those in either the Placebo or Control groups. 
Reorganization. The group means and standard deviations for the psychological response 
to sport injury subscale of reorganization at Baseline, Week 1, Week 2, and Week 3 are shown in 
Table 4.  Analyses of the subscales of the PRSII indicated a significant time main effect for 
reorganization, F (3, 75) = 5.94, p < .01, η2 = .19.  Within-subjects contrasts showed significant 
differences between Baseline and Week 2, F (1, 25) = 5.01, p < .05, η2 = .17 and Baseline and 
Week 3, F (1, 25) = 23.77, p < .001, η2 = .49, reflecting a significant increase in participants 
level of reorganization across the time phases.  Results of the analysis also produced a significant 
Time x Group interaction, F (6, 75) = 2.73, p < .05, η2 = .18.  This indicates that levels of 
reorganization at the different time phases differed between groups.  To break down this 
interaction, contrasts were performed comparing each of the weekly assessments to Baseline 
across groups.  These revealed significant interactions when comparing Experimental, Placebo, 
and Control group levels of reorganization at Week 1 compared to Baseline, F (2, 25) = 3.77, p < 
.05, η2 = .23, Week 2 compared to Baseline, F (2, 25) = 3.61, p < .05, η2 = .22, and Week 3 
compared to Baseline, F (2, 25) = 5.00, p < .05, η2 = .29.  Looking at the interaction graph, 
Figure 10, this suggests that increases in reorganization from Baseline to Week 1, Week 2, and 
Week 3 found for the Experimental group were significantly greater than for either the Placebo 
or Control group.  The 4x3 mixed design ANOVA results showed no main effect for group, 
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indicating that there were no significant differences in levels of reorganization between groups, F 
(2, 25) = .56, p = .58, η2 = .04.  As Figure 10 shows, although participants’ level of 
reorganization increased across time, it can be concluded that this increase was significantly 
more pronounced for those in the Experimental group compared to those in either the Placebo or 
Control groups. 
Feeling cheated. Table 4 contains the group means and standard deviations for the 
psychological response to sport injury subscale of feeling cheated at Baseline, Week 1, Week 2, 
and Week 3, as measured by the PRSII-19.  Analyses of the subscales of the PRSII revealed that 
there was no significant main effect of time on feeling cheated, indicating that overall, 
participants levels of feeling cheated remained relatively the same across time from Baseline to 
Week 3, F (2.25, 56.31) = .93, p = .41, η2 = .04.  There was also no significant Time x Group 
interaction found, F (4.51, 56.31) = 1.82, p = .13, η2 = .13.  The 4x3 mixed design ANOVA 
results showed no main effect for group, indicating that there were no significant differences in 
levels of feeling cheated between groups, F (2, 25) = .33, p = .72, η2 = .03.  As can be seen by 
Figure 11, group means suggest that participants’ levels of feeling cheated remained relatively 
stable over time from Baseline to Week 3. 
Restlessness. The group means and standard deviations for the psychological response to 
sport injury subscale of restlessness at Baseline, Week 1, Week 2, and Week 3 are shown in 
Table 4.  Analyses of the subscales of the PRSII revealed a significant time main effect for 
restlessness, F (2.01, 50.36) = 6.32, p < .01, η2 = .20.  Within-subjects contrasts indicated a 
significant difference between Baseline and Week 3 reflecting a significant decrease in 
participants level of restlessness between these two time phases, F (1, 25) = 10.05, p < .01, η2 = 
.29.  Although there was no significant Time x Group interaction found, F (4.03, 50.36) = 1.78, p 
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= .15, η2 = .13, results of the analysis showed a non-significant “trend” toward an interaction 
when comparing Experimental, Placebo, and Control group levels of restlessness at Week 3 
compared to Baseline, F (2, 25) = 2.85, p = .08, η2 = .19.  Looking at the interaction graph, 
Figure 12, this suggests that decreases in restlessness from Baseline to Week 3 found for the 
Experimental group were greater than for either the Placebo or Control group.  The 4x3 mixed 
design ANOVA results produced no main effect for group, indicating that there were no 
significant differences in levels of restlessness between groups, F (2, 25) = 1.03, p = .37, η2 = 
.08.  Descriptive data showed that while both group means and overall means for restlessness 
decreased by Week 3, group means for the Experimental group suggest that this decrease was 
slightly more than seen for either of the other two groups. 
Isolation. Table 4 contains the group means and standard deviations for the 
psychological response to sport injury subscale of isolation at Baseline, Week 1, Week 2, and 
Week 3, as measured by the PRSII-19.  Analyses of the subscales of the PRSII produced a 
significant time main effect for isolation, F (2.76, 69.07) = 3.75, p < .05, η2 = .13.  Within-
subjects contrasts revealed a significant difference between Baseline and Week 3 reflecting a 
significant decrease in participants level of isolation between these two time phases, F (1, 25) = 
8.05, p < .01, η2 = .24.  Results of the analysis also produced a significant Time x Group 
interaction, F (5.53, 69.07) = 2.69, p < .05, η2 = .18.  This indicates that levels of isolation at the 
different time phases differed between groups.  To break down this interaction, contrasts were 
performed comparing each of the weekly assessments to Baseline across groups.  These revealed 
a significant interaction when comparing Experimental, Placebo, and Control group levels of 
isolation at Week 3 compared to Baseline, F (2, 25) = 5.13, p < .05, η2 = .29.  Looking at the 
interaction graph, Figure 13, this suggests that decreases in isolation from Baseline to Week 3 
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found for the Experimental group were significantly greater than for either the Placebo or 
Control group.  The 4x3 mixed design ANOVA results showed no main effect for group, 
indicating that there were no significant differences in levels of isolation between groups, F (2, 
25) = 1.31, p = .29, η2 = .10.  Although there were significant decreases in isolation by Week 3, 
it can be concluded that this decrease was significantly more pronounced for those in the 
Experimental group compared to those in either the Placebo or Control groups. 
3.7 Perceived Anxiety 
The group means and standard deviations for perceived anxiety at Baseline, Week 1, 
Week 2, and Week 3 are shown in Table 5.  Results of the analysis revealed that there was no 
significant main effect of time on perceived anxiety, indicating that based on overall means, 
participants perceived anxiety remained relatively the same across time from Baseline to Week 
3, F (2.10, 52.43) = 2.43, p = .10, η2 = .09.  There was also no significant Time x Group 
interaction found, F (4.20, 52.43) = 2.33, p = .07, η2 = .16, however, within-subjects contrasts 
indicated a non-significant “trend” toward an interaction when comparing Experimental, 
Placebo, and Control group levels of anxiety at Week 1 compared to Baseline, F (2, 25) = 3.29, p 
= .05, η2 = .21.  Looking at the interaction graph, Figure 14, this suggests that improvements in 
perceived anxiety from Baseline to Week 1 found for the Experimental group were greater than 
for either the Placebo or Control group.  The 4x3 mixed design ANOVA results showed no main 
effect for group, indicating that there were no significant differences in perceived anxiety 
between groups, F (2, 25) = 1.09, p = .35, η2 = .08.  Descriptive data showed that group means 
for the Experimental group showed a decrease over time, whereas both the Placebo and Control 
groups either increased over time or remained approximately the same. 
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3.8 Pain Catastrophizing  
Total. Table 6 contains the group means and standard deviations for pain catastrophizing 
at Baseline, Week 1, Week 2, and Week 3.  Results of the analysis produced a significant main 
effect of time on pain catastrophizing, F (3, 75) = 8.33, p < .001, η2 = .25.  Within-subjects 
contrasts revealed significant differences between Baseline and Week 1, F (1, 25) = 12.34, p < 
.01, η2 = .33, Baseline and Week 2, F (1, 25) = 15.20, p < .01, η2 = .38, and Baseline and Week 
3, F (1, 25) = 15.82, p < .01, η2 = .39, indicating that based on overall means, participants level 
of pain catastrophizing significantly decreased across the time phases.  There was no significant 
Time x Group interaction found, F (6, 75) = 1.77, p = .12, η2 = .12.  Although not significant, 
group means suggest that the decrease in pain catastrophizing across time was greater for the 
Experimental group than the Placebo or Control groups (see Table 6).  The 4x3 mixed design 
ANOVA results showed no main effect for group, indicating that there were no significant 
differences in pain catastrophizing between groups, F (2, 25) = .44, p = .65, η2 = .03.  For the 
Time x Group interaction graph, see Figure 15. 
 Rumination. The group means and standard deviations for the pain catastrophizing 
subscale of rumination at Baseline, Week 1, Week 2, and Week 3 are shown in Table 6.  
Analyses of the subscales of the PCS showed a significant time main effect for rumination, F 
(3,75) = 5.48, p < .01, η2 = .18.  Within-subjects contrasts revealed significant differences 
between Baseline and Week 2, F (1, 25) = 11.22, p < .01, η2 = .31, and Baseline and Week 3, F 
(1, 25) = 9.38, p < .01, η2 = .27, indicating that based on overall means, participants level of 
rumination significantly decreased across the time phases.  There was no significant Time x 
Group interaction found, F (6, 75) = 1.80, p = .11, η2 = .13.  Although not significant, group 
means suggest that the decrease in rumination from Baseline to Week 3 was greater for the 
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Experimental group than the Placebo or Control groups (see Table 6).  The 4x3 mixed design 
ANOVA results produced no main effect for group, indicating that there were no significant 
differences in rumination between groups, F (2, 25) = .45, p = .65, η2 = .03.  For the Time x 
Group interaction graph for rumination, see Figure 16. 
Magnification. The group means and standard deviations for the pain catastrophizing 
subscale of magnification at Baseline, Week 1, Week 2, and Week 3 are shown in Table 6.  
Analyses of the subscales of the PCS produced a non-significant “trend” towards a time main 
effect for magnification, F (3,75) = 2.36, p = .08, η2 = .09.  With the time main effect 
approaching significance, the within-subjects contrasts showed significant differences between 
Baseline and Week 2, F (1, 25) = 4.77, p < .05, η2 = .16, and Baseline and Week 3, F (1, 25) = 
7.13, p < .05, η2 = .22, indicating that based on overall means, participants level of magnification 
decreased across the time phases, from Baseline to Week 2 and from Baseline to Week 3.  There 
was also a non-significant “trend” towards a Time x Group interaction found, F (6, 75) = 1.79, p 
= .11, η2 = .13, with within-subjects contrasts revealing a significant interaction when comparing 
Experimental, Placebo, and Control group levels of magnification at Week 3 compared to 
Baseline, F (2, 25) = 4.98, p < .05, η2 = .29.  To further explore these findings, the analysis for 
magnification was performed again using a 2x3 mixed design ANOVA, which confirmed the 
findings that based on overall means; magnification was significantly lower at Week 3 than at 
Baseline, however improvements in magnification between these two time phases were 
significantly greater for the Experimental group than either the Placebo or Control group (see 
Figure 17).  The 4x3 mixed design ANOVA results showed no main effect for group, indicating 
that there were no significant differences in magnification between groups, F (2, 25) = .66, p = 
.52, η2 = .05. 
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Helplessness. The group means and standard deviations for the pain catastrophizing 
subscale of helplessness at Baseline, Week 1, Week 2, and Week 3 are shown in Table 6.  
Analyses of the subscales of the PCS revealed a significant time main effect for helplessness, F 
(3,75) = 10.66, p < .001, η2 = .30.  Within-subjects contrasts showed significant differences 
between Baseline and Week 1, F (1, 25) = 22.08, p < .001, η2 = .47, Baseline and Week 2, F (1, 
25) = 16.44, p < .001, η2 = .40, and Baseline and Week 3, F (1, 25) = 18.03, p < .001, η2 = .42, 
indicating that based on overall means, participants level of helplessness significantly decreased 
across the time phases (see Figure 18).  There was no significant Time x Group interaction 
found, F (6, 75) = 1.02, p = .42, η2 = .08.  The 4x3 mixed design ANOVA results showed no 
main effect for group, indicating that there were no significant differences in helplessness 
between groups, F (2, 25) = .25, p = .78, η2 = .02. 
3.9 Perceived Pain 
Table 7 contains the group means and standard deviations for perceived pain at Baseline, 
Week 1, Week 2, and Week 3, as measured by the VAS.  Results of the analysis showed a 
significant main effect for time on perceived pain, F (3, 72) = 2.88, p < .05, η2 = .11.  Within-
subjects contrasts revealed a significant difference between Baseline and Week 3 reflecting a 
significant decrease in participants level of perceived pain between these two time phases, F (1, 
24) = 9.96, p < .01, η2 = .29.  There was no significant Time x Group interaction found, F (6, 72) 
= 1.12, p = .36, η2 = .09.  The 4x3 mixed design ANOVA results showed no main effect for 
group, indicating that there were no significant differences in perceived pain between groups, F 
(2, 24) = .04, p = .96, η2 = .003.  As Figure 19 shows, group means for perceived pain were 
relatively low among participants at Baseline and were found to be significantly improved at 
Week 3.   
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3.10 Pain Disability 
The group means and standard deviations for pain disability at Baseline, Week 1, Week 
2, and Week 3 are shown in Table 8.  Results of the analysis produced a significant main effect 
for time on pain disability, F (2.63, 65.70) = 16.24, p < .001, η2 = .39.  Within-subjects contrasts 
showed significant differences between Baseline and Week 1, F (1, 25) = 4.61, p < .05, η2 = .16, 
Baseline and Week 2, F (1, 25) = 11.75, p < .01, η2 = .32, and Baseline and Week 3, F (1, 25) = 
42.77, p < .001, η2 = .63, indicating that based on overall means, participants pain disability 
significantly decreased across the time phases.  There was no significant Time x Group 
interaction found, F (5.26, 65.70) = 1.28, p = .28, η2 = .09.  The 4x3 mixed design ANOVA 
results revealed no main effect for group, indicating that there were no significant differences in 
pain disability between groups, F (2, 25) = .73, p = .49, η2 = .06. As Figure 20 shows, group 
means for perceived pain disability levels were relatively low at Baseline and further decreased 
across time. 
3.11 Rehabilitation Adherence 
 Rehabilitation adherence was assessed at one point only (i.e., Week 3), so a one-way 
ANOVA was performed to examine for between-group differences.   
Frequency.  For the rehabilitation adherence subscale of frequency, results of the 
analysis found no significant group differences in the frequency with which participants engaged 
in their rehabilitation exercises, F (2, 23) = .004, p = N.S. (see Figure 21).  
Duration. For the rehabilitation adherence subscale of duration, results of the analysis 
found no significant group differences in duration spent performing rehabilitation exercises, F (2, 
25) = .01, p = N.S. (see Figure 22). 
Quality. For the rehabilitation adherence subscale of quality, results of the analysis found 
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no significant group differences in participants subjective ratings of the quality with which 
rehabilitation exercises were performed, F (2, 25) = 1.73, p = .20 (see Figure 23). 
3.12 Physiological Measures  
Mean HR – rest. Table 9 contains the group means and standard deviations for mean HR 
during Task A – Rest Period at Baseline, Week 1, Week 2, and Week 3.  Results of the analysis 
showed that there was a non-significant “trend” towards a time main effect for mean HR – rest, 
indicating that although not significant, based on overall means, mean HR during Task A – rest 
period slightly increased across time from Baseline to Week 3, F (3, 72) = 2.64, p = .06, η2 = .10.  
There was, however no significant Time x Group interaction found, reflecting that changes in 
HR – rest at the different time phases did not significantly differ between groups, F (6, 72) = 
1.90, p = .09, η2 = .14 (see Figure 24).  The 4x3 mixed design ANOVA results also showed no 
main effect for group, indicating that there were no significant differences in HR – rest between 
groups, F (2, 24) = .88, p = .43, η2 = .07.  
Mean HR – paced. Table 9 contains the group means and standard deviations for mean 
HR during Task B – Paced Breathing Exercise at Baseline, Week 1, Week 2, and Week 3.  
Results of the analysis of mean HR – paced showed no significant main effect for time, 
indicating that, based on overall means, participants mean HR during Task B – paced breathing 
exercise remained relatively the same across time from Baseline to Week 3, F (3, 66) = 1.68, p = 
.18, η2 = .07.  There was also no significant Time x Group interaction found, F (6, 66) = 1.89, p 
= .10, η2 = .15.  The 4x3 mixed design ANOVA results produced no main effect for group, 
indicating that there were also no significant differences in mean HR – paced between groups, F 
(2, 22) = .77, p = .48, η2 = .07 (see Figure 25). 
SDNN – rest. The group means and standard deviations for the HRV time-domain 
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indices of SDNN during Task A – Rest Period at Baseline, Week 1, Week 2, and Week 3 are 
shown in Table 10.  Results of the analysis revealed a significant time main effect for SDNN – 
rest, F (3, 72) = 3.90, p < .05, η2 = .14.  Within-subjects contrasts indicated significant 
differences between Baseline and Week 1, F (1, 24) = 10.92, p < .01, η2 = .31, and Baseline and 
Week 2, F (1, 24) = 5.51, p < .05, η2 = .19, reflecting a significant increase in SDNN – rest 
between Baseline and these two time phases.  Results of the analysis also produced a non-
significant “trend” towards a Time x Group interaction, F (6, 72) = 1.98, p = .08, η2 = .14, with 
within-subjects contrasts revealing a significant interaction when comparing Experimental, 
Placebo, and Control group measures of SDNN – rest at Week 1 compared to Baseline, F (2, 24) 
= 3.90, p < .05, η2 = .25, and a borderline significant interaction at Week 2 compared to 
Baseline, F (2, 24) = 3.39, p = .05, η2 = .22.  This suggests that the increases in SDNN – rest 
from Baseline to Week 1 and from Baseline to Week 2 for the Experimental group were greater 
than for either the Placebo or Control group (see Figure 26).  The 4x3 mixed design ANOVA 
results showed no main effect for group, indicating that there were no significant differences in 
SDNN – rest between groups, F (2, 24) = .66, p = .53, η2 = .05.   
 SDNN – paced. The group means and standard deviations for the HRV time-domain 
indices of SDNN during Task B – Paced Breathing Exercise at Baseline, Week 1, Week 2, and 
Week 3 are shown in Table 10.  Results of the analysis produced a significant time main effect 
for SDNN – paced, F (3, 66) = 4.70, p < .01, η2 = .18.  Within-subjects contrasts revealed a 
significant difference between Baseline and Week 1, indicating that based on overall means, 
SDNN – paced significantly increased between these two time phases, F (1, 22) = 5.15, p < .05, 
η2 = .19.  There was no significant Time x Group interaction found, F (6, 66) = 1.29, p = .27, η2 
= .11 (see Figure 27).  The 4x3 mixed design ANOVA results showed no main effect for group, 
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indicating that there were no significant differences in SDNN – paced between groups, F (2, 22) 
= 1.09, p = .36, η2 = .09.   
Total HRV – rest. Table 11 contains the group means and standard deviations for the 
HRV frequency-domain indices of total HRV during Task A – Rest Period at Baseline, Week 1, 
Week 2, and Week 3.  Results of the analysis showed a significant main effect for time on total 
HRV – rest, F (3, 72) = 3.62, p < .05, η2 = .13.  Within-subjects contrasts revealed a significant 
difference between Baseline and Week 1, indicating based on overall means, a significant 
increase in total HRV – rest between these two time phases, F (1, 24) = 9.35, p < .01, η2 = .28.  
There was no significant Time x Group interaction found, reflecting that changes in total HRV – 
rest at the different time phases did not significantly differ between groups, F (6, 72) = 1.51, p = 
.19, η2 = .11 (see Figure 28).  The 4x3 mixed design ANOVA results produced no main effect 
for group, indicating that there were no significant differences in total HRV – rest between 
groups, F (2, 24) = 1.04, p = .37, η2 = .08.  
 Total HRV – paced. Table 11 contains the group means and standard deviations for the 
HRV frequency-domain indices of total HRV during Task B – Paced Breathing Exercise at 
Baseline, Week 1, Week 2, and Week 3.  Results of the analysis produced a significant time 
main effect for total HRV – paced, F (3, 66) = 3.82, p < .05, η2 = .15.  Within-subjects contrasts 
showed a non-significant “trend” for differences between Baseline and Week 1, indicating that 
based on overall means, total HRV – paced increased between these two time phases, F (1, 22) = 
3.55, p = .07, η2 = .14.  Upon further analysis with a within-subjects repeated contrast, it was 
found that there was a significant difference between Week 2 and Week 3, reflecting a 
significant decrease in total HRV – paced between these two time phases, F (1, 22) = 6.02, p < 
.05, η2 = .22.  There was no significant Time x Group interaction found, indicating that changes 
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in total HRV – paced at the different time phases did not significantly differ between groups, F 
(6, 66) = .70, p = .65, η2 = .06 (see Figure 29).  The 4x3 mixed design ANOVA results produced 
no main effect for group, indicating that there were no significant differences in total HRV – 
paced between groups, F (2, 22) = 1.50, p = .25, η2 = .12. 
 LF HRV – rest. The group means and standard deviations for the HRV frequency-
domain indices of LF HRV during Task A – Rest Period at Baseline, Week 1, Week 2, and Week 
3 are shown in Table 12.  Results of the analysis showed a significant time main effect for LF 
HRV – rest, F (3, 72) = 5.04, p < .01, η2 = .17.  Within-subjects contrasts revealed significant 
differences between Baseline and Week 1, F (1, 24) = 16.16, p < .01, η2 = .40, Baseline and 
Week 2, F (1, 24) = 6.56, p < .05, η2 = .22, and Baseline and Week 3, F (1, 24) = 5.54, p < .05, 
η2 = .19, indicating based on overall means, a significant increase in LF HRV – rest across the 
time phases.  Results of the analysis also produced a significant Time x Group interaction, F (6, 
72) = 2.72, p < .05, η2 = .19.  This indicates that LF HRV – rest at the different time phases 
differed between groups.  To break down this interaction, contrasts were performed comparing 
each of the weekly assessments to Baseline across groups.  These revealed significant 
interactions when comparing Experimental, Placebo, and Control group measures of LF HRV – 
rest at Week 1 compared to Baseline, F (2, 24) = 7.26, p < .01, η2 = .38, and Week 2 compared to 
Baseline, F (2, 24) = 6.65, p < .01, η2 = .36.  Looking at the interaction graph, Figure 30, this 
suggests that increases in LF HRV – rest from Baseline to Week 1 and from Baseline to Week 2 
for the Experimental group were significantly greater than for either the Placebo or Control 
group.  The 4x3 mixed design ANOVA results produced no main effect for group, indicating that 
there were no significant differences in LF HRV – rest between groups, F (2, 24) = 1.94, p = .17, 
η2 = .14.  Although based on overall means, LF HRV – rest increased across time from Baseline, 
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it can be concluded that this increase was significantly more pronounced for those in the 
Experimental group compared to those in either the Placebo or Control groups. 
 LF HRV – paced. The group means and standard deviations for the HRV frequency-
domain indices of LF HRV during Task B – Paced Breathing Exercise at Baseline, Week 1, 
Week 2, and Week 3 are shown in Table 12.  Results of the analysis produced a significant time 
main effect for LF HRV – paced, F (3, 66) = 3.67, p < .05, η2 = .14.  Within-subjects contrasts 
showed a non-significant “trend” for differences between Baseline and Week 1, indicating that 
based on overall means, LF HRV – paced increased between these two time phases, F (1, 22) = 
3.95, p = .06, η2 = .15.  Upon further analysis with a within-subjects repeated contrast, it was 
found that there was a significant difference between Week 2 and Week 3, reflecting a 
significant decrease in LF HRV – paced between these two time phases, F (1, 22) = 4.42, p < 
.05, η2 = .17.  There was no significant Time x Group interaction found, indicating that changes 
in LF HRV – paced at the different time phases did not significantly differ between groups, F (6, 
66) = 1.48, p = .20, η2 = .12 (see Figure 31).  The 4x3 mixed design ANOVA results revealed no 
main effect for group, indicating that there were no significant differences in LF HRV – paced 
between groups, F (2, 22) = 1.36, p = .28, η2 = .11. 
HF HRV – rest. Table 13 contains the group means and standard deviations for the HRV 
frequency-domain indices of HF HRV during Task A – Rest Period at Baseline, Week 1, Week 
2, and Week 3.  Results of the analysis revealed that there was no significant main effect of time 
on HF HRV – rest, indicating that based on overall assessment means, measures of HF HRV – 
rest remained relatively the same across time from Baseline to Week 3, F (2.44, 58.66) = 1.29, p 
= .29, η2 = .05.  There was also no significant Time x Group interaction found, F (4.89, 58.66) = 
.99, p = .43, η2 = .08 (see Figure 32).  The 4x3 mixed design ANOVA results showed no main 
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effect for group, indicating that there were no significant differences in HF HRV – rest between 
groups, F (2, 24) = 1.80, p = .19, η2 = .13.   
 HF HRV – paced. Table 13 contains the group means and standard deviations for the 
HRV frequency-domain indices of HF HRV during Task B – Paced Breathing Exercise at 
Baseline, Week 1, Week 2, and Week 3.  Results of the analysis produced a significant time 
main effect for HF HRV – paced, F (3, 66) = 4.65, p < .01, η2 = .18.  Within-subjects contrasts 
showed a significant difference between Baseline and Week 1, indicating that based on overall 
means, HF HRV – paced significantly increased between these two time phases, F (1, 22) = 5.06, 
p < .05, η2 = .19.  Upon further analysis with a within-subjects repeated contrast, it was found 
that there was also a significant difference between Week 2 and Week 3, reflecting a significant 
decrease in HF HRV – paced between these two time phases, F (1, 22) = 4.81, p < .05, η2 = .18.  
This indicates that although HF HRV – paced significantly increased by Week 1, measures of HF 
HRV – paced decreased thereafter.  There was no significant Time x Group interaction found, 
indicating that changes in HF HRV – paced at the different time phases did not significantly 
differ between groups, F (6, 66) = .27, p = .95, η2 = .02 (see Figure 33).  The 4x3 mixed design 
ANOVA results produced no main effect for group, indicating that there were no significant 
differences in HF HRV – paced between groups, F (2, 22) = 1.61, p = .22, η2 = .13. 
 Mean Respiration Rate – rest. The group means and standard deviations for mean 
respiration rate during Task A – Rest Period at Baseline, Week 1, Week 2, and Week 3 are 
shown in Table 14.  Results of the analysis produced a significant time main effect for mean 
respiration rate – rest, F (3, 72) = 14.96, p < .001, η2 = .38.  Within-subjects contrasts revealed 
significant differences between Baseline and Week 1, F (1, 24) = 24.38, p < .001, η2 = .50, 
Baseline and Week 2, F (1, 24) = 25.92, p < .001, η2 = .52, and Baseline and Week 3, F (1, 24) = 
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28.54, p < .001, η2 = .54, reflecting a significant decrease in participants mean respiration rates 
during Task A – rest period across the time phases.  Results of the analysis also produced a 
significant Time x Group interaction, F (6, 72) = 7.37, p < .001, η2 = .38.  This indicates that 
rates of breathing at the different time phases differed between groups.  To break down this 
interaction, contrasts were performed comparing each of the weekly assessments to Baseline 
across groups.  These revealed significant interactions when comparing Experimental, Placebo, 
and Control group respiration rate – rest measures at Week 1 compared to Baseline, F (2, 24) = 
8.96, p < .01, η2 = .43, Week 2 compared to Baseline, F (2, 24) = 15.33, p < .001, η2 = .56, and 
Week 3 compared to Baseline, F (2, 24) = 13.22, p < .001, η2 = .52.  Looking at the interaction 
graph, Figure 34, this suggests that decreases in mean respiration rate during Task A – rest 
period from Baseline to Week 1, Week 2, and Week 3 found for the Experimental group were 
significantly greater than for either the Placebo or Control group.  The 4x3 mixed design 
ANOVA results also showed a significant main effect for group, indicating that there were 
significant differences in respiration rates during Task A between groups, F (2, 24) = 6.32, p < 
.01, η2 = .35.  Tukey follow-up tests revealed that respiration rates during Task A across 
assessments for the HRV BFB Experimental group were significantly lower than those for either 
the Placebo or Control group.  However, there were no significant differences in respiration rates 
– rest between the Placebo and Control groups.  
 Mean Respiration Rate – paced. The group means and standard deviations for mean 
respiration rate during Task B – Paced Breathing Exercise at Baseline, Week 1, Week 2, and 
Week 3 are shown in Table 14.  Results of the analysis showed that there was no time main 
effect for mean respiration rate – paced, indicating that based on overall means, mean respiration 
rates during Task B – paced breathing exercise remained relatively the same across time from 
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Baseline to Week 3, F (2.62, 60.16) = 2.78, p = .06, η2 = .11.  There was also no significant Time 
x Group interaction found, reflecting that changes in respiration rate – paced at the different time 
phases did not significantly differ between groups, F (5.23, 60.16) = .57, p = .73, η2 = .05 (see 
Figure 35).  The 4x3 mixed design ANOVA results also revealed no main effect for group, 
indicating that there were no significant differences in respiration rates during Task B between 
groups, F (2, 23) = .13, p = .88, η2 = .01. 
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Chapter 4: Discussion 
 The following chapter will serve to (a) present a summary of the study results and 
highlight key findings, (b) compare and contrast the findings presented herein with those of 
previous studies, (c) emphasize current study strengths and limitations, (d) direct attention 
towards future recommendations in this field of study, and finally (e) specify both theoretical and 
practical implications.  
4.1 Summary of Findings   
The purpose of the current study was to examine the effectiveness of HRV biofeedback, a 
form of psychophysiological skills training intervention, to improve athletes’ psychological 
response following an injury.  Specifically, to explore the effects of HRV BFB training on 
rehabilitation self-efficacy, perceived stress and anxiety, pain management, and the 
psychological responses of injured athletes.  The effectiveness of the HRV BFB intervention to 
facilitate improvements in athletes’ physiological indices including HRV, HR, and respiration 
rate was also assessed.  A 4 x 3 mixed model design (Time: Baseline, Week 1, Week 2, Week 3; 
assessments across time; Group: HRV BFB Experimental group, HRV BFB Placebo group, 
Control group; experimental conditions) was used to examine the emotional experience and 
psychological responses of injured athletes as they progressed through injury recovery over a 
three-week duration.  Different experimental conditions were employed in order to evaluate the 
effectiveness of HRV BFB in (a) improving athletes' psychological responses regarding injury 
and rehabilitation, (b) promoting increased perceptions of self-efficacy and reorganization, (c) 
contributing to reductions in perceived stress, anxiety, pain, and pain catastrophizing, (d) 
fostering declines in disability due to pain, and (e) demonstrating improvements in physiological 
indices.  It was hypothesized that injured athletes who received the HRV BFB intervention 
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would demonstrate significantly greater improvements in psychological outcomes pertaining to 
injury and rehabilitation across time than injured athletes who were not provided with this form 
of intervention (i.e., HRV BFB Placebo group and Control group).  As a secondary hypothesis, it 
was hypothesized that injured athletes who received the HRV BFB intervention would also 
demonstrate significantly greater improvements in physiological indices corresponding to BFB 
training than injured athletes who were not provided with this form of intervention (i.e., HRV 
BFB Placebo group and Control group). 
Psychological outcomes. Results provided partial support in terms of the first hypothesis 
regarding the influence of the HRV BFB intervention on athletes’ psychological outcomes 
pertaining to injury and rehabilitation.  Injured athletes who received the HRV BFB intervention 
reported significantly greater improvements on a number of psychological outcomes than those 
in either the placebo or control groups.  Results with respect to each of the specific psychological 
outcomes measured will be discussed.  
 Perceptions of task self-efficacy regarding rehabilitation were found to be high among 
injured athletes in each group at Baseline.  Results suggest that injured athletes, regardless of the 
group to which they were assigned, maintained high task self-efficacy regarding rehabilitation 
across time.  Although differences in task self-efficacy between groups did not reach statistical 
significance, observation of group means showed the HRV BFB Experimental and HRV BFB 
Placebo groups to have higher levels of task-self efficacy than the Control group regarding injury 
rehabilitation.  Perceptions of coping self-efficacy regarding rehabilitation were also relatively 
high among injured athletes in each group at Baseline, however, there was also a significant 
main effect for time on coping self-efficacy in that injured athletes across groups were 
significantly higher in coping self-efficacy at Week 3 compared to Baseline.  Similar to the 
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results found for task self-efficacy, although not statistically significant, observation of group 
means showed the HRV BFB Experimental and HRV BFB Placebo groups to have higher levels 
of coping self-efficacy than the Control group regarding injury rehabilitation.  High perceptions 
of task and coping self-efficacy over the three-week duration among the injured athletes in the 
current study is in line with previous research which examined injured athletes perceptions of 
self-efficacy during an eight week rehabilitation program and found that mean scores for both 
task and coping self-efficacy remained relatively stable and high (Wesch et al., 2012).  The high 
self-efficacy scores reported by injured athletes in the current study may also be associated with 
the fact that 79% of participants had a previous history of athletic injury.  Bassett and 
Prapavessis (2010) proposed that high self-efficacy among injured athletes may be attributed to 
participants having had prior experience with athletic injury and rehabilitation programs.  The 
findings of the present study are also consistent with those reported by Evans and Hardy (2002) 
in a goal setting study with injured athletes, who found that a goal setting intervention group and 
social support control group both had higher levels of self-efficacy than the no treatment control 
group.  In terms of perceived stress, results demonstrated a significant main effect of time 
between Baseline and Week 3 indicating that injured athletes across groups experienced 
significant reductions in perceived stress between these two time phases.  
 Results of the current investigation supported the hypothesis that HRV BFB would 
significantly improve athletes’ psychological responses post-injury, as measured by the PRSII-19 
(Evans et al., 2008).   Injured athletes’ negative psychological responses regarding injury and 
recovery (with the exception of feeling cheated) were found to significantly decrease across time.  
Specifically, with regards to devastation, the results indicated that while based on overall means, 
there were significant reductions in injured athletes’ levels of devastation each week as 
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compared to Baseline; the HRV BFB Experimental group demonstrated significantly greater 
reductions in devastation than either of the other two groups across time.  Not only did the HRV 
BFB Experimental group report significantly greater improvements in levels of devastation at 
each assessment, but group means show these individuals were the highest in devastation at 
Baseline and reported the lowest levels of devastation by Week 3.  This speaks to the potential 
effectiveness of HRV BFB to reduce feelings of devastation in injured athletes post-injury and 
throughout the rehabilitation process.  Individuals in the HRV BFB Experimental group reported 
significantly greater reductions in terms of feelings of intense shock and devastation across time 
(Evans et al., 2008), as compared to injured athletes who received a sham HRV BFB intervention 
and those who received no training throughout their recovery.  In terms of the psychological 
response to sport injury subscale of reorganization, which represents feelings of increased 
confidence and a sense of psychological recovery (Evans et al., 2008), results of the current 
study revealed that, based on overall means, perceptions of reorganization among injured athletes 
significantly increased across time from Baseline to Week 2 and Baseline to Week 3.  However, 
injured athletes in the HRV BFB Experimental group reported significantly greater increases in 
feelings of reorganization than those in either the Placebo or Control groups across time.  Similar 
to the findings regarding devastation, this speaks to the potential of HRV BFB as a useful tool 
for fostering increased feelings of reorganization in injured athletes recovering from athletic 
injury.  Individuals in the HRV BFB Experimental group demonstrated significantly greater 
improvements in terms of feelings of confidence and perceptions of psychological recovery, as 
compared to injured athletes who received a HRV BFB Placebo condition and those who 
received no training throughout their recovery.   
Looking at the psychological response to sport injury subscale of feeling cheated, based 
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on overall means, it was found that injured athletes remained relatively stable in feeling cheated 
regarding their injury across time.  Results of the current study did not reveal any significant 
differences between groups in terms of their reductions of feeling cheated over time, however, an 
exploratory analysis showed that while group means for both the Placebo and Control groups 
remained the same or increased over time, group means for the HRV BFB Experimental group 
showed reductions in the psychological response to sport injury of feeling cheated, which can be 
defined as representing feelings of bitterness towards being injured (Evans et al., 2008).  This 
trend should be investigated further in future studies examining the effects of HRV BFB in the 
athletic injury population.  With regards to the subscale of restlessness, which has been 
characterized by feelings of anxiety, guilt, and hostility (Evans et al., 2008), results indicated, 
based on overall means, that injured athletes demonstrated significant reductions in feelings of 
restlessness by Week 3.  While it was not statistically significant, there were trends indicating 
that the HRV BFB Experimental group displayed greater reductions in restlessness compared to 
either of the other groups across time.  Similar to devastation, group means show that these 
individuals were the highest in feelings of restlessness at Baseline and reported the lowest levels 
of restlessness by Week 3.  It follows that HRV BFB may be effective in promoting reductions in 
feelings of restlessness in injured athletes post-injury and throughout the rehabilitation process.  
Individuals in the HRV BFB Experimental group reported greater declines in terms of feelings of 
anxiety, hostility, and guilt by Week 3 post-intervention, as compared to injured athletes who 
received a HRV BFB Placebo condition and those who received no training throughout their 
recovery.   
Finally, in terms of feelings of isolation, results of the study demonstrated, based on 
overall means, that there were significant reductions in injured athletes’ levels of perceived 
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isolation by Week 3, post-intervention.  With this being said, the HRV BFB Experimental group 
reported significantly greater reductions in feelings of isolation than either of the other two 
groups between Baseline and Week 3.  Not only did the HRV BFB Experimental group report 
significantly greater improvements in isolation at Week 3, but group means show that these 
individuals were the highest in feelings of isolation at Baseline and reported the lowest levels of 
isolation by Week 3.  This speaks to the potential effectiveness of HRV BFB to contribute to 
reductions in feelings of isolation in injured athletes post-injury and throughout the rehabilitation 
process.  The findings surrounding the effects of HRV BFB training on athletes’ psychological 
responses following injury are consistent with previous research regarding the use of goal setting 
as a form of psychological skills training for injured athletes (Evans & Hardy, 2002).  Although, 
whereas Evans & Hardy (2002) only found differences across time on measures of psychological 
responses to sport injury, the current study demonstrated significantly greater improvements on a 
number of these variables in the HRV BFB Experimental group, compared to the Placebo and 
Control groups.  The current findings are also consistent with previous research findings 
regarding the use of HRV BFB in other populations and its beneficial effects on stress, anxiety, 
negative affect, and mood disturbances (Hassett et al., 2007; Karavidas et al., 2007; Lagos et al., 
2008; Paul & Garg, 2012).   
 With regards to perceived anxiety, study findings indicated that, based on overall means, 
injured athletes remained relatively stable in perceived anxiety across time.  Results of the 
current study did not reveal any significant differences between groups in terms of their 
reductions in perceived anxiety, however, an exploratory analysis showed that while group 
means for both the Placebo and Control groups remained the same or increased over time, group 
means for the HRV BFB Experimental group showed declines in perceived anxiety.  Further, 
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group means show that these individuals were the highest in perceptions of anxiety at Baseline 
and reported the lowest levels of anxiety by Week 3.  From this, it is speculated that HRV BFB 
may be effective in fostering declines in levels of anxiety in injured athletes post-injury and 
throughout the rehabilitation process.  This trend should be investigated further in future studies 
examining the effects of HRV BFB in the athletic injury population.  The findings of the present 
study are somewhat consistent with previous research regarding the use of HRV BFB in other 
populations and its beneficial effects on anxiety levels (Siepmann et al., 2008; Lagos et al., 2008; 
Paul & Garg, 2012).  The trends in lowered anxiety levels demonstrated by injured athletes in 
this study are consistent with findings found by Paul and Garg (2012), which showed that a 
group of basketball players demonstrated significantly less anxiety after undergoing a HRV BFB 
intervention.  Findings of the current study regarding anxiety also show similarities between the 
effects of HRV BFB and other psychological interventions that have been employed with injured 
athletes.  Ross and Berger (1996) found that a stress inoculation-training program significantly 
reduced anxiety in the intervention group in the post-surgical rehabilitation process, as compared 
to controls.   
 Findings of the current investigation revealed that, based on overall means, injured 
athletes showed significant reductions in levels of pain catastrophizing across time from Baseline 
to each subsequent week, respectively.  Results did not reveal any significant differences 
between groups in terms of their reductions in pain catastrophizing over time, however, group 
means suggest that injured athletes in the HRV BFB Experimental group demonstrated a greater 
decline in pain catastrophizing over time from Baseline to Week 3, compared to either of the 
other two groups.  In terms of the pain catastrophizing subscale of rumination, findings indicated 
again that, based on overall means, injured athletes’ levels of pain rumination significantly 
HEART RATE VARIABILITY BIOFEEDBACK 71 
declined across time.  As seen with pain catastrophizing, group means suggest that injured 
athletes in the HRV BFB Experimental group showed a greater decline in rumination regarding 
pain from Baseline to Week 3, post-intervention, than either of the other two groups.  However, 
this did not reach statistical significance.  With regards to the pain catastrophizing subscale of 
magnification, results of the study demonstrated that, based on overall means, there were 
significant reductions in injured athletes’ levels of pain magnification by Week 3, post-
intervention.  With this being said, the HRV BFB Experimental group reported significantly 
greater reductions in magnification regarding pain than either of the other two groups between 
Baseline and Week 3.  This speaks to the potential effectiveness of HRV BFB to contribute to 
declines in pain magnification in injured athletes post-injury and throughout the rehabilitation 
process.  Finally, findings regarding the subscale of helplessness showed that, based on overall 
means, injured athletes reported significant reductions in levels of helplessness across time from 
Baseline to each subsequent week, respectively.  Results did not reveal any significant 
differences between groups in terms of their reductions in helplessness regarding pain, however, 
an exploratory analysis showed that individuals in the HRV BFB Experimental group were the 
highest in feelings of helplessness at Baseline and reported the lowest levels of helplessness by 
Week 3.  The findings of the current study are in line with those of previous research by Riddle 
et al. (2011), who investigated the effects of a pain coping skills intervention in patients 
scheduled for knee arthroplasty procedures and found that those who received the coping skills 
training demonstrated significantly greater reductions in pain catastrophizing, compared to a 
usual care cohort.  The findings of the current study suggest that HRV BFB may be effective in 
promoting declines in levels of pain catastrophizing in injured athletes following injury and 
throughout the subsequent recovery process.   
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 In terms of perceived pain experienced by injured athletes post-injury, findings 
demonstrated, based on overall means, that there were significant reductions in athletes’ levels of 
perceived pain by Week 3, post-intervention.  However, results of the current study did not 
reveal any significant differences between groups in terms of their reductions in perceived pain 
over time.  These findings are consistent with those of previous injury rehabilitation research by 
Brewer et al. (2007) who found that daily pain ratings decreased significantly over the first six 
weeks of rehabilitation following ACL reconstruction.  However, prior research involving the 
use of psychological skills interventions in injury rehabilitation has found that individuals who 
received stress inoculation training demonstrated significantly less post-surgical pain during the 
rehabilitation process, compared with controls (Ross & Berger, 1996).  Future research will need 
to focus inquiries into the effects of BFB on injured athletes’ levels of perceived pain.   
 With regards to pain disability, results of the current study revealed that, based on overall 
means, perceptions of disability due to pain among injured athletes significantly decreased across 
time from Baseline to each week, respectively.  Results did not reveal any significant differences 
between groups in terms of their reductions in pain disability; however, an exploratory analysis 
suggested that declines in perceived disability due to pain were greater for those in the HRV 
BFB Experimental group, compared to those for either of the other two groups.  These findings 
are consistent with those of previous research employing a HRV BFB intervention in a chronic 
low-back pain population (Kapitza et al., 2010) which found no significant differences in terms 
of pain disability reductions between a BFB intervention and placebo group, but commented that 
pre-post changes in the intervention group were higher than in the placebo group.  It is possible 
that receiving the HRV BFB intervention fostered greater declines in perceived disability due to 
pain throughout rehabilitation, as compared to not receiving the HRV BFB intervention.    
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 Adherence, measured in terms of frequency, duration, and quality, was found to be high 
among injured athletes in each of the three groups.  This is not surprising given the high scores in 
both task and coping self-efficacy reported by injured athletes in the current study, which has 
been associated with high levels of rehabilitation adherence (Brewer et al., 2003, Wesch et al., 
2012).   
Physiological outcomes. Results provided partial support in terms of the second 
hypothesis made regarding the influence of the HRV BFB intervention on athletes’ physiological 
indices.  Injured athletes who received the HRV BFB intervention demonstrated significantly 
greater declines in resting respiration rate and significantly greater increases in LF HRV at rest 
than those in either the placebo or control groups.  Results with respect to each of the specific 
physiological indices will be discussed. 
It was hypothesized that injured athletes in the HRV BFB Experimental group would 
report significantly greater declines in heart rate (HR) during both Task A – Rest Period and 
Task B – Paced Breathing Exercise over the three-week study duration, than those in either of 
the other two groups, who were expected to remain relatively the same across time.  However, 
findings of the current study did not support this hypothesis.  Results indicated that, based on 
overall means, injured athletes’ average heart rates (during both Task A and Task B) remained 
relatively stable across time.  Further, there were no significant differences between groups in 
terms of their variation in HR across time.  Surprisingly, group means actually suggest a slight 
increase in the heart rates of injured athletes between Baseline and Week 3, post-intervention. 
These findings are not consistent with previous research on the use of HRV BFB with depressed 
individuals (Siepmann et al., 2008), in which it was found that depressed patients had 
significantly reduced heart rates under conditions of both relaxed rest and paced breathing after 
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receiving six sessions of HRV BFB over a two-week duration.  There are a number of reasons 
for why injured athletes in the current study (especially those in the HRV BFB Experimental 
group) did not show reduced heart rates over time.  First, in previous studies examining the 
effects of HRV BFB, the populations under review have been clinical in nature and/or involving 
participants considered to be ‘unhealthy’ populations.  While upon initial hypotheses, it was 
speculated that injured athletes might have shown increased heart rates post-injury, similar to 
what has been seen in depressed individuals, this appears to not have been the case.  The 
participants in the current study were young, relatively healthy (with exception of injury), 
competitive athletes and it appears that HR was not influenced in a negative manner upon injury 
and in dealing with the recovery process.  This can explain the stability seen across time in 
overall means for heart rate during both tasks.  Reasons for the slight increases in heart rates 
from Baseline to Week 3, seen across the groups, may have been due to participants becoming 
more active as recovery progressed over time.   
Findings in the current study revealed that, based on overall means, injured athletes 
demonstrated significant increases in SDNN, a time-domain indices of HRV, during Task A – 
Rest Period at Week 1, as compared to Baseline.  SDNN, based on overall means showed a 
decline thereafter, however, remained significantly increased at Week 2, and increased at Week 3 
compared to Baseline.  While it was not statistically significant, there were trends indicating that 
the HRV BFB Experimental group displayed greater increases in SDNN during Task A, 
compared to either of the other groups across time.  It follows that HRV BFB training may be 
effective in leading to increased HRV, as measured by SDNN, in injured athletes post-injury and 
throughout the rehabilitation process.  The results seen in this study are consistent with prior 
HRV BFB studies by Del Pozo et al. (2004), Karavidas et al. (2007), and Zucker et al. (2009), 
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who found that individuals who received a HRV BFB intervention showed significant increases 
in SDNN across time.  Findings of the current study regarding SDNN during Task B – Paced 
Breathing Exercise were less clear.  Based on overall means, SDNN during Task B significantly 
increased from Baseline to Week 1, however, decreased to Baseline levels by Week 3, post-
intervention.  There were no significant differences seen between groups in terms of variation in 
SDNN during Task B across time.   
 With regards to the frequency-domain indices of total HRV, findings revealed that, based 
on overall means, injured athletes showed significant increases in total HRV during Task A – 
Rest Period at Week 1, as compared to Baseline.  Total HRV, based on overall means showed a 
decline thereafter, however, remained increased at Week 2 and Week 3 compared to Baseline.  
Although not statistically significant, an exploratory analysis revealed that based on group 
means, injured athletes in the HRV BFB Experimental group displayed greater increases in total 
HRV during Task A from Baseline to Week 3, compared to those in either the Placebo or 
Control groups.  Findings of the current study regarding total HRV during Task B – Paced 
Breathing Exercise revealed that, based on overall means, total HRV significantly increased in 
injured athletes from Baseline to Week 1, however, decreased thereafter.  There were no 
significant differences between groups in terms of variation in total HRV during Task B across 
time.   
 In terms of LF HRV, findings indicated that while, based on overall means, injured 
athletes showed significant improvements in LF HRV during Task A – Rest Period each week as 
compared to Baseline, the HRV BFB Experimental group demonstrated significantly greater 
increases in LF HRV during Task A than either of the other two groups.  This speaks to the 
potential effectiveness of HRV BFB training to increase LF HRV in injured athletes post-injury 
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and throughout the rehabilitation process.  Individuals in the HRV BFB Experimental group 
reported significantly greater gains in LF HRV during rest, as compared to injured athletes who 
received a sham HRV BFB intervention and those who received no training throughout their 
recovery.  The findings regarding LF HRV during Task A in the current study are consistent with 
those by Paul, Garg, and Sandhu (2012) who found that basketball players who underwent a 
HRV BFB intervention demonstrated significantly greater increases in LF HRV from pre- to 
post-intervention, than those in either the placebo or control groups.  Findings regarding LF 
HRV during Task B – Paced Breathing Exercise are consistent with those seen for Total HRV 
Task B – Paced Breathing Exercise.    
 With regards to HF HRV, findings indicated that based on overall means, HF HRV 
during Task A – Rest Period for injured athletes remained relatively stable across time from 
Baseline to Week 3.  Findings for HF HRV during Task B – Paced Breathing Exercise indicated 
that, based on overall means, HF HRV significantly increased from Baseline to Week 1 before 
decreasing to Baseline levels thereafter.  For both HF HRV during Tasks A and B, results 
indicated that there were no significant differences between groups in terms of variation in HF 
HRV over time.  A lack of change in HF HRV for those in the Placebo and Control groups was 
as expected.  In terms of the HRV BFB Experimental group, it was hypothesized that due to an 
increase in total HRV over time, these individuals would also demonstrate increases in HF HRV.  
However, Wheat and Larkin (2010) in a review of the literature on HRV BFB, concluded that all 
results were in agreement that HF HRV does not increase subsequent to HRV BFB training.  
This lack of change in HF HRV is proposed to be due to individuals reducing their respiratory 
rate and breathing in a slow and controlled manner causing RSA to shift from the HF to the LF 
range of HRV (Karavidas et al., 2007; Wheat & Larkin, 2010).  
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Finally, findings revealed that while respiration rates during Task A – Rest Period 
remained relatively the same for those in both the Placebo and Control groups, injured athletes in 
the HRV BFB Experimental group displayed significant reductions in respiration rate during 
Task A at each week, compared to Baseline.  Overall, injured athletes in the HRV BFB 
Experimental group had significantly lower respiration rates than injured athletes who were not 
provided with HRV BFB training.  These findings are consistent with those of Paul, Garg, and 
Sandhu (2012) who found respiration rates to be significantly reduced in basketball players who 
received HRV BFB training, compared to those who had not received such training.  This speaks 
to the effectiveness of HRV BFB in enhancing individuals’ awareness and control over their 
respiratory patterns to aid in self-regulation and relaxation.  Findings with regards to respiration 
rates during Task B – Paced Breathing Exercise were as expected.  All injured athletes seemed 
capable of reducing respiration to approximately six breaths per minutes with the aid of a 
respiratory pacer.   
 In conclusion, it appears that HRV BFB may hold promise as a form of psychological 
skills training intervention to facilitate injured athletes throughout rehabilitation and the 
subsequent recovery period.  From the findings of the current investigation, it can be concluded 
that a HRV BFB intervention may be an effective tool within the rehabilitation setting to 
improve athletes’ psychological responses and psychological outcomes pertaining to injury and 
rehabilitation.   
4.2 Study Strengths 
 It is important to recognize the relative strengths and merit of the current study and its 
respective design.  First and foremost, it would appear from the literature reviewed to date that 
this was the first study of its kind examining the effectiveness of a HRV BFB intervention in the 
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context of an athletic injury population.  While other techniques have been used within sport 
psychology, the use of HRV biofeedback was a novel and new approach within the athletic 
rehabilitation setting.  This form of psychophysiological skills training has yet to be extensively 
researched as a form of intervention to facilitate the injured athlete during their rehabilitation 
process.  More specifically, as a means to reduce the negative affect and emotional distress 
experienced by injured athletes, while enhancing psychological traits seen to be beneficial to a 
successful recovery with optimal outcomes, both physical and psychological.  The current study 
was therefore exploratory in nature, and the findings will inform the research community of 
HRV BFB’s potential in the sport injury context.  Findings from the current study may serve as a 
foundation from which future studies examining the effects of HRV BFB and its relative use in 
the athletic injury population may build off.  Cupal (1998), in a review of the literature on 
rehabilitative psychological interventions for sport injury, argued that psychological intervention 
studies demonstrate preliminary evidence of treatment efficacy and that further empirical 
investigation into the rehabilitative injury process is warranted.  The present study not only 
served to further investigate the effects of psychological skills training in the athletic injury 
population, but will hopefully speak to the potential of BFB as an available and useful 
rehabilitation tool, and as a plausible and efficacious technique to facilitate injured athletes 
throughout recovery and in their return to sport.  
 The current investigation had a number of strengths in the study design.  As an 
intervention study exploring the effects of a novel and new approach to psychological recovery 
within the athletic injury rehabilitation setting, the inclusion of both a placebo and a control 
group was a relative strength.  Prior research regarding the use of HRV BFB in other populations 
and other forms of psychological skills training within the athletic injury setting have 
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emphasized the importance of utilizing a control and/or placebo group in study designs (Hassett 
et al., 2007; Cupal, 1998; Wheat & Larkin, 2010).  Cupal (1998) argued that without adequate 
controls, including assessing the impact of potential placebo effects in psychological 
intervention, it is difficult to separate treatment effects from effects of other intervening 
variables.  Therefore, the current study can cite the inclusion of not only a control group, but also 
a placebo or active control group as definite strength.  Specific to HRV BFB interventions, 
Hassett et al. (2007) expressed that these interventions should be compared to a sham or another 
form of BFB to allow differentiation between actual treatment effects and potential placebo 
effects or effects resulting from factors other than the intervention itself.  In the current study, 
this recommendation was attended to by utilization of a HRV BFB placebo group, similar to 
those used in prior HRV BFB studies conducted by Lehrer et al. (2004) and Siepmann et al. 
(2008).  Overall, the inclusion of both a control group and placebo group in this study helped in 
ruling out the Hawthorne effect and in evaluating the efficacy of the HRV BFB intervention 
itself. 
 A further strength of the current study was the implementation of a pre-existing HRV 
BFB training protocol that has been used in the majority of previous studies employing HRV 
BFB interventions.  The intervention utilized in the current study was structured based on the 
HRV BFB training protocol outlined in the manual by Lehrer et al. (2000).  This was seen as a 
strength due to the fact that by incorporating a training protocol previously used in other BFB 
studies with proven efficacy, procedural reliability was increased.  A third strength of the current 
study was the randomization of participants into the three experimental conditions.  Randomly 
assigning participants to one of the three experimental conditions helped in increasing the 
likelihood that groups would not be vastly different in terms of demographics.   
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 Furthermore, inclusion of multiple data collection points or assessments was seen as a 
major strength of the current study in that it allowed us to examine the temporal effects on a 
number of psychological outcomes pertaining to injury and rehabilitation over the duration of a 
3-week period.  Including four data assessments into the study design allowed the researchers to 
examine differences in perceptions of various psychological outcomes and the measured 
physiological indices over time, rather than just at Baseline and post-intervention.  Due to 
previous research regarding injury rehabilitation supporting the idea that negative affect, mood 
disturbance, and psychological distress tend to dissipate over time, multiple assessment periods 
allowed the researchers to examine if psychological responses of injured athletes differed across 
time depending on the specific training, or lack thereof received (Tracey, 2003; Brewer et al., 
2007).  
 Finally, a last important feature of the present investigation was the use of psychological 
and emotional response variables designed for specific use within the context of injury 
rehabilitation.  Specifically, the AISEQ (Milne et al., 2005) used to measure self-efficacy, the 
PRSII-19 (Evans et al., 2008), and the adherence measure utilized were all population specific 
measures to the athletic injury domain.  This was seen as a strength in allowing researchers to not 
just assess differences in outcomes assessed by general population measures, such as overall 
perceived anxiety, stress, and pain, but also in outcomes specifically designed to assess the 
experiences of injured athletes.  Noteworthy, due to this being a preliminary study, it was chosen 
to include injured athletes from a range of sports displaying an array of injuries to gain an 
introductory understanding as to the effects of HRV BFB training in the athletic injury domain, 
increase generalizability of findings, and to maximize potential recruitment. 
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4.3 Study Limitations 
Despite the numerous strengths of this study, there are a few limitations that must be 
addressed in terms of (a) the sample that was acquired, (b) equipment and technical procedures, 
(c) design/procedural weaknesses, and (d) data analysis. 
 Sample. The sample for the current study displayed a few characteristics that must be 
noted and understood in the interpretation of study findings, as well as for future study 
recommendations.  First, the current sample consisted of majority males (i.e., 68%), young adult 
(Mage) = 20.82, university students who were varsity athletes competing in sport at provincial and 
national levels.  Results should be interpreted with this in mind and caution should thereby be 
upheld when generalizing the study findings to populations of different age groups, 
socioeconomic status, and competition levels.  Another issue with the current study is that an 
overwhelming majority of the injured athletes who took part had prior history of injury and 
experience dealing with rehabilitation (i.e.79%).  Walker et al. (2007) suggested that after 
sustaining an injury and experiencing an extensive rehabilitation period, athletes may 
demonstrate greater dedication, focus, and mental toughness than before the injury had occurred.  
This may explain some of the current study findings in that a lot of the group mean scores on 
psychological outcome measures were truncated to the lower end (i.e., less severe).  Future 
studies should consider controlling for injury history in order to examine the extent of athletes 
psychological response having never been through a rehabilitation process before.  A final 
limitation pertaining to the sample of the current study was that eligibility criteria required only 
that participants (a) had sustained a recent musculoskeletal injury in sport and/or athletic activity, 
(b) be currently out of practice and/or training for the sport in which the injury occurred, and (c) 
be undergoing rehabilitation for the injury.  Due to time constraints in terms of data collection 
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and study completion, the nature of injury rehabilitation research, issues surrounding the fact that 
one cannot control when individuals sustain an injury, and the delay between injury onset, 
initiation of rehabilitation, and actual recruitment notification, it was not possible to control for 
and/or match participants across groups based on time since injury.  Therefore, although 
recruitment was preferred and most desirable immediately post-injury or in the days following, 
this was majority of the time not the case as 93% of participants were recruited more than a week 
after sustaining the injury.  Future studies should consider controlling for time since injury or 
examining methods by which participants can be streamlined into the study upon injury onset, 
especially given the current injury rehabilitation research, which indicates that negative affect 
and mood disturbance improves over time (Tracey, 2003; Brewer et al., 2007).  Together, the 
inability of the current study to include stricter inclusion criteria regarding injury severity, 
history of injury, and time since injury onset was a limitation in that it may have impacted the 
levels to which injured athletes perceived psychological outcomes with respect to injury and 
rehabilitation and the degree to which the injured athletes were experiencing negative 
psychological responses as a result.  Future studies that are able to control for any of the above 
would be encouraged in order to examine how results may differ from the current study.   
 Equipment and technical procedures. A few limitations in terms of equipment and 
technical procedures were found in the current study.  First, due to this being a masters’ thesis 
study and funding being an issue, securing the appropriate BFB equipment, desired HRV BFB 
software, and laboratory space needed for study completion proved to be challenging.  
Nonetheless, eventually issues were resolved, however, not without a few issues that must be 
taken into consideration.  While the software obtained for the implementation of the 
psychophysiological assessment and BFB training sessions met requirements and offered all of 
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the essential capabilities needed, there are a number of more advanced software packages 
available with multi-display screens and a variety of training modules that would have allowed 
for easier and more effective BFB training for those allocated to the HRV BFB Experimental 
group.  Furthermore, while the training sessions and psychophysiological assessments were 
carried out in a controlled setting, construction in the facility where study participation took 
place posed some noise and disturbance.  This may have partially taken away from the ideal 
environment for BFB training.  Another limitation with regards to technical procedures is that 
psychophysiological assessments were not carried out at the same time each week for each 
individual.  As much as this was a priority of the researcher, this was simply not possible due to 
(a) there being a sole researcher completing data collection, (b) having to revolve around 
participant’s schedules, and (c) scheduling multiple participants on a given day.  From a 
consistency point of view, this would have been seen as a strength in the study design, however, 
it was not possible in the current study.  Finally, with respect to the psychophysiological 
assessment during data collection sessions, participants were asked to refrain from vigorous 
exercise, caffeine, nicotine, and/or alcohol beforehand, however controlling for this was not 
addressed procedurally.  It is therefore possible that participants did not uphold this request.   
 Design and study procedures. While not all of the following may be viewed as 
limitations as much as future directions for research to follow, a few issues with the current study 
design will be addressed.  First, while it was seen as a strength of the current study including 
multiple assessments to gain an understanding of the emotional experience and psychological 
responses of injured athletes as they progressed through injury recovery over a three-week 
duration, it would have been a strength to include a follow-up assessment post-intervention to 
gain insight into long-term effects of the HRV BFB intervention.  One limitation of a repeated 
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measures design that must be noted is the potential for social desirability on behalf of the 
participants and the possible introduction of biases towards self-report measures.  Secondly, 
previous studies exploring the effectiveness of psychological interventions in athletic injury 
rehabilitation have cited that injured athletes perceptions of the delivered psychological 
intervention may offer important information for subsequent research (Evans & Hardy, 2002).  
The current study unfortunately did not include a post-intervention qualitative assessment 
evaluating injured athletes perceptions of HRV BFB, however it is acknowledged that this would 
have strengthened the study design and possibly provided an information-rich piece of data.  
Likewise, it would have also been an improvement in the study design to have included a short 
assessment of the degree to which injured athletes in the experimental group engaged in BFB 
practice or the techniques learned through BRB training outside of training sessions.  Further, 
because recruitment was heavily completed through athletic therapy clinics at Wilfrid Laurier 
University, it is possible that crossover effects or social comparison may have occurred between 
participants in that those who received the control condition or placebo condition may have 
spoken with individuals who were allocated to the intervention and heard of the “true” 
experimental procedures.  This would have possibly led to a limitation in that by vicarious 
experience, individuals may have learned BFB techniques.  Previous research regarding 
psychological interventions in athletic injury rehabilitation have expressed that these studies 
should include measures of rehabilitation outcomes, functional outcomes, and/or treatment 
outcomes (Brewer, 1998; Evans & Hardy, 2002; Wesch et al., 2012).  Unfortunately, due to the 
exploratory nature of this study and broad inclusion criteria (e.g., variation in both sports and 
injuries), these were not assessed.  A final gap in the present study that should be addressed in 
future studies examining the effects of HRV BFB on injured athletes’ psychological responses 
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post-injury is the inclusion of a healthy control group to examine how injured athletes compare 
on various outcomes to healthy individuals.  
 Data Analysis. Although the initial recruitment goal of 30 participants was almost 
achieved, a larger sample size would have served to increase statistical power and possibly 
generate more pronounced effects, especially for those measures bordering significance for either 
a time or interaction main effect.  Another limitation with regards to data analysis is that due to a 
relatively small sample size, and a number of scores on the psychological outcome measures 
being truncated to one end, there were a number of instances where either the assumptions of 
normality or homogeneity of variance were violated.  However, after a number of considerations, 
it was decided against utilizing a series of data transformations to attempt to improve the 
skewness and kurtosis present.  Reasons included (a) the preliminary nature of the study, (b) the 
relatively small sample size which considering possible scores on the outcome measures made it 
almost impossible to achieve a truly normal distribution, (c) the fact that skewed scores may 
have actually demonstrated what was normal in this study, and finally (d) the possibility that 
transforming data would actually cause more problems (i.e., the groups and assessment periods 
where normality was achieved may actually become violated) and make interpretation of the 
results difficult.  Nonetheless, this was a study limitation and must be acknowledged. 
4.4 Future Directions 
 A number of future recommendations should be considered with respect to the findings 
presented herein.  Future directions stemming from the current investigation may be categorized 
in terms of (a) psychological skills interventions in injury rehabilitation, (b) BFB specifically and 
its use in the athletic injury population, and finally, (c) research pertaining to the use of BFB in 
general.  For future investigations regarding the use of psychological skills interventions in this 
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population, researchers should consider including larger sample sizes, participants matched 
across demographic variables, homogenous populations, and randomization of participants into 
both a placebo and control group. 
Future investigations are encouraged to build off the results found in the current study to 
design and implement BFB interventions for injured athletes.  Wheat and Larkin (2010) 
emphasized the importance of replicating BFB investigations that have been completed because 
until studies have been embedded within a larger network of investigations surrounding HRV 
BFB’s effects in the same population, each study completed continues to be isolated and a 
complete understanding will not be reached.  Therefore, researchers should replicate the current 
investigation with injured athletes in order to develop a solid foundation of the potential effects 
of HRV BFB in this population.  Specifically, future recommendations should include 
investigations of potential mechanisms by which HRV BFB may lead to beneficial outcomes in 
injured athletes.  Until this is truly understood, the most effective BFB interventions cannot be 
implemented and how this may influence athletes’ psychological responses following injury will 
not be fully understood.  Second, it would be interesting to investigate whether individuals 
naturally higher in HRV display improved psychological responses to sport injury, experience 
less mood disturbances, and improved recovery outcomes.  Additionally, exploring the effects of 
combining HRV BFB with more traditional forms of psychological intervention techniques 
could prove to be a viable avenue.  Paul and Garg (2012) suggested combining HRV BFB with 
relaxation imagery, progressive muscle relaxation, and other forms of mental skills training 
interventions so as to generate physiological and psychological domains more consistently and 
extensively.  Fourth, although recruitment with this population poses difficulty, now that the 
exploratory study regarding HRV BFB in the injury population has been completed, future 
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researchers are encouraged to investigate the efficacy of BFB with regards to particular injury 
types and specific sports.  Conducting subsequent investigation where by the time since injury 
can be controlled for would be an interesting next step within this field.  An approach whereby 
participants could be accessed immediately post-injury would allow researchers to gain a true 
sense of the temporal patterns in various psychological and physical outcomes pertaining to 
injury and rehabilitation.  Future investigations are also encouraged to include stricter criteria 
regarding injury severity in order to identify potential benefits of BFB when improvements are 
there to be made.  Inclusion of follow-up assessments in future studies examining this population 
would also be recommended to identify any long-term benefits, which may be present.  
Furthermore, there is a strong call for future investigations employing the use of HRV BFB in 
athletic injury to investigate its potential effects on functional outcomes, recovery outcomes, 
direct adherence, return to play statuses, and satisfaction with rehabilitation.  It would be 
interesting to examine if BFB has the ability to promote functional gains in these athletes.  
Finally, inclusion of qualitative methods to get a true sense of athletes’ perceptions of HRV BFB 
as a form of psychological skills training intervention would be a strength of future studies.   
 There is still much research to be done with regards to the use of HRV BFB in general.  
Future research is required in order to ascertain the mechanisms by which HRV BFB may lead to 
improvements.  Continued efforts are also needed to validate methods of measuring and 
analyzing HRV and to strengthen protocols for HRV BFB training.  Lastly, the potential effects 
of HRV BFB over a longer duration than in the present study should be examined in order to 
identify whether any long-term benefits are maintained.   
4.5 Implications 
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With this study being one of the first investigations surrounding the effectiveness of HRV 
BFB in the athletic injury domain to improve athletes’ psychological response regarding injury 
and rehabilitation, there are a number of practical implications that can be noted with respect to 
both BFB and psychological skills training.  First, there should be continued efforts to raise 
awareness of the psychological impact that an injury can have on athletes.  Second, 
psychological skills training is a tool all athletes, especially injured athletes should be aware of 
and provided with avenues by which to obtain access to.  Practitioners should also be educated 
on the relative efficacy of psychological intervention techniques in the athletic injury population 
and encouraged to employ these using established protocols.  Third, psychological rehabilitation 
tools should be used in conjunction with physical rehabilitation tools to facilitate optimal 
recovery outcomes from both a psychological and physical standpoint.  A multidisciplinary 
approach should be taken with regards to injury and the subsequent recovery process in order to 
address elements of both physical and psychological healing.  Fourth, with regards to BFB, this 
study emphasized the importance of teaching athletes self-regulatory techniques with respect to 
both physiological and emotional arousal.  This research speaks to the potential efficacy of HRV 
BFB as an available and useful rehabilitation tool, within the athletic injury population, and it 
may be a worthwhile technique to utilize to facilitate injured athletes throughout recovery.  
Practical implications may be extended through this research, as it speaks to the importance of 
educating and enabling injured athletes to be proactive, informed, and involved to achieve an 
optimal rehab outcome.  Injured athletes should be provided with opportunities to obtain 
improved self-regulation of mood states and arousal, effective relaxation techniques, along with 
greater adaptability and coping strategies when faced with stressors throughout their recovery 
and return to sport. 
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Chapter 5: Conclusion 
Given the genesis of the research study to evaluate the effectiveness of HRV 
biofeedback, a form of psychophysiological skills training intervention, to improve athletes’ 
psychological response following an injury, the purpose was to examine the effects of HRV BFB 
training on self-efficacy, perceived stress and anxiety, pain management, and the psychological 
responses of injured athletes.  HRV BFB effects on athletes’ physiological indices including 
HRV, HR, and respiration rate were also assessed.  Participants recruited for this study were 
individuals who had sustained a moderate to severe musculoskeletal sports injury (Fuller et al., 
2006), preventing their participation in training and competition for their respective sport.  
Eligibility criteria included: (a) participants to be at least 16 years of age, (b) injuries to have 
occurred during participation in sport/athletic activity, (c) participants to be out of practice and/or 
competition for the sport in which the injury occurred, (d) participants to be undergoing 
rehabilitation for the injury (e.g., physiotherapy, massage therapy, athletic therapy, etc.) and (e) 
participants to be athletes involved in sport at a competitive level (e.g., regional, rep, varsity, 
provincial, national) and/or to be engaging in sport in a competitive environment (e.g., adult 
competitive league, training for specific events, road races, competitions, etc.).   
This investigation was experimental in nature with a randomized, single-blinded study 
design.  A 4 (Time: Baseline, Week 1, Week 2, Week 3; assessments across time) x 3 (Group: 
HRV BFB Experimental group, HRV BFB Placebo group, Control group; experimental 
conditions) mixed model design was utilized to examine the emotional experience and 
psychological responses of injured athletes as they progressed through injury recovery.  Different 
groups were utilized in order to evaluate if athletes' psychological responses regarding injury and 
rehabilitation differed depending on the specific training they received.  Specifically, there was 
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an experimental group, which received the HRV BFB intervention, a placebo group, which 
perceived themselves to be receiving a BFB intervention to control for any effects which may 
influence the athlete’s psychological responses and physiological indices other than the 
intervention training protocol itself, and finally a control group, who received no treatment over 
the course of their rehabilitation and recovery.  It was hypothesized that injured athletes who 
received the HRV BFB intervention would demonstrate significantly greater improvements in 
psychological outcomes pertaining to injury and rehabilitation across time than injured athletes 
who were not provided with this form of intervention (i.e., HRV BFB Placebo group and Control 
group).  Specifically, it was hypothesized that the HRV BFB Experimental group would report 
significantly greater increases in perceptions of self-efficacy and reorganization, significantly 
greater decreases in perceived stress, anxiety, and pain, significantly greater reductions in 
psychological responses of devastation, feeling cheated, restlessness, and isolation, and finally, 
significantly greater declines in pain catastrophizing and disability due to pain over time, 
compared to both the HRV BFB Placebo group and Control group.  Further, it was hypothesized 
that injured athletes who received the HRV BFB intervention would demonstrate significantly 
greater improvements in physiological indices corresponding to BFB training than injured 
athletes who were not provided with this form of intervention (i.e., HRV BFB Placebo group and 
Control group).  Specifically, it was hypothesized that the HRV BFB Experimental group would 
demonstrate significant increases in both time-domain (i.e., SDNN) and frequency-domain (i.e., 
Total HRV, LF HRV, HF HRV) measures of HRV, and significant declines in HR and 
respiration rate over the duration of the study, compared to both the HRV BFB Placebo group 
and Control group.   
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Results demonstrated that injured athletes who received the HRV BFB intervention (i.e., 
HRV BFB Experimental group) reported (a) significantly greater reductions in psychological 
responses of devastation, reorganization, and isolation, (b) significantly greater declines in 
magnification regarding pain, (c) significantly greater improvements in LF HRV during rest, and 
(d) significantly greater declines in resting respiration rate across time than injured athletes who 
were not provided with this form of intervention (i.e., HRV BFB Placebo group and Control 
group).  While not reaching statistical significance, injured athletes who received the HRV BFB 
intervention also demonstrated (a) greater reductions in the psychological response of 
restlessness, (b) greater declines in perceived anxiety, (c) greater improvements in pain 
catastrophizing and rumination, (d) greater declines in disability due to pain, and (e) greater 
improvements in HRV during rest as measured by SDNN across time than injured athletes who 
were not provided with this form of intervention.  This preliminary investigation was the first 
known sport psychology study regarding psychological skills interventions in injury 
rehabilitation to attempt to improve the psychological response of injured athletes with the use of 
a HRV BFB intervention.  As such, there were a number of relative strengths to the current 
study, however, limitations were also discussed with reference to recommendations for future 
research in this exciting field of study.  Further, with this being an introductory study into the 
effectiveness of HRV BFB in the athletic injury population, there are numerous future directions 
for other researchers interested in this discipline to branch off of in subsequent investigations.  
The present study provides an introductory basis for the use of HRV BFB interventions in the 
athletic injury population to improve psychological responses and physiological indices of 
injured athletes throughout the rehabilitation and recovery process.  In conclusion, it appears that 
HRV BFB may hold potential to improve athletes’ psychological response after sustaining an 
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injury and that it shows promise as a useful psychological skills intervention for injury 
rehabilitation.  
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Table 1 
Participant Demographic Information based on group 
 Group 
Variable Experimental  
(n = 9) 
Placebo 
(n = 9) 
Control 
(n = 10) 
Age  (Years) 
Mean (SD) 
22.0 years  
(5.5) 
21.0 years 
(1.5) 
19.6 years 
(1.7) 
Sex (M/F) 5 Females 
(55.6%) 
4 Males 
(44.4%) 
1 Female 
(11.1%) 
8 Males 
(88.9%) 
3 Females 
(30%) 
7 Males 
(70%) 
Injury 
History (i.e., 
number of 
previous 
injuries) 
No 1 (11.1%) 1 (11.1%) 4 (40%) 
1 3 (33.3%) 1 (11.1%) 1 (10%) 
2 1 (11.1%) 1 (11.1%) 2 (20%) 
3 2 (22.2%) 2 (22.2%) 2 (20%) 
4 2 (22.2%) 4 (44.4%) 1 (10%) 
Sport Soccer 3 (33.3%) 2 (22.2%) 3 (30%) 
 
Football --- 3 (33.3%) 3 (30%) 
Hockey 2 (22.2%) 3 (33.3%) 1 (10%) 
Rugby 1 (11.1%) 1 (11.1%) 2 (20%) 
Baseball --- --- 1 (10%) 
Basketball 1 (11.1%) --- --- 
Cheerleading 1 (11.1%) --- --- 
Ultra running 1 (11.1%) --- --- 
Competition Varsity/University 7 (77.8%) 9 (100%) 9 (90% 
Competitive 
Recreational 
1 (11.1%) --- 1 (10%) 
Other 1 (11.1%) --- --- 
Injury Type Knee 4 (44.4%) 3 (33.3%) 5 (50%) 
Hip 1 (11.1%) 4 (44.4%) --- 
Ankle 2 (22.2%) --- 3 (30%) 
Shoulder --- 1 (11.1%) 1 (10%) 
Other 2 (22.2%) 1 (11.1%) 1 (10%) 
Time Since 
Injury 
Onset  
Less than week 1 (11.1%) 1 (11.1%) --- 
More than week, 
less than month 
5 (55.6%) 5 (55.6%) 3 (30%) 
More than month 3 (33.3%) 3 (33.3%) 7 (70%) 
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Table 2 
Descriptive Statistics for Task Self-Efficacy and Coping Self-Efficacy at Baseline, Week 1, Week 
2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Task 
Self-
Efficacy  
Experimental  9 94.08 
(6.41) 
92.22 
(6.87) 
95.56 
(4.71) 
96.30 
(5.12) 
 
94.54 
Placebo 9 96.67 
(5.53) 
96.30 
(7.35) 
95.93 
(8.13) 
94.82 
(9.44) 
95.93 
Control 10 86.33 
(16.44) 
88.00 
(13.44) 
90.00 
(12.47) 
89.67 
(13.47) 
88.50 
Total 28 92.14 
(11.48) 
92.02 
(10.12) 
93.69 
(9.27) 
93.45 
(10.16) 
--------- 
Coping 
Self-
Efficacy 
Experimental 9 85.28 
(13.02) 
85.00 
(12.37) 
86.11 
(11.05) 
89.58 
(13.05) 
86.49 
 
Placebo 9 87.78 
(13.89) 
86.67 
(13.52) 
88.89 
(12.06) 
90.28 
(13.14) 
88.40 
Control 10 75.00 
(17.72) 
73.75 
(18.68) 
79.75 
(20.22) 
80.50 
(22.91) 
77.25 
Total 28 82.41 
(15.64) 
81.52 
(15.85) 
84.73 
(15.20) 
86.56 
(17.26) 
--------- 
Note. Self-Efficacy scores range from a low of 0% to a high of 100%. 
 
 
Table 3  
Descriptive Statistics for Perceived Stress at Baseline, Week 1, Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Perceived 
Stress  
Experimental  9 17.78 
(4.94) 
16.33 
(5.36) 
13.11 
(6.86) 
 
10.44 
(4.77) 
 
14.42 
Placebo 9 12.00 
(5.85) 
11.89 
(8.43) 
12.11 
(8.22) 
11.56 
(7.91) 
11.89 
Control 10 16.90 
(8.23) 
17.50 
(9.86) 
16.70 
(6.48) 
11.80 
(7.29) 
15.73 
Total 28 15.61 
(6.82) 
15.32 
(8.25) 
14.07 
(7.22) 
11.29 
(6.58) 
--------- 
Note. Perceived stress scores range from a low of 0 to a high of 40.  
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Table 4  
Descriptive Statistics for Psychological Response to Sport Injury subscales at Baseline, Week 1, 
Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Devastation  Experimental  9 12.11 
(2.52) 
9.44 
(3.47) 
7.33 
(2.69) 
 
6.00 
(2.35) 
 
8.72 
Placebo 9 7.22 
(3.42) 
8.11 
(4.83) 
7.44 
(3.36) 
7.56 
(4.22) 
7.58 
Control 10 10.40 
(4.67) 
9.30 
(4.69) 
9.00 
(4.32) 
8.00 
(5.08) 
9.18 
Total 28 9.93 
(4.09) 
8.96 
(4.26) 
7.96 
(3.51) 
7.21 
(4.03) 
--------- 
Reorganization Experimental 9 7.33 
(1.66) 
9.56 
(3.36) 
9.89 
(2.42) 
10.33 
(2.35) 
9.28 
 
Placebo 9 9.67 
(2.40) 
10.44 
(3.09) 
10.56 
(3.05) 
10.67 
(2.50) 
10.33 
Control 10 9.70 
(2.36) 
8.80 
(2.15) 
9.30 
(2.26) 
10.40 
(2.32) 
9.55 
Total 28 8.93 
(2.37) 
9.57 
(2.86) 
9.89 
(2.54) 
10.46 
(2.30) 
--------- 
Feeling Cheated Experimental 9 9.44 
(3.05) 
8.11 
(2.76) 
7.33 
(2.40) 
6.67 
(2.74) 
7.89 
 
Placebo 9 7.33 
(3.16) 
7.11 
(3.86) 
7.78 
(4.55) 
7.78 
(5.07) 
7.50 
Control 10 8.60 
(4.20) 
9.20 
(4.85) 
9.10 
(4.98) 
8.50 
(5.19) 
8.85 
Total 28 8.46 
(3.51) 
8.18 
(3.91) 
8.11 
(4.09) 
7.68 
(4.41) 
--------- 
Restlessness Experimental 9 9.78 
(2.28) 
8.33 
(2.35) 
7.44 
(1.81) 
5.78 
(2.22) 
7.83 
 
Placebo 9 7.22 
(2.91) 
7.00 
(3.28) 
7.11 
(3.48) 
6.22 
(2.99) 
6.89 
Control 10 9.20 
(3.46) 
9.60 
(5.19) 
9.00 
(4.90) 
8.40 
(5.48) 
9.05 
Total 28 8.75 
(3.04) 
8.36 
(3.87) 
7.89 
(3.65) 
6.86 
(3.94) 
--------- 
Isolation Experimental 9 7.33 
(1.94) 
7.11 
(2.09) 
6.11 
(3.06) 
5.00 
(1.66) 
6.39 
 
Placebo 9 5.33 
(1.66) 
5.22 
(1.56) 
6.11 
(2.76) 
5.44 
(2.30) 
5.53 
Control 10 7.30 
(2.91) 
7.30 
(3.47) 
8.00 
(3.77) 
6.80 
(3.36) 
7.35 
Total 28 6.68 6.57 6.79 5.79 --------- 
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(2.37) (2.63) (3.26) (2.60) 
Note. Psychological Response to Sport Injury subscales range from a low of 4 to a high of 20, 
with the exception of reorganization, which ranges from a low of 3 to a high of 15. 
 
Table 5 
Descriptive Statistics for Perceived Anxiety at Baseline, Week 1, Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Perceived 
Anxiety 
Experimental  9 41.11 
(12.38) 
38.33 
(10.98) 
35.67 
(8.68) 
 
32.89 
(8.58) 
 
37.00 
Placebo 9 33.00 
(12.40) 
33.44 
(13.13) 
33.67 
(13.58) 
34.22 
(12.50) 
33.583 
Control 10 39.90 
(11.93) 
43.90 
(13.15) 
43.60 
(14.10) 
38.20 
(15.27) 
41.40 
Total 28 38.07 
(12.30) 
38.75 
(12.79) 
37.86 
(12.76) 
35.21 
(12.30) 
--------- 
Note. Perceived anxiety scores range from a low of 20 to a high of 80. 
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Table 6 
Descriptive Statistics for Pain Catastrophizing and respective subscales at Baseline, Week 1, 
Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Pain 
Catastrophizing 
Total 
Experimental  9 21.78 
(9.46) 
13.78 
(8.18) 
14.56 
(9.91) 
 
10.11 
(9.99) 
 
15.06 
Placebo 9 15.22 
(13.54) 
13.56 
(13.31) 
12.89 
(14.10) 
12.56 
(13.56) 
13.56 
Control 10 22.40 
(9.32) 
18.80 
(13.27) 
14.00 
(10.38) 
17.20 
(13.85) 
18.10 
Total 28 19.89 
(10.98) 
15.50 
(11.72) 
13.82 
(11.16) 
13.43 
(12.54) 
--------- 
Rumination Experimental 9 8.22 
(4.24) 
5.67 
(3.87) 
5.78 
(3.73) 
3.89 
(3.92) 
5.89  
 
Placebo 9 5.33 
(4.18) 
5.33 
(4.06) 
4.78 
(4.87) 
5.11 
(4.86) 
5.14 
Control 10 8.90 
(4.07) 
7.30 
(4.76) 
4.50 
(4.30) 
6.20 
(4.54) 
6.73 
Total 28 7.54 
(4.30) 
6.14 
(4.21) 
5.00 
(4.20) 
5.11 
(4.40) 
--------- 
Magnification Experimental 9 5.33 
(2.78) 
3.67 
(2.60) 
3.78 
(2.28) 
2.67 
(2.06) 
3.86 
 
Placebo 9 3.44 
(3.78) 
3.67 
(3.81) 
3.56 
(4.00) 
3.33 
(4.00) 
3.50 
Control 10 5.50 
(2.64) 
4.80 
(3.85) 
4.50 
(2.99) 
5.30 
(3.86) 
5.03 
Total 28 4.79 
(3.12) 
4.07 
(3.40) 
3.96 
(3.07) 
3.82 
(3.51) 
--------- 
Helplessness Experimental 9 8.22 
(3.80) 
4.44 
(2.51) 
5.00 
(4.18) 
3.56 
(4.85) 
5.31  
 
Placebo 9 6.44 
(6.02) 
4.56 
(5.94) 
4.56 
(5.55) 
4.11 
(5.30) 
4.92 
Control 10 8.00 
(4.47) 
6.70 
(5.50) 
5.00 
(3.97) 
5.70 
(6.08) 
6.35 
Total 28 7.57 
(4.73) 
5.29 
(4.85) 
4.86 
(4.43) 
4.50 
(5.34) 
--------- 
Note. Total pain catastrophizing scores range from a low of 0 to a high of 52; rumination 
subscale a low of 0 to a high of 16; magnification subscale a low of 0 to a high of 12; 
helplessness subscale a low of 0 to a high of 24. 
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Table 7  
Descriptive Statistics for Perceived Pain at Baseline, Week 1, Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Perceived 
Pain 
Experimental  9 3.22 
(1.92) 
2.56 
(2.07) 
1.67 
(1.50) 
 
1.78 
(2.64) 
 
2.31 
Placebo 9 2.22 
(2.39) 
2.11 
(2.52) 
2.56 
(2.88) 
2.00 
(2.78) 
2.22 
Control 9 3.00 
(2.35) 
2.67 
(2.00) 
2.67 
(1.41) 
1.56 
(1.42) 
2.47 
Total 27 2.81 
(2.19) 
2.44 
(2.14) 
2.30 
(2.02) 
1.78 
(2.28) 
--------- 
Note. Perceived pain scores range from a low of 0 to a high of 10. 
 
Table 8 
Descriptive Statistics for Pain Disability at Baseline, Week 1, Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Pain 
Disability  
Experimental  9 24.33 
(11.30) 
19.89 
(12.16) 
11.11 
(10.91) 
 
8.67 
(7.45) 
 
16.00  
Placebo 9 16.11 
(15.50) 
15.78 
(16.69) 
14.00 
(17.86) 
9.56 
(16.82) 
13.86 
Control 10 26.30 
(13.22) 
22.10 
(9.97) 
17.90 
(9.10) 
13.60 
(5.70) 
19.98 
Total 28 22.39 
(13.69) 
19.36 
(12.91) 
14.46 
(12.87) 
10.71 
(10.77) 
--------- 
Note. Pain Disability scores range from a low of 0 to a high of 70. 
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Table 9  
Descriptive Statistics for Mean Heart Rate – Rest and Mean Heart Rate – Paced at Baseline, 
Week 1, Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Mean 
Heart 
Rate - 
Rest  
Experimental  9 67.98 
(7.48) 
68.81 
(4.22) 
72.09 
(6.37) 
 
76.46 
(8.08) 
 
71.33 
Placebo 9 64.33 
(5.08) 
68.07 
(12.06) 
69.41 
(10.47) 
67.31 
(6.34) 
67.28 
Control 9 74.10 
(12.56) 
70.40 
(11.39) 
70.18 
(15.40) 
74.85 
(13.46) 
72.38 
Total 27 68.80 
(9.52) 
69.09 
(9.54) 
70.56 
(10.98) 
72.87 
(10.23) 
--------- 
Mean 
Heart 
Rate - 
Paced 
Experimental 9 70.04 
(7.10) 
68.58 
(5.02) 
70.76 
(6.95) 
75.66 
(6.66) 
71.26 
 
Placebo 9 65.58 
(4.86) 
69.70 
(12.28) 
69.61 
(10.12) 
67.76 
(7.14) 
68.16 
Control 7 74.96 
(12.04) 
70.96 
(10.41) 
71.77 
(14.00) 
75.07 
(13.79) 
73.19 
Total 25 69.82 
(8.68) 
69.65 
(9.31) 
70.63 
(10.00) 
72.65 
(9.67) 
--------- 
Note. Mean HR is measured in beats per minute (bpm). 
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Table 10 
Descriptive Statistics for SDNN – Rest and SDNN – Paced at Baseline, Week 1, Week 2, and 
Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
SDNN - 
Rest  
Experimental  9 62.52 
(27.96) 
109.11 
(39.24) 
101.43 
(36.66) 
 
87.41 
(31.37) 
 
90.12 
Placebo 9 88.28 
(33.23) 
100.44 
(55.09) 
83.99 
(36.97) 
92.93 
(33.79) 
91.41 
Control 9 71.61 
(36.09) 
76.93 
(30.99) 
84.94 
(25.27) 
76.38 
(25.81) 
77.46 
Total 27 74.14 
(33.15) 
95.49 
(43.53) 
90.12 
(33.13) 
85.57 
(30.14) 
--------- 
SDNN – 
Paced  
Experimental 9 99.23 
(26.19) 
104.36 
(32.30) 
98.38 
(29.68) 
82.82 
(24.18) 
96.20 
 
Placebo 9 115.92 
(44.05) 
130.27 
(46.65) 
116.46 
(43.14) 
117.95 
(33.59) 
120.15 
Control 7 98.72 
(43.20) 
122.52 
(46.61) 
124.19 
(48.18) 
103.07 
(40.32) 
112.13 
Total 25 105.10 
(37.56) 
118.77 
(41.81) 
112.12 
(40.18) 
101.13 
(34.79) 
--------- 
Note. SDNN = standard deviation of normal-to-normal intervals; measured in milliseconds (ms). 
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Table 11 
Descriptive Statistics for Total HRV – Rest and Total HRV – Paced at Baseline, Week 1, Week 2, 
and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Total 
HRV - 
Rest  
Experimental  9 4373.99 
(4003.15) 
12991.54 
(8815.61) 
11173.84 
(8130.79) 
 
8094.16 
(5525.49) 
 
9158.38 
Placebo 9 8581.49 
(6289.67) 
12917.80 
(13493.82) 
7504.58 
(6385.24) 
9091.39 
(6749.95) 
9523.82 
Control 9 5504.22 
(5760.63) 
6313.67 
(5130.24) 
7067.98 
(4202.07) 
5842.37 
(4649.94) 
6182.06 
Total 27 6153.23 
(5531.42) 
10741.00 
(9910.33) 
8582.14 
(6468.40) 
7675.97 
(5655.43) 
--------- 
Total 
HRV - 
Paced 
Experimental 9 9893.85 
(5071.20) 
11662.33 
(7573.81) 
10329.41 
(5394.35) 
6766.24 
(3382.51) 
9662.96 
 
Placebo 9 15138.19 
(12525.72) 
18831.65 
(13318.33) 
14834.00 
(9680.58) 
14628.40 
(7974.81) 
15858.06 
Control 7 11197.02 
(7158.39) 
16399.34 
(11104.88) 
16872.11 
(11166.32) 
11639.24 
(8088.80) 
14026.93 
Total 25 12146.70 
(8899.61) 
15569.65 
(10908.37) 
13783.02 
(8931.93) 
10961.06 
(7290.17) 
--------- 
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Table 12 
Descriptive Statistics for LF HRV – Rest and LF HRV – Paced at Baseline, Week 1, Week 2, and 
Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
LF HRV 
– Rest   
Experimental  9 1917.23 
(2192.45) 
10535.90 
(7673.33) 
7764.45 
(4229.39) 
 
6030.91 
(4375.39) 
 
6562.12 
Placebo 9 4046.28 
(5943.67) 
5436.61 
(8051.19) 
3258.58 
(4724.04) 
4819.40 
(6141.06) 
4390.22 
Control 9 2035.99 
(1776.63) 
3080.32 
(4483.46) 
2913.88 
(3880.51) 
2758.06 
(4302.20) 
2697.06 
Total 27 2666.50 
(3782.99) 
6350.94 
(7368.98) 
4645.64 
(4698.40) 
4536.13 
(5008.49) 
--------- 
LF HRV 
- Paced 
Experimental 9 7518.97 
(3724.06) 
7305.14 
(4705.26) 
7591.59 
(4193.89) 
4636.20 
(2442.96) 
6762.98 
 
Placebo 9 9654.77 
(6375.36) 
13409.81 
(9488.48) 
9980.31 
(7171.43) 
10686.00 
(7108.84) 
10932.72 
Control 7 8292.53 
(5144.29) 
11556.51 
(8587.64) 
12121.95 
(7663.42) 
8374.81 
(6366.17) 
10086.45 
Total 25 8504.45 
(5065.64) 
10693.21 
(7944.60) 
9720.03 
(6410.54) 
7860.94 
(5994.67) 
--------- 
Note. LF HRV = low frequency; measured in ms^2/Hz; HRV in frequency band of 0.04-0.15 Hz. 
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Table 13 
Descriptive Statistics for HF HRV – Rest and HF HRV – Paced at Baseline, Week 1, Week 2, and 
Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
HF HRV 
- Rest  
Experimental  9 1534.71 
(1537.12) 
1149.07 
(1102.91) 
1461.31 
(2202.09) 
 
772.17 
(1147.13) 
 
1229.32 
Placebo 9 2521.14 
(2827.32) 
4026.19 
(5632.19) 
1739.16 
(1842.60) 
1989.98 
(1331.68) 
2569.12 
Control 9 1545.27 
(2748.84) 
1357.18 
(992.79) 
1497.74 
(944.34) 
926.04 
(567.80) 
1331.56 
Total 27 1867.04 
(2394.53) 
2177.48 
(3495.73) 
1566.07 
(1681.34) 
1229.40 
(1163.71) 
--------- 
HF HRV 
- Paced 
Experimental 9 831.07 
(639.84) 
1362.45 
(1479.65) 
988.65 
(906.11) 
763.60 
(620.53) 
986.44 
 
Placebo 9 1601.82 
(1243.66) 
2239.27 
(1923.10) 
1708.43 
(1160.03) 
1252.35 
(1059.45) 
1700.47 
Control 7 1506.44 
(1527.77) 
2362.43 
(1609.57) 
2175.48 
(1843.50) 
1464.51 
(1077.33) 
1877.22 
Total 25 1297.64 
(1168.16) 
1958.10 
(1679.47) 
1580.08 
(1346.33) 
1135.81 
(938.73) 
--------- 
Note. HF HRV = high frequency; measured in ms^2/Hz; HRV in frequency band of 0.15-0.4 Hz.  
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Table 14 
Descriptive Statistics for Mean Respiration Rate – Rest and Mean Respiration Rate – Paced at 
Baseline, Week 1, Week 2, and Week 3 
   Assessment 
Variable Group n Baseline 
M (SD) 
Week 1 
M (SD) 
Week 2 
M (SD) 
Week 3 
M (SD) 
Group 
Total 
Respiration 
Rate – Rest   
Experimental  9 12.59 
(2.53) 
6.61 
(1.04) 
6.09 
(1.14) 
 
6.67 
(1.32) 
 
7.99 
Placebo 9 12.50 
(4.71) 
11.35 
(3.08) 
12.51 
(5.25) 
12.14 
(4.71) 
12.12  
Control 9 13.82 
(3.41) 
12.84 
(3.98) 
12.55 
(3.87) 
12.53 
(3.68) 
12.93 
Total 27 12.97 
(3.57) 
10.27 
(3.93) 
10.38 
(4.80) 
10.45 
(4.35) 
--------- 
Respiration 
Rate - 
Paced 
Experimental 9 7.61 
(2.08) 
6.65 
(0.75) 
6.81 
(0.93) 
6.61 
(0.99) 
6.92 
 
Placebo 9 7.25 
(1.45) 
7.09 
(1.00) 
6.99 
(1.50) 
7.14 
(1.69) 
7.12 
Control 8 7.73 
(2.12) 
7.03 
(1.05) 
6.76 
(0.76) 
7.22 
(1.54) 
7.19 
Total 26 7.52 
(1.83) 
6.92 
(0.92) 
6.86 
(1.08) 
6.98 
(1.40) 
--------- 
Note. Respiration rate = average breaths per minute. 
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Figure 1. Participant Recruitment Flow Chart.  
 
 
 
 
 
 
 
Analysis 
(n = 9) 
Analysis 
(n = 9) 
Analysis 
(n = 10) 
Assessed for Eligibility 
(N = 46) 
Refused to Participate (n = 6) 
Ineligible (n = 8) 
-­‐ Return to play (n = 7) 
-­‐ Age (n = 1) 
	  
Randomized 
(n = 32) 
Allocated to  
HRV Placebo Group (n = 11) 
Received allocated intervention  
& provided complete data (n = 9) 
Dropped out of study (n = 2) 
	  
Allocated to Control Group (n = 11) 
Received allocated intervention  
& provided complete data (n = 10) 
Dropped out of study (n = 1) 
	  
Allocated to  
HRV Experimental Group (n = 10) 
Received allocated intervention  
& provided complete data (n = 9) 
Dropped out of study (n = 1) 
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Baseline: 
HRV BFB Experimental Group Protocol: 
 
HRV BFB Placebo Group Protocol: 
 
 
 
 
 
1. Study Details 2. Informed Consent  3. Demographics Questionnaire  
4. Self-report 
Questionnaires  
5. Introduction to 
setting, equipment, 
etc. 
6. 
Psychophysiological 
Assessment  
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Control Group Protocol: 
 
Figure 2. Illustrated Overview of Research Protocol.  
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Figure 3. Image of respiration belt placement used in biofeedback procedures. 
 
 
Figure 4. Image of ECG electrode placement used in biofeedback procedures. 
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Figure 5. AD Instruments LabChart Pro 7.0 software display screen used for both biofeedback 
training sessions and psychophysiological assessments. 
 
 
 
 
 
 
 
 
 
 
 
 
HEART RATE VARIABILITY BIOFEEDBACK 118 
	  
	  
Figure 6. A graphic depiction of the interaction effect demonstrated for perceptions of task self-
efficacy across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB 
Placebo group (n=9), and Control group (n=10) injured athletes. 
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Figure 7. A graphic depiction of the interaction effect demonstrated for perceptions of coping 
self-efficacy across assessments (time) between the HRV BFB Experimental group (n=9), HRV 
BFB Placebo group (n=9), and Control group (n=10) injured athletes. 
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Figure 8. A graphic depiction of the interaction effect demonstrated for perceived stress across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=10) injured athletes. 
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Figure 9. A graphic depiction of the interaction effect demonstrated for psychological response 
to sport injury subscale of devastation across assessments (time) between the HRV BFB 
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured 
athletes. 
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Figure 10. A graphic depiction of the interaction effect demonstrated for psychological response 
to sport injury subscale of reorganization across assessments (time) between the HRV BFB 
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured 
athletes. 
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Figure 11. A graphic depiction of the interaction effect demonstrated for psychological response 
to sport injury subscale of feeling cheated across assessments (time) between the HRV BFB 
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured 
athletes. 
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Figure 12. A graphic depiction of the interaction effect demonstrated for psychological response 
to sport injury subscale of restlessness across assessments (time) between the HRV BFB 
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured 
athletes. 
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Figure 13. A graphic depiction of the interaction effect demonstrated for psychological response 
to sport injury subscale of isolation across assessments (time) between the HRV BFB 
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured 
athletes. 
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Figure 14. A graphic depiction of the interaction effect demonstrated for perceived anxiety 
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo 
group (n=9), and Control group (n=10) injured athletes. 
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Figure 15. A graphic depiction of the interaction effect demonstrated for total pain 
catastrophizing across assessments (time) between the HRV BFB Experimental group (n=9), 
HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes. 
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Figure 16. A graphic depiction of the interaction effect demonstrated for the pain catastrophizing 
subscale of rumination across assessments (time) between the HRV BFB Experimental group 
(n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes. 
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Figure 17. A graphic depiction of the interaction effect demonstrated for the pain catastrophizing 
subscale of magnification across assessments (time) between the HRV BFB Experimental group 
(n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes. 
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Figure 18. A graphic depiction of the interaction effect demonstrated for the pain catastrophizing 
subscale of helplessness across assessments (time) between the HRV BFB Experimental group 
(n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes. 
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Figure 19. A graphic depiction of the interaction effect demonstrated for perceived pain across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=9) injured athletes. 
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Figure 20. A graphic depiction of the interaction effect demonstrated for pain disability across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=10) injured athletes. 
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Figure 21. A graphic depiction of the main effect demonstrated for rehabilitation adherence – 
frequency between the HRV BFB Experimental group (n=9), HRV BFB Placebo group (n=8), 
and Control group (n=9) injured athletes. 
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Figure 22. A graphic depiction of the main effect demonstrated for rehabilitation adherence – 
duration between the HRV BFB Experimental group (n=9), HRV BFB Placebo group (n=9), and 
Control group (n=10) injured athletes. 
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Figure 23. A graphic depiction of the main effect demonstrated for rehabilitation adherence – 
quality between the HRV BFB Experimental group (n=9), HRV BFB Placebo group (n=9), and 
Control group (n=10) injured athletes. 
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Figure 24. A graphic depiction of the interaction effect demonstrated for mean HR – rest across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=9) injured athletes. 
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Figure 25. A graphic depiction of the interaction effect demonstrated for mean HR – paced 
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo 
group (n=9), and Control group (n=7) injured athletes. 
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Figure 26. A graphic depiction of the interaction effect demonstrated for SDNN – rest across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=9) injured athletes. 
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Figure 27. A graphic depiction of the interaction effect demonstrated for SDNN – paced across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=7) injured athletes. 
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Figure 28. A graphic depiction of the interaction effect demonstrated for total HRV – rest across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=9) injured athletes. 
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Figure 29. A graphic depiction of the interaction effect demonstrated for total HRV – paced 
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo 
group (n=9), and Control group (n=7) injured athletes. 
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Figure 30. A graphic depiction of the interaction effect demonstrated for LF HRV – rest across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=9) injured athletes. 
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Figure 31. A graphic depiction of the interaction effect demonstrated for LF HRV – paced across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=7) injured athletes. 
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Figure 32. A graphic depiction of the interaction effect demonstrated for HF HRV – rest across 
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group 
(n=9), and Control group (n=9) injured athletes. 
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Figure 33. A graphic depiction of the interaction effect demonstrated for HF HRV – paced 
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo 
group (n=9), and Control group (n=7) injured athletes. 
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Figure 34. A graphic depiction of the interaction effect demonstrated for mean respiration rate – 
rest across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB 
Placebo group (n=9), and Control group (n=9) injured athletes. 
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Figure 35. A graphic depiction of the interaction effect demonstrated for mean respiration rate – 
paced across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB 
Placebo group (n=9), and Control group (n=8) injured athletes. 
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Appendix A 
Wilfrid Laurier 
University 
 
Founded 1911 
 
Letter of Information 
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological Response 
Following Injury 
 
Lead researcher: Scott Rollo 
Supervisor: Jill Tracey, Ph.D. 
 
We are conducting a research study and would greatly appreciate it if you would be willing to assist us.  
The purpose of this letter is to provide you with some details regarding the proposed study.  
 
The purpose of this study is to evaluate the effectiveness of heart rate variability biofeedback (HRV 
BFB), a form of psychophysiological skills training intervention, to improve athletes’ psychological 
responses following an injury.  Further, to examine the effects of HRV BFB training on self-efficacy, 
perceived stress and anxiety, pain management, and the psychological responses of injured athletes.  HRV 
BFB effects on athletes’ physiological indices including heart rate variability, heart rate, and respiration 
rate will also be assessed.  
 
A potential contribution of this research is to assess whether using biofeedback in rehabilitation can serve 
as a helpful intervention for those recovering from an injury.  While other techniques have been used 
within sport psychology, the use of biofeedback is a novel and new approach within the athletic 
rehabilitation setting.  If successful, this research could speak to the effectiveness of biofeedback as an 
available and useful rehabilitation tool within the athletic injury population.  Biofeedback has the 
potential of improving the injured athletes’ psychological response and reducing emotional distress 
throughout their recovery.  Participants may be given the opportunity to obtain improved self-regulation 
of mood states and arousal, effective relaxation techniques, and greater ability to cope when faced with 
stressors regarding rehabilitation. 
 
Participants will be randomly assigned to one of three study groups. These groups involve a HRV BFB 
experimental group, HRV BFB placebo group, and one group that will receive no training and act as a 
control group. Participants assigned to either the HRV BFB experimental group or HRV BFB placebo 
group will receive six BFB training sessions over a 3-week duration. Participants assigned to the control 
group will receive no training. Psychological outcome questionnaires (to measure: self-efficacy, 
perceived stress, anxiety, pain management & psychological responses of injured athletes) and a 
physiological assessment (to measure: HR, HRV, & respiratory rate) will be administered on four 
occasions over a 3-week duration for all participants. Data will be collected to examine the emotional 
experience and psychological responses of injured athletes as they progress through injury recovery. 
Different groups are required in order to evaluate if athletes' psychological responses regarding injury and 
rehabilitation differ depending on the specific training they receive. It is important to conceal this 
information (i.e., true purpose, study objectives, procedures), as we want behaviour to remain as 
natural as possible. Initial deception and/or concealment is neither arbitrary nor capricious.  
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This project has been reviewed and approved by the University Research Ethics Board. If you have any 
questions and/or ethical concerns surrounding this study, you may contact Dr. Robert Basso, Chair, 
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225 or 
rbasso@wlu.ca. 
 
In order to assist us in the recruitment process, we are asking that you provide your clients, who you 
know to be injured athletes, with a recruitment poster.  Your client’s participation is completely voluntary 
and it is their decision as to whether they contact myself, Scott Rollo to take part in the study.  If you are 
willing to provide assistance by helping with recruitment for our research project, please contact either 
Scott Rollo or Dr. Jill Tracey, by phone or email ASAP.  
 
Thank you. 
 
Scott Rollo MSc(c), BA 
Department of Kinesiology & Physical Education 
Wilfrid Laurier University 
Waterloo, ON N2L 3C5 
roll2100@mylaurier.ca  
(226) 678-4926 
 
Dr. Jill Tracey  
Associate Professor/Sport Psychology Consultant 
Wilfrid Laurier University 
Department of Kinesiology & Physical Education 
Waterloo, ON N2L 3C5 
jtracey@wlu.ca 
(519) 884-0710 ext. 4216 
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Appendix C 
Wilfrid Laurier 
University 
 
Founded 1911 
 
Letter of Information 
An Examination of Athletes’ Psychological Response Following Injury 
Lead researcher: Scott Rollo 
Supervisor: Jill Tracey, Ph.D. 
 
You are invited to participate in a study as a varsity athlete who has sustained an injury and is currently in 
the recovery process.  The purpose of this study is to examine the psychological response of athletes 
regarding the injury and rehabilitation process. We are interested in assessing various psychological 
outcomes and physiological measures (i.e., heart rate variability, respiration, self-efficacy, stress, anxiety, 
pain management & psychological responses of injured athletes) as you progress through different phases 
of injury recovery. 
 
You will be asked to complete a series of questionnaires and physiological assessments over three weeks.  
The questionnaires should take approximately 15-20 minutes to complete.  The physiological assessment 
will also be 20 minutes in duration.  Data will be collected to examine the emotional experience and 
psychological responses of injured athletes as they progress through injury recovery.  All study 
participants will receive a $10 gift certificate to Tim Hortons at study completion.  
 
This project has been reviewed and approved by the University Research Ethics Board (REB #3670).  
Any results found will be for the use of research only, and will have no impact or influence on your 
athletic therapist’s recommendations to return to play.  If you are interested in participating, please 
contact myself, Scott Rollo by email at roll2100@mylaurier.ca or provide your contact information 
below.  
 
Thank you. 
 
Scott Rollo  
MSc Graduate Student  
Department of Kinesiology & Physical Education 
Wilfrid Laurier University 
Waterloo, ON N2L 3C5 
roll2100@mylaurier.ca  
(226) 678-4926 
------------------------------------------------------------------------------------------------------------------------------- 
Potential Participant Name: _____________________________________________________ 
 
Email Address: _______________________________________________________________ 
 
Phone Number (optional): _______________________________________________________ 
 
Injury: _______________________________________________________________________ 
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Appendix D 
 
Proposed Recruitment Screening Email 
 
Hello (Insert Name),  
 
Thank you for your interest in participating in this research study. Please confirm your eligibility 
to participate in this study by ensuring you meet all criteria listed below:  
 
(A) You are at least 16 years of age 
(B) You recently sustained your injury during participation in sport/athletic activity 
(C) Your injury is not a concussion and/or head injury 
(D) You are currently out of practice and/or competition for the sport in which your injury 
occurred 
(E) You are currently undergoing rehabilitation for your injury 
(F) You are an athlete at a competitive level (i.e., regional, rep, varsity, provincial, national, 
etc.) and/or engage in your sport in a competitive environment (i.e., adult competitive 
league, training for specific events, road races, competitions, etc.) 
(G) You have no known heart condition (i.e., heart abnormalities and/or cardiac arrhythmias) 
(H) You have no history/current diagnosis of coronary artery disease, heart disease, heart 
failure, high blood pressure, and/or chronic low blood pressure 
(I) You are not currently receiving any formal training in any form of relaxation, 
biofeedback, or breathing technique. 
 
If you meet all of the above criteria, you are deemed eligible for participation in this study.  
If participation is still of interest to you, please respond to this email with a few dates and times, 
according to your schedule, when you would be available to meet for a baseline assessment 
session.  
This baseline session will be held in the Physiology Laboratory in the Athletic Complex at 
Wilfrid Laurier University. At this time, you will be provided with an informed consent to sign if 
you wish to continue with study participation, and study details in greater length. 
 
If you have any additional questions or require clarification of any kind, please do not hesitate to 
include in any email response you provide.  
 
Look forward to hearing from you! 
 
Scott Rollo 
Department of Kinesiology & Physical Ed. 
Wilfrid Laurier University 
Waterloo, ON, Canada, N2L 3C5 
roll2100@mylaurier.ca 
 
BA. Hon. Kinesiology 2012 
University of Western Ontario 
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Appendix E 
 
INFORMED CONSENT 
 
WILFRID LAURIER UNIVERSITY 
 
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological 
Response Following Injury 
 
You are invited to participate in a research study. As part of the thesis requirement for 
completion of a Master’s of Science degree at Wilfrid Laurier, Scott Rollo, a graduate student in 
the Department of Kinesiology and Physical Education, and Dr. Jill Tracey, an associate 
professor in the Department of Kinesiology and Physical Education are completing a research 
study. The purpose of this study is to evaluate the effectiveness of biofeedback, a form of 
psychological skills training intervention during your injury rehabilitation process. We will be 
assessing various psychological outcomes/physiological measures (i.e., heart rate variability, 
respiration, self-efficacy, stress, anxiety, pain management & psychological responses of injured 
athletes) as you progress through injury recovery.  
 
INFORMATION 
Your participation in this study is strictly voluntary. You may withdraw from the study at 
anytime during the 3 weeks if you have initially chosen to participate. You are being asked to 
complete a series of questionnaires, in addition to a physiological assessment on four occasions 
and to participate in a biofeedback intervention. The questionnaires should take approximately 
15-20 minutes to complete. The physiological assessment will also be 20 minutes in duration. If 
for any reason you are uncomfortable with a question you do not have to respond. You may also 
withdraw from the study at any time without penalty and without loss of benefits to which you 
are otherwise entitled. The biofeedback portion of the study will involve meeting with Scott in 
the physiology lab at Wilfrid Laurier University on 9 occasions (3x/week). During the 
intervention sessions, you will be guided through a biofeedback training protocol and instructed 
to practice paced breathing using a pursed lips abdominal procedure. Heart rate and respiration 
will be monitored throughout. Additionally, your health care professionals will not be aware of 
your participation in this study and therefore your decision to participate or not will have no 
effect on your ongoing rehabilitation outside of this study. Study objectives cannot be fully 
described at this time, but at the conclusion of participation, an explanation will be provided. 
  
RISKS AND BENEFITS 
This project will add to the body of research in this area of sports psychology and injury 
rehabilitation. While other techniques have been used within sport psychology, the use of 
biofeedback is a novel and new approach within the athletic injury population. A potential 
benefit is to assess whether using biofeedback in athletic rehabilitation can serve as a helpful 
intervention for those recovering from an injury. The only foreseeable risks to you as a 
participant would be potential boredom during completion of the questionnaires, physiological 
assessment, and/or biofeedback training sessions.  
 
CONFIDENTALITY  
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All foreseeable efforts will be made to insure your confidentiality during the data collection, 
publication and presentation of the data. The information you provide will be accessible only to 
Dr. Jill Tracey and Scott Rollo. It is expected that there will be approximately 30 participants. 
You will not be identified by name in any of the data presentation. Additionally, your name will 
not be used in any publication or presentation of this research instead participant number will be 
assigned. Also, neither your health care professionals and/or coaches will know whether you 
have participated in this study or the information you have provided unless you choose to discuss 
it with them. Your data will be retained for 5 years in a locked office at Wilfrid Laurier 
University accessible only to Dr. Jill Tracey and Scott Rollo as required by the Research Ethics 
Board. 
 
COMPENSATION 
If you participate in the study you will receive a $10 gift certificate to Tim Hortons at study 
completion.  
 
CONTACT 
If you have any questions at any time about this study of the procedures (or you have 
experienced adverse effects as a result of participating in this study) you may contact Dr. Jill 
Tracey at Wilfrid Laurier University at 519-884-0710 extension 4216. This project has been 
reviewed and approved by the University Research Ethics Board. If you feel you have not been 
treated according to the description in this form, or your rights as a participant in research have 
been violated during the course of this project you may contact Dr. Robert Basso, Chair, 
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225 
or rbasso@wlu.ca. 
 
FEEDBACK AND PUBLICATION 
You can receive feedback regarding the study’s findings by contacting the researcher, Scott 
Rollo. The information from this research project will be submitted, upon completion, for 
publication in various sports psychology and sport rehabilitation journals as well as presented at 
relevant conferences.  
 
CONSENT 
I have read and understand the above information. I have received a copy of this form. I agree to 
participate in this study. 
 
Participant’s signature____________________________ Date______________________ 
 
Investigator’s signature___________________________ Date ______________________ 
 
 
If you agree to be contacted to participate in this research study please provide your email 
address and/or phone number for correspondence with the researcher and to allow confirmation 
of scheduled sessions. 
______________________________________    ______________________________________ 
Email Address      Phone Number 
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Appendix F 
 
INFORMED CONSENT 
 
WILFRID LAURIER UNIVERSITY 
 
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological 
Response Following Injury 
 
You are invited to participate in a research study. As part of the thesis requirement for 
completion of a Master’s of Science degree at Wilfrid Laurier, Scott Rollo, a graduate student in 
the Department of Kinesiology and Physical Education, and Dr. Jill Tracey, an associate 
professor in the Department of Kinesiology and Physical Education are completing a research 
study. The purpose of this study is to evaluate the effectiveness of biofeedback, a form of 
psychological skills training intervention during your injury rehabilitation process. We will be 
assessing various psychological outcomes/physiological measures (i.e., heart rate variability, 
respiration, self-efficacy, stress, anxiety, pain management & psychological responses of injured 
athletes) as you progress through injury recovery. 
 
INFORMATION 
Your participation in this study is strictly voluntary. You may withdraw from the study at 
anytime during the 3 weeks if you have initially chosen to participate. You are being asked to 
complete a series of questionnaires, in addition to a physiological assessment on four occasions 
and to participate in a biofeedback intervention. The questionnaires should take approximately 
15-20 minutes to complete. The physiological assessment will also be 20 minutes in duration. If 
for any reason you are uncomfortable with a question you do not have to respond. You may also 
withdraw from the study at any time without penalty and without loss of benefits to which you 
are otherwise entitled. The biofeedback portion of the study will involve meeting with Scott in 
the physiology lab at Wilfrid Laurier University on 9 occasions (3x/week). During the 
intervention sessions, you will be instructed to relax and continue your normal resting breathing 
pattern. Heart rate and respiration will be monitored throughout. Additionally, your health care 
professionals will not be aware of your participation in this study and therefore your decision to 
participate or not will have no effect on your ongoing rehabilitation outside of this study. Study 
objectives cannot be fully described at this time, but at the conclusion of participation, an 
explanation will be provided. 
  
RISKS AND BENEFITS 
This project will add to the body of research in this area of sports injury psychology and 
rehabilitation. While other techniques have been used within sport psychology, the use of 
biofeedback is a novel and new approach within the athletic injury population. A potential 
benefit is to assess whether using biofeedback in athletic rehabilitation can serve as a helpful 
intervention for those recovering from an injury. The only foreseeable risks to you as a 
participant would be potential boredom during completion of the questionnaires, physiological 
assessment, and/or biofeedback training sessions.  
 
CONFIDENTALITY  
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All foreseeable efforts will be made to insure your confidentiality during the data collection, 
publication and presentation of the data. The information you provide will be accessible only to 
Dr. Jill Tracey and Scott Rollo. It is expected that there will be approximately 30 participants. 
You will not be identified by name in any of the data presentation. Additionally, your name will 
not be used in any publication or presentation of this research instead participant number will be 
assigned. Also, neither your health care professionals and/or coaches will know whether you 
have participated in this study or the information you have provided unless you choose to discuss 
it with them. Your data will be retained for 5 years in a locked office at Wilfrid Laurier 
University accessible only to Dr. Jill Tracey and Scott Rollo as required by the Research Ethics 
Board. 
 
COMPENSATION 
If you participate in the study you will receive a $10 gift certificate to Tim Hortons at study 
completion.  
 
CONTACT 
If you have any questions at any time about this study of the procedures (or you have 
experienced adverse effects as a result of participating in this study) you may contact Dr. Jill 
Tracey at Wilfrid Laurier University at 519-884-0710 extension 4216. This project has been 
reviewed and approved by the University Research Ethics Board. If you feel you have not been 
treated according to the description in this form, or your rights as a participant in research have 
been violated during the course of this project you may contact Dr. Robert Basso, Chair, 
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225 
or rbasso@wlu.ca. 
 
FEEDBACK AND PUBLICATION 
You can receive feedback regarding the study’s findings by contacting the researcher, Scott 
Rollo. The information from this research project will be submitted, upon completion, for 
publication in various sports psychology and sport rehabilitation journals as well as presented at 
relevant conferences.  
 
CONSENT 
I have read and understand the above information. I have received a copy of this form. I agree to 
participate in this study. 
 
Participant’s signature____________________________ Date______________________ 
 
Investigator’s signature___________________________ Date ______________________ 
 
 
If you agree to be contacted to participate in this research study please provide your email 
address and/or phone number for correspondence with the researcher and to allow confirmation 
of scheduled sessions. 
______________________________________    ______________________________________ 
Email Address      Phone Number 
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Appendix G 
 
INFORMED CONSENT  
 
WILFRID LAURIER UNIVERSITY 
 
An Examination of Athletes’ Psychological Response Following Injury 
 
You are invited to participate in a research study. As part of the thesis requirement for 
completion of a Master’s of Science degree at Wilfrid Laurier, Scott Rollo, a graduate student in 
the Department of Kinesiology and Physical Education, and Dr. Jill Tracey, an associate 
professor in the Department of Kinesiology and Physical Education are completing a research 
study. The purpose of this study is to examine the psychological response of athletes regarding 
the injury and rehabilitation process as they progress through injury recovery. We will be 
assessing various psychological outcomes and physiological measures (i.e., heart rate variability, 
respiration, self-efficacy, stress, anxiety, pain management & psychological responses of injured 
athletes) as you progress through different phases of injury rehabilitation. 
 
INFORMATION 
Your participation in this study is strictly voluntary. You may withdraw from the study at 
anytime during the 3 weeks if you have initially chosen to participate. You are being asked to 
complete a series of questionnaires, in addition to a physiological assessment on four occasions. 
The questionnaires should take approximately 15-20 minutes to complete. The physiological 
assessment will also be 20 minutes in duration. If for any reason you are uncomfortable with a 
question you do not have to respond. You may also withdraw from the study at any time without 
penalty and without loss of benefits to which you are otherwise entitled. Additionally, your 
health care professionals will not be aware of your participation in this study and therefore your 
decision to participate or not will have no effect on your ongoing rehabilitation outside of this 
study. Study objectives cannot be fully described at this time, but at the conclusion of 
participation, an explanation will be provided. 
 
 RISKS AND BENEFITS 
This project will add to the body of research in this area of sports injury psychology and 
rehabilitation. A potential benefit from this study is to gain a better understanding of the 
psychological recovery from athletic injury, and consequently, to better assist injured athletes 
during their rehabilitation process. The only foreseeable risks to you as a participant would be 
potential boredom during completion of the questionnaires and/or physiological assessment. 
 
CONFIDENTALITY  
All foreseeable efforts will be made to insure your confidentiality during the data collection, 
publication and presentation of the data. The information you provide will be accessible only to 
Dr. Jill Tracey and Scott Rollo. It is expected that there will be approximately 30 participants. 
You will not be identified by name in any of the data presentation. Additionally, your name will 
not be used in any publication or presentation of this research instead participant number will be 
assigned. Also, neither your health care professionals and/or coaches will know whether you 
have participated in this study or the information you have provided unless you choose to discuss 
it with them. Your data will be retained for 5 years in a locked office at Wilfrid Laurier 
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University accessible only to Dr. Jill Tracey and Scott Rollo as required by the Research Ethics 
Board. 
 
COMPENSATION 
If you participate in the study you will receive a $10 gift certificate to Tim Hortons at study 
completion.  
 
CONTACT 
If you have any questions at any time about this study of the procedures (or you have 
experienced adverse effects as a result of participating in this study) you may contact Dr. Jill 
Tracey at Wilfrid Laurier University at 519-884-0710 extension 4216. This project has been 
reviewed and approved by the University Research Ethics Board. If you feel you have not been 
treated according to the description in this form, or your rights as a participant in research have 
been violated during the course of this project you may contact Dr. Robert Basso, Chair, 
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225 
or rbasso@wlu.ca. 
 
FEEDBACK AND PUBLICATION 
You can receive feedback regarding the study’s findings by contacting the researcher, Scott 
Rollo. The information from this research project will be submitted, upon completion, for 
publication in various sports psychology and sport rehabilitation journals as well as presented at 
relevant conferences.  
 
CONSENT 
I have read and understand the above information. I have received a copy of this form. I agree to 
participate in this study. 
 
Participant’s signature____________________________ Date______________________ 
 
Investigator’s signature___________________________ Date ______________________ 
 
 
If you agree to be contacted to participate in this research study please provide your email 
address and/or phone number for correspondence with the researcher and to allow confirmation 
of scheduled sessions. 
______________________________________    ______________________________________ 
Email Address      Phone Number 
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Appendix H 
 
 
June 17, 2013 
 
Dear Andrew Scott, 
 
REB # 3670 
Project, "Effects of a Heart Rate Variability Biofeedback Intervention on Athletes' Psychological 
Response Following Injury" 
Expiry Date: May 04, 2014 
 
The Research Ethics Board of Wilfrid Laurier University has reviewed the above proposal and 
determined that the proposal is ethically sound.  If the research plan and methods should change 
in a way that may bring into question the project's adherence to acceptable ethical norms, please 
submit a "Request for Ethics Clearance of a Revision or Modification" form for approval before 
the changes are put into place.  This form can also be used to extend protocols past their expiry 
date, except in cases where the project is more than four years old. Those projects require a new 
REB application. 
 
Please note that you are responsible for obtaining any further approvals that might be required to 
complete your project. 
 
If any participants in your research project have a negative experience (either physical, 
psychological or emotional) you are required to submit an "Adverse Events Form" to the 
Research Office within 24 hours of the event. 
 
According to the Tri-Council Policy Statement, you must complete the "Annual/Final Progress 
Report on Human Research Projects" form annually and upon completion of your project.  All 
forms, policies and procedures are available via the REB 
website: http://www.wlu.ca/research/reb. 
 
All the best for the successful completion of your project. 
 
Yours sincerely, 
 
 
 
Robert Basso, PhD 
Chair, University Research Ethics Board  
Wilfrid Laurier University 
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Appendix I 
Wilfrid Laurier 
University 
 
Founded 1911 
 
Post-Study Letter of Information 
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological Response 
Following Injury 
Lead researcher: Scott Rollo 
Supervisor: Jill Tracey, Ph.D. 
 
We appreciate your participation in our study and want to thank you for spending the time to help us with 
our research project. The purpose of this letter is to provide some extra details about the completed study. 
Originally, you were informed that the study was designed to examine the psychological response of 
athletes regarding the injury and rehabilitation process. You were told that various psychological 
measures and physiological indices would be measured as you progressed through your injury recovery. 
While this was a purpose of the investigation, complete study objectives have been only partially 
disclosed, and there was more involved than originally explained.   
 
The true purpose of this study was to evaluate the effectiveness of heart rate variability biofeedback 
(HRV BFB), a form of psychological skills training intervention, to improve athletes’ psychological 
response following an injury.  Further, to examine the effects of HRV BFB training on self-efficacy, 
perceived stress and anxiety, pain management, and the psychological responses of injured athletes.  HRV 
BFB effects on athletes’ physiological indices including HRV, HR, and respiration rate were also 
assessed.  
 
Upon study recruitment and being deemed eligible for study participation, you were randomly assigned to 
one of three study groups. These groups involved a HRV BFB experimental group, HRV BFB placebo 
group, and one group that received no training and acted as a control group. Participants assigned to either 
the HRV BFB experimental group or HRV BFB placebo group received six BFB training sessions over a 
3-week duration. Participants assigned to the control group received no training. Psychological outcome 
questionnaires (measuring: self-efficacy, perceived stress, anxiety, pain management & psychological 
responses of injured athletes) and the physiological assessment (measuring: HR, HRV, & respiratory rate) 
were administered on four occasions over a 3-week duration for all participants. Data was collected to 
examine the emotional experience and psychological responses of injured athletes as they progressed 
through injury recovery. Different groups were required in order to evaluate if athletes' psychological 
responses regarding injury and rehabilitation differed depending on the specific training they received. It 
was important to conceal this information (i.e., true purpose, study objectives, procedures) as we wanted 
behaviour to remain as natural as possible. Initial deception and/or concealment was neither arbitrary nor 
capricious. In the interest of your right to withdraw at any time, you are now given the option to remove 
your information from this research.  
 
A potential contribution of this research is to assess whether using biofeedback in rehabilitation can serve 
as a helpful intervention for those recovering from an injury. While other techniques have been used 
within sport psychology, the use of biofeedback is a novel and new approach within the athletic 
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rehabilitation setting. If successful, this research could speak to the effectiveness of biofeedback as an 
available and useful rehabilitation tool within the athletic injury population. 
 
We apologize for not providing you with complete and accurate information about the purpose, 
objectives, and procedures of the study, but we hope that you understand why this was necessary to truly 
understand the effects. This project has been reviewed and approved by the University Research Ethics 
Board. If you feel that you have not been treated according to the descriptions in this form, or your rights 
as a participant in research have been violated during the course of this project, you may contact Dr. 
Robert Basso, Chair, University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, 
extension 5225 or rbasso@wlu.ca. 
 
We truly appreciate your participation in this study, and hope that you achieve a healthy and successful 
recovery from your injury! 
 
Scott Rollo MSc(c), BA 
Department of Kinesiology & Physical Education 
Wilfrid Laurier University 
Waterloo, ON N2L 3C5 
roll2100@mylaurier.ca  
(519) 884-0710 ext. 4216 
	  
	  
	  
 
 
 
 
 
 
 
 
 
 
HEART RATE VARIABILITY BIOFEEDBACK 162 
Appendix J 
Demographics Questionnaire 
 
Please take a moment to complete the following questionnaire. 
 
Name:  
 
Age: 
 
Sex:  Male  ☐           Female  ☐ 
 
Prior to your current injury, have you had any previous history of athletic injury?  
 
 YES          NO 
 
If YES, please specify: 
 
 
What sport(s) were you participating in before sustaining your current injury? 
 
 
During participation in which sport/athletic activity did your current injury occur? 
 
 
For the sport in which you sustained your injury, what is the level of competition you are 
involved in? Please circle the appropriate response and specify the club/team/organization 
you are a part of.  
 
Regional Team/Club   ____________________ 
Varsity/University Level (i.e., OUA) _________________________ 
Provincial _________________________ 
National __________________________ 
Other  _______________________________ 
 
What type of injury did you sustain (Location on body)? Please Circle. 
 
Shoulder          Hip          Leg          Knee          Ankle          Other _________________________ 
 
When did you sustain your injury? Please check the one that applies. 
 
Less than a week ago  ☐ 
More than a week ago, Less than a month ago  ☐ 
More than a month ago  ☐ 
 
Are you currently out of practice and/or competition for the sport in which you sustained 
your injury?  
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YES          NO        
 
How long have you been told that you will be unable to participate in training and/or 
competition for your sport? 
 
 
Are you currently undergoing rehabilitation for your injury (i.e. physiotherapy, sports 
medicine, acupuncture, massage therapy, etc.)? 
 
YES          NO 
 
If YES, please specify: 
______________________________________________________________________________ 
 
Do you have a known heart condition (i.e., heart abnormalities, cardiac arrhythmias)? 
 
YES          NO 
 
Do you have a history and/or current diagnosis of any of the following?  
 
Coronary artery disease          YES    NO 
Heart disease            YES NO  
Heart failure                            YES    NO 
Hypertension   YES    NO 
Chronic low blood pressure    YES    NO 
Kidney disease                        YES    NO 
 
Are you currently receiving any formal training in any form of relaxation, biofeedback, 
and/or breathing technique? 
 
YES          NO 
 
If YES, please specify:  
______________________________________________________________________________ 
 
Are you receiving/participating in another psychological intervention (i.e., modeling, 
imagery, stress management training) of any kind? 
 
YES          NO 
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Appendix L 
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Appendix M 
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Appendix N 
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Appendix O 
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Appendix P 
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Appendix Q 
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Appendix R 
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Glossary 
Frequency-domain HRV Measures: Spectrum of oscillatory components.  Frequency-domain 
methods involve a series of normalized IBI values to be processed through a mathematical 
operation, such as a fast Fourier transform (FFT), to analyze the frequency information contained 
in the recording.  The result is displayed on a power spectrum, which shows a breakdown of all 
the frequencies (oscillations) contained in each epoch.   
HRV: Heart rate variability (HRV) refers to the beat-to-beat changes in the duration of RR 
intervals (RRIs) in the electrocardiogram (ECG).  Further, HRV can be expressed as variability 
in the duration of interbeat intervals (IBIs) between consecutive heart beats.  
Injury Severity: The number of days that have elapsed from the date of injury to the date of the 
player’s return to full participation in team training and availability for match selection. 
Moderate Athletic Injury: Classified as an injury with 8-28 days elapsing from the date of 
injury to the date of the player’s return to full participation in team training and availability for 
match selection. 
Respiratory Sinus Arrhythmia (RSA): Variation in HR that accompanies respiration. 
Resonant Frequency: The frequency of breathing, or respiratory rate, at which high-amplitude 
HR oscillations are evoked, and power is maximized.  The respiratory frequency at which RSA 
is maximized.  
Severe Athletic Injury: Classified as an injury extending up to 428 days from the date of injury 
to the date of the player’s return to full participation in team training and availability for match 
selection.  
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Time-domain HRV Measures: Changes in HRV over time. 
 
 
 
 
 
 
